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Abstract 
RNA editing is a conserved posttranscriptional mechanism diversifying RNA and proteins 
from limited genetic information. A to I editing is carried out by ADARs (Bass). Editing has 
profound effect in various biological processes as anti-viral defense, alternation of splicing, 
codon changes and modulation of microRNA processing. 
Editing deregulation has been linked to CNS diseases as depression and epilepsy. Recently, 
global hypoediting has been found in tumor tissues indicating a correlation between editing 
and cancer. Until now, splicing and post translational modifications are proposed to modulate 
ADAR2 activity. To identify potential cellular modulators of ADAR 2 activity a yeast-editing 
assay was established. In this assay, an amber stop codon located in a stem loop in the 5’ 
region of the URA3 gene can be edited into a tryptophan codon by ADAR2. Conversion of 
the amber codon to a tryptophan codon thereby allows URA3 expression. However, addition 
of the drug 5-FOA selectively kills the cells expressing URA3. To identify cellular proteins 
that inhibit editing, a human cDNA library was transformed into the reporter strain. In the 
presence of 5-FOA only colonies that fail to express URA3, i.e colonies in which editing was 
inhibited could grow. A tissue culture reporter assay was established for secondary screening 
of the potential inhibitors in the mammalian system. Three RNA binding candidate proteins 
RPS-14 (small subunit ribosomal protein 14), SFRS-9 (splicing factor, arginine/serine rich 9), 
and DDX-15 (DEAH-box protein 15, pre-mRNA processing factor) were isolated from this 
screen as inhibitors of editing in mammalian cells. Further co-localization and co-
immunoprecipitation studies are done in order to dissect the mode of interaction. RPS-14 and 
SFRS-9 were found to interact with ADAR2. RPS-14, SFRS-9, and DDX-15 show editing 
inhibition on endogenous substrates. DDX-15 entailed ADAR2 activity inhibition is 
conserved in Caenorhabditis elegans when compared to other RNA helicases. 
Our results indicate that RPS-14, SFRS-9 and DDX-15 are potential cellular inhibitors of 
ADAR2 mediated editing, proving the functionality of the candidates in mammalian cells.  
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Zusammenfassung 
RNA-editing ist ein konservierter Mechanismus zur Diversifizierung der RNA von der 
genetisch codierten Information. Adenosin zu Inosin (A zu I) Editing bewirkt eine 
Informationsänderung an der RNA von A zu G  und wird durch Doppelsträngige RNA 
spezifische Adenosin Deaminasen (ADARs)positionsabhängig  katalysiert. Die biologische 
Bedeutung von Editing ist weitreichend und umfasst antivirale Mechanismen, alternatives 
Splicing, selektive Codonumwandlung, als auchModulierung der microRNA Prozessierung. 
Defekte in der Regulation des RNA Editings werden mit verschiedenen neuronalen 
Erkrankungen des Menschen in Verbindung gebracht wie Depression und Epilepsie. Auch 
wurde vermindertes RNA Editing als Eigenschaft von Tumorgewebe identifiziert. 
Bislang wird angenommen, dass die Aktivität von ADAR2 über RNA Splicing und post-
translationelle Modifikationen reguliert wird. Um potentielle Modulatoren der ADAR2 
Proteinaktivität zu identifizieren, wurde ein Editing System in Hefe konstruiert. Dieses 
System enthält ein mutiertes URA3 Gen, in dessen 5‘ Region ein UAG Stop Codon liegt, 
dieses jedoch durch ADAR2 in ein codierendes Tryptophan Codon editiert wird. Die 
Konvertierung dieses internen Stop Codons gestattet in Folge die Expression von URA3. 
Durch Anwesenheit des Selektionsmittels 5-FOA (5-Fluororotsäure) wird nun das Wachstum 
der URA3 exprimierenden Zellen jedoch verhindert. Um Editing inhibierende Proteine zu 
finden, wurde eine humane cDNA Bibliothek in das Systemtransformiert. Durch 5-FOA 
können Kolonien nur aus jenen Transformanten hervorgehen, in denen ADAR2 Editing 
inhibiert wurde. DiecDNA möglicher Editinginhibitoren wurde aus den gewonnenen 
Transformanten isoliert. 
Um die Relevanz potentieller ADAR2 Inhibitoren in Säugerzellen zu bestimmen, wurde für 
die Sekundäranalyse ein Zellkulturreportersystem in Säugerzellen etabliert und eingesetzt.  
Letztlich konnten drei RNA bindende Proteine, RPS-14 (kleine ribosomale Untereinheit, 
Protein 14), SFRS-9 (Splicing Faktor, Arginin/Serin-reich 9), und DDX-15 (DEAH-box 
protein 15), als wahrscheinliche Editing-Inhibitoren identifiziert werden. 
Mittels Kolokalisations- und Koimmunopräzipitationsexperimenten konnten RPS-14 und 
SFRS-9  als ADAR2-Interaktoren identifiziert werden. Weiters konnte für RPS-14, SFRS-9 
und DDX-15 eine Beteiligung in der Editing-Inhibierung an endogenen ADAR2 Substraten 
nachgewiesen werden. Zudem konnte die Editing inhibierende Aktivität von DDX-15im 
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Fadenwurm Caenorhabditis elegans wiedergefunden werden, Indiz für einen konservierten 
Mechanismus. 
Unsere Resulate lassen daher auf die erfolgreiche Identifikation von drei bisher unbekannten 
Inhibitoren des ADAR2 vermittelten RNA Editings, RPS-14, SFRS-9 und DDX-15, 
schliessen. 
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INTRODUCTION 
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1.1 RNA modification 
The realization of the enormous diversity found in eukaryotic gene expression at the RNA level 
has helped to solve a biological paradigm of recent years: The result of the human genome 
sequencing project has revealed a similar number of protein coding genes in humans, C. elegans, 
and Drosophila. However, post transcriptional and post translational modifications can provide 
an additional level of intricacy to gene expression (Licatalosi and Darnell, 2010). Nascent 
transcripts produced after transcription are processed into mature transcripts via 5’capping, 
polyadenylation and splicing. Apart from RNA processing, to this end 109 RNA modifications 
have been found. The majority of these post transcriptional modifications catalyzed by RNA 
modifying enzymes are encompassing tRNA (Cantara et al., 2011).  
RNA Editing  
RNA editing is an evolutionary conserved, targeted sequence alteration mechanism that can 
involve insertion, deletion, or substitution of individual bases (Bass, 2002b). It is a dynamic and 
versatile base recoding phenomenon which can modify a broad array of protein coding mRNAs 
and many non-coding RNAs. Various forms of RNA editing occur in metazoa giving rise to 
intricate complexity occurred during mammalian evolution (Mehler and Mattick, 2007). 
1.2 Deletion and insertion RNA editing 
This type of RNA editing was discovered by Benne and colleagues when reading frame shifts 
were observed in the mRNA encoding cytochrome oxidase II (cox2) of kinetoplasts in 
Trypanosoma brucei and Crithidia fasciculata due to the insertion of 4 uridine residues (Benne 
et al., 1986; Licatalosi and Darnell, 2010). The extent of RNA editing is so immense in 
kinetoplasts that it can change up to 90% of the codons within a reading frame. One such 
example is cytochrome oxidase III  gene of Trypanosoma brucei in which editing affects 60% of 
all nucleotides by inserting 550 uridines and deleting 41others (Feagin et al., 1988). The 
mitochondria of trypanosomes consist of thousands of minicircles and 50 maxicircles catenated 
together to form an extensive network termed as kinetoplast DNA (kDNA). The maxicircles 
harbour the genes for mitochrondrial proteins and ribosomal RNA synthesis (Simpson, 1987). 
Minicircles encode the guide RNA which act as templates for maxicircle RNA editing (Igo et al., 
2002). Each guide RNA comprises of three sequence domains. The 5’ domain forms an anchor 
duplex with the site 3’ to the editing spot within the target mRNA. The central domain specifies 
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the edited sequence, and the 3’ domain has an oligo U tail which stabilizes the interaction 
between guide RNA and mRNA. Unpaired A or G residues in the central domain define the site 
and number of uridine residues that will be deleted or inserted. The base pairing of guide RNA 
progresses from 3’ to 5’ within the edited mRNA. The uridines are added by terminal uridinyl 
transferase (TUTase) or are removed by uridine specific 3’-5’exonuclease. The processed 
fragments are then rejoined by RNA ligase. The cascade of editing reactions is accomplished by 
a multiprotein complex, the 20S editosome [see Fig 1.1], and is directed by trans-acting guide 
RNAs (Aphasizheva et al., 2009).The 
thousands of minicircles and approximately 50 maxicircles 
c    tenated together into a single large ne 
Fig 1.1 A highly simplified view of the uridine insertion type of RNA editing in kinetoplastid 
mitochondria. The three major biochemical activities for uridine insertion are an endonuclease 
activity cleaving the pre-mRNA at the site of editing, a terminal uridylyl transferase adding 
uridylates from UTPs to the free 3’OH end of the upstream part of the pre-mRNA, and a ligase 
rejoining the transcript ends after editing. In the case of uridine deletion editing, a 3’--uridine-
exonuclease of the *20S editosome comes into play that removes unpaired ‘‘extra’’ uridines 
from the pre-mRNA, which remained unpaired in the hybrid with the respective gRNA (Knoop, 
2011). 
 
1.2.2 Subsitution RNA editing 
Apart from insertion and deletion editing, also base substitutions can occur that alter the base 
pairing properties of modified ribonucleosides. This type of RNA editing occurs in both mRNA 
and non-coding RNAs. 
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1.2.2.1 C to U editing 
The first molecular explanation of having two different forms of apolipoprotein B came in lime 
light with the discovery of C to U editing in 1987 (Hersberger et al., 1999a). APOB is a 
component of the plasma lipoproteins and is crucial for the transport of cholesterol and of 
triglycerides in the plasma (Chan, 1992). In vertebrate apolipoprotein B mRNA a glutamine 
codon is changed to a stop codon resulting in the production of two forms of apo B proteins i.e. 
ApoB100 and ApoB48 (Hospattankar et al., 1987; Powell et al., 1987). This nuclear deamination 
event at C4 of cytosine is tissue specific yielding the long version ApoB100 in the liver and the 
carboxy terminal shortened version ApoB48 (48kDA) in the intestine. Expression of ApoB48 is 
a result of C to U deamination of 6666 (C6666) altering the glutamine codon into a premature 
stop codon in the mature transcript (Chester et al., 2000) 
Additional known targets of cytosine deamination encode the translational repressor “novel 
APOBEC-1 target” (NAT1) (Yamanaka et al., 1997) and the neurofibromatosis 1 protein (NF1) 
(Mukhopadhyay et al., 2002). In both cases editing leads to the generation of a stop codon. NF1 
editing was found to be several folds higher in tumors as compared to normal tissues (Skuse et 
al., 1996). However, with recent progress in high throughput sequencing, 32 additional targets in 
the AU rich region of 3’untranslated region are identified by employing a transcriptome wide 
comparative RNA sequencing screen (Rosenberg et al., 2011) 
The protein responsible for the deamination of these substrates is the zinc-containing 
homodimeric cytidine deaminase APOBEC1. The selection of one cytidine out of 14,000 
nucleotides in case of apoB mRNA has provoked scientist to look for factors contributing to the 
stringency of this targeted deamination. Site-specific cytidine deamination results from 
interactions of cis and trans-acting factors in the assembly of editing complexes, or “editosomes” 
(Smith et al., 1991). Four sequence elements spanning 139kb were identified on apoB mRNA 
that consist of a mooring sequence, a spacer element and 5’ and 3’efficiency elements that 
enhance editing (Hersberger et al., 1999b). The mooring sequence is a 11 nt motif located 3’ of 
the cytidine to be deaminated. It is necessary and sufficient for editosome assembly and site-
specific editing in a variety of native and chimeric RNA contexts (Sowden et al., 1996). The 
'spacer' region can vary in length between 2-8nt with an optimal length of 4nt and is located 
between the editing site and the 3' mooring sequence (Backus et al., 1994). Under physiological 
conditions, APOBEC1 needs APOBEC1 complementation factor (ACF) that belongs to the 
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hnRNP family (Maris et al., 2005; Mehta et al., 2000). ACF has 3 RNA recognition motifs which 
enables its efficient binding to RNA. The stem loop formed between the mooring sequence and 
3’efficiency element is melted by ACF exposing the amino group of the to be edited cytidine 
(Maris et al., 2005). Apart from ACF phosphorylation also regulates the editing efficiency of 
Apobec1 (Chen et al., 2001). 
er physiological conditions Apobec1 needs he 
mitochondrial genome of trypanosomes contains 
thousands of minicircles and approximately 50 maxicircles 
a1.2.2.3 A to I editing  
This is the most abundant form of RNA editing in metazoa occurring in widespread 
organisms from insects to mammals. It harnesses partially or perfectly double-stranded RNA 
structures as editing substrate and hydrolytic deamination occurs with the aid of a base flipping 
mechanism of the targeted adenosine leading to the formation of inosine. Inosines are read as 
guanosines by the translational and splicing machinery (Penn and Greger, 2009b; Rueter et al., 
1999). Furthermore, inosines basepair with cytosines instead of uridines changing the A-U 
basepair into an I-U mismatch resulting in alternation of RNA secondary structure. Until now 
editing events have been found in both coding and non-coding regions of protein-coding genes, 
in viral transcripts, in tRNAs and in miRNAs (Athanasiadis et al., 2004a; Blow et al., 2004; 
Cattaneo et al., 1988; Kim et al., 2004; Morse et al., 2002; Polson et al., 1996).  
Fig. 1.2: Editing of APOB mRNA by 
APOBEC1 (Keegan et al., 2001). 
APOBEC1 binds APOB mRNA in a complex 
with ACF. It is not known if the protein 
binds in the monomeric or dimeric state. 
Essential for editing specificity are: 
Mooring sequence and 5’ and 3’ efficiency 
elements. 
	  
	   	  	   Introduction	  
	  
	  
6	  
A to I RNA editing is mediated by two groups of adenosine deaminases. First, ADATs 
(adenosine deaminases that act on tRNA/tRNA-specific adenosine deaminase) are a protein 
family responsible for numerous tRNA editing events (Gerber and Keller, 2001; Keller et al., 
1999). In tRNAs editing occurs mainly at the wobble position and allows translation of codons 
ending in C, U or A. The first ADAT was identified in Saccharomyces cerevisiae with the 
discovery of inosine at position 37 in eukaryotic tRNAAla in eukaryotes. This enzyme was first 
named Tad1p (for tRNA adenosine deaminase1) and later renamed ADAT1 (Maas et al., 1999). 
ADAT1 is a nonessential gene in yeast, required for the editing of inosine-37, whereas ADAT2 
and ADAT3 form an essential two-subunit heterodimeric complex that specifically converts A-
34 to I-34 in the wobble position of several tRNAs. Although ADATs do not act on duplex 
RNA, they do require the unique L-shaped tertiary structure of tRNAs for substrate recognition 
(Gott and Emeson, 2000). All the three ADATs lack dsRBDs and any recognizable RNA binding 
motif suggesting novel RNA protein interaction (Schaub and Keller, 2002). A homolog of 
ADAT2 has been found in E.coli tadA that forms a heterodimer and edits A 34 in tRNA Arg 
(Wolf et al., 2002). 
 The second family of adenosine deaminases are ADARs that are derived from ADATs by 
fusion of two or more dsRBDs with a conserved deaminase domain (Bass, 2002b). 
 
Adenosine deaminases that act on RNA  
Adenosine deamination by adenosine deaminases that act on RNA (ADAR) seemingly only 
affects metazoan nuclear encoded RNAs. Deamination of adenosines leads to the formation of 
inosines which are recognized as guanosines by most cellular machineries (Bass and Weintraub, 
1988). Editing in coding regions of mRNAs can therefore lead to a codon exchange and the 
subsequent translation of a protein that differs from the genomically encoded version. Moreover, 
editing can also introduce or remove splice sites and thereby lead to the formation of novel 
mRNAs (Rueter et al., 1999). Finally, inosines in RNA can change the base-pairing propensity of 
an RNA and therefore alter their folding and change their signature for RNA-binding proteins 
(Nishikura, 1992). Thus, also editing in non-translated regions of an mRNA may have profound 
impact on the fate of the affected RNA. Besides mRNAs, also primary and precursor miRNAs 
can be targets for RNA-editing by ADARs. Editing of pri- and pre-miRNAs can alter their 
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processing but also their basepairing potential with target mRNAs. Therefore, editing of 
miRNAs can indirectly change the abundance and translatability of their target mRNAs. 
Editing of mRNAs was originally believed to be a rare event. In recent years, however, editing 
was found to be widespread in mRNAs of higher eukaryotes (Athanasiadis et al., 2004b; 
Levanon et al., 2004). In all organisms editing by ADARs is most abundant in the nervous 
system. The profound alterations of the transcriptome and proteome introduced by RNA-editing 
may thus help to solve a long lasting biological paradigm, namely, how biological complexity 
can be achieved with an almost constant number of genes: editing-induced alterations of splice 
patterns and coding potential of mRNAs may, together with alternative splicing, contribute to the 
formation of a complex proteome from a limited number of genes. Consistently, alterations in the 
editing patterns or loss of editing is accompanied by pathological conditions and disease 
(Morabito and Emeson, 2009).  
 
The ADAR protein family 
ADARs were first discovered in Xenopus laevis as an unwinding activity that destabilizes RNA 
duplexes upon A to I editing (Bass and Weintraub, 1987; Rebagliati and Melton, 1987). ADARs 
have been well characterized in many organisms including insects, worms and vertebrates (Bass, 
2002a). The first ADAR gene identified was vertebrate ADAR1 harboring three double-stranded 
RNA-binding domains (dsRBDs) and a conserved deaminase domain with zinc binding motifs. 
Subsequent screens led to the identification of ADAR2 (Melcher et al., 1996b; O'Connell et al., 
1997). Recent analyses have shown the presence of ADAR1 and ADAR2 in many species 
including sea urchin and sea anemones (Jin et al., 2009). The vertebrate genome encodes two 
additional, ADAR proteins. ADAR3, which presumably arose from ADAR2 by gene 
duplication, contains all functional domains. However, no function has been ascribed to this 
isoform (Chen et al., 2000). The fourth ADAR-like gene, termed TENR, is expressed in the male 
germ line and has one dsRBD. TENR lacks conserved zinc chelating residues in the deaminase 
domain thus explaining its inactivity (Hough and Bass, 1997). ADARs are related to the tRNA 
editing family of ADATs which are found in all kingdoms of life (Jin et al., 2009). 
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Fig1.3:  Schematic representation of ADAR functional domains. Zα/β DNA BD Zα/β DNA binding domain, 
NES nuclear exporting signal, NLS nuclear localization signal, dsRBM double-stranded RNA binding motif, 
M296 methionine 296, R-domain arginine rich domain adapted from (Orlandi et al., 2011) 
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Phenotypes of ADAR deficiency 
Different phenotypes are associated with the lack of individual ADAR isoforms. ADAR2 null 
mice have episodes of epileptic seizures and show subsequent postnatal death. A key substrate of 
ADAR 2 is the mRNA encoding GluA2. Underedited GluA2 allows increased influx of Ca2+ 
leading to death of neurons (Brusa et al., 1995). Consistently, ADAR2−/−mice can be rescued by 
replacing the genomic, unedited GluA2 copy with a “pre-edited” gene copy (Higuchi et al., 
2000). Still, even the rescued ADAR2−/− mice display a range of subtle phenotypes ranging from 
a decreased acoustic startle response to decreased blood glucose level. The molecular 
mechanisms underlying these changes are still to be determined (Horsch et al., 2011). ADAR2 
overexpressing mice, in contrast, display hyperphagia and obesity (Singh et al., 2007). This 
phenotype can be reproduced by a catalytically inactive version of ADAR2 that retains its RNA-
binding ability. This suggests that RNA binding of ADARs can lead to editing-independent 
phenotypes (Singh et al., 2007).  
Mice lacking ADAR1 die during embryonic development, show defective hematopoiesis, 
widespread apoptosis, and liver disintegration (Hartner et al., 2004). Molecularly, ADAR1 
deficient mice show an increase in interferon signaling with the precise molecular mechanisms 
leading to death remaining unknown (Hartner et al., 2009). 
In Drosophila melanogaster inactivation of the single ADAR gene causes tremors, lack of 
coordination, mating defects, and neurodegeneration presumably resulting from underediting of 
important dADAR target genes such as Na+ (para), Ca2+(Heale et al.), and glutamate-gated Cl− 
channels (DrosGluCl-α) (Palladino et al., 2000). Caenorhabditis elegans strains with 
homozygous deletions in either of the two ADARs adr-1 or adr-2 show chemotactic defects, also 
indicating a role in the editing of neuronally expressed substrates (Tonkin et al., 2002). 
 
Substrates	  of	  ADAR	  
RNA editing by adenosine deaminases can affect coding and non-coding RNA sequences. 
Substrate RNAs are recognized by the double-stranded RNA-binding domains located in 
ADARs. These domains bind to A-form helices formed by double-stranded RNAs. Thus, editing 
sites are defined by basepaired regions of 20 or more nucleotides in length. A-form helices 
display a wide minor groove and a narrow major groove. Sequence specific information of the 
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bases cannot be easily contacted making a sequence specific positioning of ADARs difficult 
(Ryter and Schultz, 1998). Still, various mechanisms can contribute to substrate and editing 
specificity. Multiple dsRBDs found in ADARs can coordinately bind to substrates (Stefl et al., 
2005). Most double-stranded structures formed by endogenous RNAs are disrupted by bulges. 
These bulges set natural boundaries for the binding of dsRBDs (Lehmann and Bass, 1999). If 
two or more dsRBDs need to bind to a double-stranded region of limited length they can help to 
position each other. Structural analysis of ADAR2 bound to a stem loop substrate shows nicely 
that some dsRBDs can also bind to terminal loops thus helping to increase substrate specific 
binding (Stefl et al., 2006). Recently, specific minor groove interactions between dsRBDs and 
nucleotides have been identified. These interactions can increase sequence specificity 
dramatically, therefore aiding in selecting specific adenosines within a stretch of double-stranded 
RNA (Stefl et al., 2010). Finally, also the deaminase domains of ADAR1 and ADAR2 display 
substrate specificities that preferentially select certain adenosines depending on their local 
sequence context (Eggington et al., 2011; Polson and Bass, 1994). As the adenosine to be edited 
typically lies within a double-stranded structure the target adenosine needs to be accessed 
through a base flipping mechanism (Stephens et al., 2000; Yi-Brunozzi et al., 2001). 
The altered basepairing potential of inosines can lead to an alteration of the RNA 
secondary structure. Thus, editing in the non-translated regions of mRNAs may alter their 
localization, stability, and translatability. However, the biological consequences of editing in 
these targets is still under debate. The consequences of adenosine deamination in coding regions 
of mRNAs and pri-miRNAs on the other hand are more easy to understand. As inosines are read 
as guanosines during translation, inosines can alter the coding potential or targeting specificity of 
mRNAs and miRNAs, respectively (Vesely et al., 2012).  
The proteins encoded by edited pre-mRNAs vary widely in their function. However, 
frequently editing induced amino acid exchanges affect receptors and ion channels expressed in 
the brain. Another class of proteins affected by RNA editing play a role in cytoskeletal 
remodeling which also plays an important role in neuronal outgrowth and plasticity. In the 
following, representative examples of both classes of proteins and the functional implications of 
their editing will be described.	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Glutamate gated ion channels 
Five subunits of the glutamate receptor (GluA2, GluA3, GluA4, GluK1 and GluK2) are found to 
undergo ADAR-mediated RNA editing (Bass, 2002a). A total of 4 editing sites that result in 
amino acid changes have been identified, namely glutamine to arginine (Q/R), arginine to 
glycine (R/G), isoleucine to valine (I/V), and tyrosine to cysteine (Y/C) [see Table 1]. 
AMPA GluA2 subunit mRNA was the first target discovered. It is edited mainly at two coding 
sites leading to a glutamine to arginine and arginine to glycine conversion (Lomeli et al., 1994; 
Sommer et al., 1991) [see Figure 1.5].  
 Two additional editing sites are found in intron 11 of GluA2 mRNA, called hotspot 1 (or +60 
site) and hotspot 2 (or+262/263/264 site), respectively (Higuchi, 1993). Editing at the Q/R site 
reduces Ca2+ permeability [see Figure 1.4]. The edited GluA2R isoforms also show reduced 
endoplasmic reticulum (ER) exit efficiency, whereas unedited GluA2Q isoforms readily 
tetramerize and are transported to the synaptic membrane (Greger et al., 2003; Greger et al., 
2002). GluA2 in the unedited Q form leads to epileptic seizures and subsequent postnatal death. 
This toxic effect has been attributed to increased calcium influx (Higuchi et al., 2000). 
Additionally increased receptor density due to faster ER exit may also contribute to this effect 
(Greger et al., 2002) [see Figure 1.4].  
The R/G conversion reduces the assembly of homomeric receptors and slows down receptor 
maturation in the ER (Greger et al., 2006). Additionally, R/G site editing results in enhanced 
recovery from desensitization (Lomeli et al., 1994). Editing events in the GluA2 pre-mRNA also 
affect splicing of nearby introns. Editing at the R/G site of GluA2 takes place two nucleotides 
upstream of the 5’ splice-site in intron13. The Q/R site is located in exon 11, 25 nucleotides 
upstream of the 5’ splice site of intron 11 (Higuchi, 1993). Editing at the Q/R site and the 
intronic hotspot enhances splicing of the nearby intron, while editing at the R/G site represses 
splicing at the downstream intron (Schoft et al., 2007). Editing at the R/G site may affect 
basepairing of the pre-mRNA with the U1 snRNA (Schoft et al., 2007). R/G site editing also 
influences the alternative splicing of the two downstream exons as editing promotes inclusion of 
exon 15 (flip) over exon 14 (flop). GluA2 protein with an edited G and the flip variant undergoes 
rapid maturation in the ER relative to the flop form. The flip variant also stimulates dendritic 
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growth (Hamad et al., 2011). The flop isoform, in turn, promotes assembly of heteromeric 
AMPA receptors (Penn and Greger, 2009a).  
Also kainate receptor subunits GluK1 and -2 are edited at the Q/R position. GluK2 undergoes 
additional editing at the I/V and Y/C sites, located at positions 621, 567 and 571 respectively, 
which may lead to higher calcium permeability (Kohler et al., 1993).  
 
 
 
Fig1.4 : Impact of editing on several neuronal receptors 
Shown are several receptors and channels in their unedited (black) and edited (E in pink) 
versions. Editing at the Q/R site of ionotropic glutamate receptor GluA2 subunit decreases 
Ca2+permeability and endoplasmic exit efficiency. Membrane trafficking of GABA-A receptor is 
reduced by editing of I to M in the alpha3 subunit. Editing of serotonin 5-HT2C` receptor 
converts the aminoacid I-N-I to V-S-V or V-N-V.This reduces G protein coupling in the receptor. 
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The editing induced I to V exchange in Kv1.1(I/V) alters the interaction with Kvβ1.1 (see Fig 
1.5) for detail. Editing of the IQ motif in Cav1.3 to MR abolishes calmodulin binding. Filamin 
alpha (FLNa) is edited in a region that is known to interact with metabotropic glutamate 
receptor mGlu7b and some of its relatives. 
 
GABAA Receptor 
GABAA receptors are ligand gated chloride channels consisting of 5 subunits: 2 α subunits, 2 β 
subunits, and either a γ or a δ subunit (Hevers and Luddens, 1998). The existence of six α, β, γ,  
and δ subunits allows for the assembly of a wide variety of stoichometries. Position 342 of the α3 
subunit is highly edited, resulting in an isoleucine (AUA) to methionine (AUI) codon change 
(Ohlson et al., 2007) [see Figure 1.5]. The editing site is defined by a specific RNA structure 
marked by bulges at a defined distance from the editing site as well as a specific terminal loop 
structure (Tian et al., 2011). With age, the two α subunits show opposing expression patterns. 
While α1 expression increases with age the α3 subunit is predominant at embryonic level 
(Hutcheon et al., 2004). Moreover, editing is developmentally regulated. The pre mRNA is 
mostly found unedited around day E15 but is edited from 80% to 100% at postnatal day 7 (P7) 
(Ohlson et al., 2007; Rula et al., 2008)  
The I/M change in GABAA receptor causes a delay in currents and faster deactivation upon 
stimulation by GABA (Rula et al., 2008). Expression of unedited GABAA receptor in the 
developing brain is crucial for synapse formation (Ben-Ari et al., 2007). Recently, editing has 
been proposed to affect the stability of the α3 subunit as the edited version displays low cell 
surface expression. The M version of the receptor maintains the hydrophobic environment but 
can influence the interaction between α and γ subunits or ligand interaction (Daniel et al., 2011)  
[see Table 1, Figure 1.4]. 
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Figure 1.5:Topography of neuronal channels containing editing sites 
Ionotropic glutamate receptor, GABA-A receptor subunit α3, Kv1.1, Cav1.3 and 5HT-2C 
receptors are shown. The relative position of the editing sites are highlighted. Consequences of 
editing are indicated. 
 
Voltage-gated Potassium channels 
Neuronal Kv1.1 channels are built of a tetramer of pore forming α subunits along with 4 
regulatory beta subunits and accessory subunits. The channels regulate action potential and 
modulate neuronal excitability by opening and closing of a potassium selective pore. The human 
Kv1.1 (KCNA1) gene is intronless and undergoes A to I RNA editing leading to an isoleucine to 
valine exchange [see Figure 1.4]. The amino acid exchange is located within the sixth 
transmembrane segment (S6) which lies at the ion conducting pore (Bhalla et al., 2004) [see 
Figure 1.5]. Kv1.1 channels are edited up to 65-80% in medulla, thalamus and spinal cord 
(Decher et al., 2010). The I to V change is evolutionarily conserved and also occurs in Kv2 
(DmShab Shaker) channels in Drosophila melanogaster together with four other editing events 
(Bhalla et al., 2004; Ryan et al., 2008). 
Kv1.1 associates with the redox sensor Kv beta 1 in the ER (Pan et al., 2008). Kv beta harbors an 
N terminal inactivation domain that controls inactivation and lag time of Kv1.1. The edited 
Kv1.1 shows a 20 fold higher recovery from Kv beta 1 mediated inactivation than the unedited 
version of the channel (Bezanilla, 2004; Bhalla et al., 2004) [see Figure 1.6].  
The Kv channel blocker 4-aminopyridine (4-AP) has been shown to induce epileptic seizures. 
RNA editing makes the channel insensitive to 4-AP by disrupting the interaction between the 
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pore lining and the channel blocker [see Table1] (Streit et al., 2011). A similar insensitivity was 
observed against arachidonic acid (Decher et al., 2010).  
Squid Kv 1.1A has also been shown to be extensively edited (Rosenthal and Bezanilla, 2002). 
Here editing not only affects channel gating but also influences the tetramerization of the 
channel. 
 
 
Fig 1.6: Regulation of Kv1.1 channel by Kvβ1.1 
Kvβ1.1 has an inactivation gate which interacts with unedited (I) form of Kv1.1 receptor. Editing 
of Kv1.1 changes isoleucine (I) to valine (V). This reduces the affinity of Kvβ1.1 and enhances 
fast recovery from inactivation. Figure adapted from (Bezanilla, 2004). 
 
Voltage-gated Calcium channels 
Voltage gated calcium channels (VGCC) are classified into two types: Low voltage activated and 
high voltage activated (HVA) channels (Lacinova, 2005). Low voltage activated L-type calcium 
channels are involved in a broad range of neuronal processes such as neuronal pacemaking, 
secretion of neurotransmitters, synaptic transmission, mRNA stability and modulation of other 
ion channels (Singh et al., 2008). The opening of these channels permits calcium influx. The 
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channels are inactivated by voltage dependent inhibition (VDI) and intracellular calcium 
dependent inhibition (CDI). The pore forming α1 subunit contains four domains (I-IV), each 
domain consisting of six transmembrane segments (S1-S6) (Catterall et al., 2005) [see Fig1.5]. 
S5 and S6 of all four domains form the central pore with S6 lining the inner surface of the pore 
and occluding the pore in the inactive state. S1 to S4 from each domain form the voltage sensing 
domain and on activation the S4 segment moves outward triggering S6 movement leading to gate 
opening (Swartz, 2004).  
Calmodulin (CaM) binds to the IQ domain located at the C terminus of the pore forming α1 
subunit. The formation of a Ca+2-CaM complex results in CDI (Tadross et al., 2008). Calcium 
binding to the N and C terminal CaM lobes can induce distinct channel regulation (Dick et al., 
2008). Recently, editing of the core sequence of the IQ domain of Cav1.3 by ADAR2 has been 
discovered. The core sequence comprises of the 4 amino acids IQDY. Upon editing different 
isoforms such as MQDY, IRDY, MQDC, MRDY, MRDC, or IQDC can be generated [see 
Figures 1.4 & 1.7]. This editing event is restricted to the central nervous system (Huang et al., 
2012). Additionally, the pattern of editing is developmentally regulated. It is negligible at E14 
and prominently increases at P4. RNA editing of the IQ domain shows spatial distribution being 
highest at the frontal cortex and hippocampus (Huang et al., 2012). The MQ and IR versions 
show weaker CDI while the MR variant exhibits up to 50% reduction of CDI and faster recovery 
from inactivation. Reduction in CDI consequently increases the cellular calcium load [see Table 
1].  
 
Figure 1.7: Cav1.3 and 
calmodulin interaction 
Calmodulin binds to Cav1.3  
without calcium as apoCam at the 
IQ motif. Calmodulin binds to 
calcium through its N terminal 
and C terminal loop and mediated 
calcium dependent inhibition 
(CDI). Editing modifies IQ to MR 
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and inhibits calmodulin binding. Intracellular calcium increases in the absence of CDI. 
Serotonin 2 receptor 
The mammalian 5-hydroxytryptamine receptor subtype 2C (5-HT2c) is found widely distributed 
in the central nervous system. 5-HT2c belongs to the G protein-coupled receptor superfamily that 
stimulates phospholipase C (PLC) activity (Hoyer et al., 2002). The 5HT2c receptor interacts 
with the multi PDZ-domain bearing protein (MPDZ). Both these proteins co-localize on the 
apical membrane of choroid plexus cells (Drago and Serretti, 2009). The pre-mRNA encoding 
serotonin receptor 5HT2c is edited at five sites termed A, B, C, D, and E. Editing can lead to the 
exchange of three amino acids that are located within the second intracellular loop of the 
receptor [see Figure 1.5]. This region has been shown to be important for efficient G-protein 
coupling (Niswender et al., 1998). Editing at the five positions in RNA can, in principle, yield a 
combination of 32 different mRNAs which encode 24 different protein isoforms (Burns et al., 
1997; Niswender et al., 1999). In mouse brain, however, only eight major receptor variants can 
be detected at significant levels. Also sequencing analysis of human brain samples only detected 
12 possible isoforms derived from RNA editing. This suggests that not all possible combinations 
of editing do exist in vivo (Wahlstedt et al., 2009b; Wang et al., 2000b). Moreover, the repertoire 
of possible editing combinations varies throughout development (Wahlstedt et al., 2009b). 
Editing at sites A and B is accomplished by ADAR1, sites C, D, and E, however, are 
preferentially deaminated by ADAR2 (Hartner et al., 2004).  
Upon editing, reduced G-protein coupling is observed in the edited states (Burns et al., 1997) 
[see Figure 1.4]. Editing not only reduces the constitutive activity of the receptor but also 
diminishes agonist potency and calcium release (Price et al., 2001). At the cellular level, editing 
changes the surface expression of the receptor. The subcellular distribution of the receptor 
depends on β arrestin-2 interaction with inverse correlation to the constitutive activity of the 
receptor. Editing decreases the constitutive activity and enhances surface expression. The fully 
edited VGV isoform displays complete surface expression. The unedited INI isoforms exhibit 
endosomal accumulation whereas the edited VSV isoforms with moderate activity display 
vesicular and cell surface expression (Marion et al., 2004). Editing also modulates the expression 
of the receptor through splicing. Unedited 5HT2c transcripts result in a splice version that yield a 
shorter protein, while edited transcripts form the full length receptor (Flomen, 2004). However, 
the underlying factors resulting in alternative splicing are still not entirely clear. It was shown, 
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for instance, that the human and mouse C/D box snoRNAs HBII-52 and MBII-52, respectively, 
can inhibit site C editing via base pairing (Vitali et al., 2005). This base pairing event also 
seemingly masks a silencer element important for the regulation of splicing (Kishore and Stamm, 
2006).  
The serotonin 2c receptors can also activate extracellular signal-regulated kinase (Bossy-Wetzel 
et al.) independent of G-protein coupling. Expression of the unedited INI isoform increases 
ERK1/2 phosphorylation in transfected HeK293 cells while expression of the edited VGV form 
decreases phosphorylation. However, this activation is significantly reduced upon β-arrestin 
depletion (Labasque et al., 2010). Editing also decreases downstream ERK signaling. 
Consistently, a shift towards the edited isoforms leads to reduced ERK signaling in prefrontal 
cortex of ADAR2 transgenic mice (Singh et al., 2011). Overexpression of ADAR2 and 
hyperediting of the 5HT-2c receptor is also correlated with depressive behavior (Singh et al., 
2009).  
Mice carrying either a completely unedited “INI” version or a completely edited “VGV” version 
of the 5HT-2c receptor have been generated (Kawahara et al., 2008). While the INI mice grow 
normally but are rather immobile in a forced swim assay, resembling a depressive behavior 
(Mombereau et al., 2010). It has also been shown that a decrease in the INI form of the receptor 
can lead to a decrease in ERK1/2 phosphorylation in transgenic ADAR2 mice (Singh et al., 
2011). Aberrant ERK1/2 phosphorylation in turn is linked to depression and suicidal behavior as 
ERK1/2 plays a critical role in synaptic plasticity (Dwivedi et al., 2009).  
Mice expressing the fully edited VGV version of the receptor, in contrast, have reduced fat mass, 
growth retardation, and high energy expenditure most likely due to hyperactivation of the 
sympathetic nervous system (Kawahara et al., 2008). Mutant mice with fully edited VGV 
isoforms have also been shown to display symptoms resembling those of the Prader-Willi 
syndrome (PWS) (Morabito et al., 2010).  
Thus, data from transgenic mice clearly demonstrate that the editing status of 5-HT2c-R can 
directly influence behavior underscoring the importance of RNA editing for the etiology of 
psychiatric disorders. 
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Actin organization by filamins 
Two actin crosslinking proteins Filamin A (FLNa) and Filamin B (FLNb) are amongst a group of 
newly identified mammalian editing targets (Levanon et al., 2005; Li et al., 2009; Nishimoto et 
al., 2008). The two 280kDa proteins form homo- and heterodimers and mediate orthogonal 
branching of actin filaments (Fucini et al., 1997; Popowicz et al., 2006; Sheen et al., 2002). 
Mammalian filamins are built of 24 immunoglobulin (Ig) like repeats divided into two rod 
segments. Rod 1 consisting of repeats 1-15 interacts with actin filaments whereas rod 2 is built 
from repeats 16-23  and interacts with several proteins (Chen et al., 2011). Repeat 24 is required 
for dimerization. Actin reorganization is essential for cell motility and migration and is an 
important determinant in dendritic spine and synapse formation (Dillon and Goda, 2005; 
Popowicz et al., 2006). Depletion of FLNa leads to embryonic lethality with severe 
cardiovascular and bone development defects (Feng et al., 2006; Hart et al., 2006). Also FLNb 
deficient mice show defective microvasculature and bone malformation (Zhou et al., 2007). 
Editing of FLNa or FLNb leads to a conserved glutamine (Q) to arginine (R) codon exchange in 
repeat 22 (Li et al., 2009) that is developmentally regulated (Wahlstedt et al., 2009b). Repeat 22 
has been shown to be involved in the interaction with a broad range of proteins (Popowicz et al., 
2006) [see Table 1]. 
FLNa interacts with the C-terminus of the metabotrobic glutamate receptor mGlu5a, 5b, 7b and 
8a [see Figure 1.4]. Moreover, low affinity binding was also detected for mGlu4a and mGlu7a. 
Repeats 21 and 22 of FLNA harboring the edited amino acid represent the minimal region 
critical for this interaction (Enz, 2002). Editing may thus regulate this interaction the potential 
consequences of which remain to be determined. 
FLNa also interacts with potassium channel Kv4.2 at filipodial roots and shows overlapping 
expression in cortical and hippocampal neurons. A “PTPP” amino acid motif in Kv4.2 (AA 601-
604) is critical for this interaction. Again, FLNa repeats 21-24 are involved in this interaction. 
Coexpression of filamin in heterologous cells enhances the whole cell current density by ~2.7 
fold most likely by properly positioning functional KV4.2 receptors at the cell surface (Petrecca 
et al., 2000). 
Presenilins (PS) belong to a conserved protein family that were the first proteins identified 
responsible for familial Alzheimer disease (FAD) (Nelson et al., 2010). Presenilins harbor eight 
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transmembrane domains. PS1 and PS2 were identified in a yeast two hybrid assay to interact 
with repeats 21-24 of FLNa. A region between TM6 and TM7 of the presenilins is responsible 
for this interaction. The same loop harbors 14 different mutations that are associated with FAD. 
FLNa and PS1 co-localize in astrocytes (Zhang et al., 1998). Moreover, overexpression of PS1 in 
cultured HEK293 cells redistributes filamin from the cell periphery to the cytoplasm. The FAD-
linked mutation PS1 M146L induces FLNa expression (Lu et al., 2010). The FLNa PS1 
interaction is well conserved and could be physically and genetically demonstrated in Drosophila 
melanogaster (Guo et al., 2000).  
FLNa also colocalizes with the neuronal microtubule associated protein Tau. Tau is involved in 
polymerization and stability of microtubules. Tau protein is abnormally phosphorylated and 
forms neurofibrillary tangles in the hippocampus in Alzheimer patients. It is believed that Tau 
induced FLNa depletion leads to actin network destabilization and consequently to synaptic loss 
(Feuillette et al., 2010). 
The functional implication of editing induced Q2341R amino acid exchange in repeat 22 of 
FLNA is still unknown. However, it may have an effect on a broad range of interactions (Chen et 
al., 2011). One example is the interaction of filamin a with β-integrin. Repeat 21 cannot interact 
with β- integrin unless repeat 20 disassociates from it (Lad et al., 2007). Similarly, FLNa editing 
may change neuronal receptor organization as well as synaptic transmission by altering the 
interaction profile with binding partners.  
 
Cytoplasmic FMRP interacting protein 2 (CyFIP2)  
CyFIP2 was identified as an interaction partner of the fragile X mental retardation protein 
(FMRP) in a yeast two hybrid screen. The region of interaction between CyFIP2 and FMRP 
overlaps with the FMRP dimerization site (Schenck et al., 2001). CyFIP2 also interacts with 
FMRP–related proteins FXR1P and FXR2P (Schenck et al., 2001). The CyFIP2 encoding pre-
mRNA is primarily edited by ADAR2 introducing a single K320E amino acid exchange in 
mouse and human CyFIP2 (Levanon et al., 2005; Nishimoto et al., 2008). 
CyFIP2 is a member of the WAVE/SCAR complex and is involved in actin remodeling. It plays 
a pivotal role in neuronal wiring as it directly interacts with FMRP and Rac-1 (Schenck et al., 
2003). Flies have a single Cyfip gene which is 67% identical to human CyFIP1 and CyFIP2. 
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Mutant Cyfip flies display shorter synapses and profound axonal path finding, growth and 
branching defects (Schenck et al., 2003; Schenck et al., 2004). CyFIP2 is mainly involved in 
maintaining synaptic plasticity as it is involved in translational regulation impeded in fragile X 
mental retardation. In vertebrates like Zebrafish that harbor both CyFIP1 and CyFIP2, Cyfip2 
mutants exhibit dorso-nasal axonal pathfinding defects (Pittman et al., 2010). RNAi of CyFIP2 in 
murine melanoma cells leads to aberrant lamellipodia proving the functionality of Cyfip2 in actin 
remodeling and cell motility (Steffen et al., 2004).  
Editing at the K/E position of CyFIP2 increases during mouse brain development ranging from 
4% at E15 to 75% editing at P21 (Wahlstedt et al., 2009b). However, there seems a significant 
decline in CyFIP2 editing with age in human brain (Nicholas et al., 2010).  
The biological significance of Cyfip2 editing is currently not clear. One possibility would be that 
the migratory behavior of cells is regulated by CyFIP2 by antagonizing Rac-1. However, 
interactions with FMR1 or the nucleo-cytoplasmic shuttling of Cyfip2 might equally be affected 
by editing. With the new discovery of modulation of ADAR by FMR1 in flies the possibility of a 
feed back loop of CyFip2 and ADAR regulation also appears possible as Cyfip antagonizes 
FMR1 in flies (Schenck et al., 2003). 
 
Hu proteins  
Hu proteins are RNA binding proteins which play an essential role in neuronal differentiation 
and plasticity. HuB, HuC and HuD are neuron specific whereas HuR is associated with cell 
stress responses. Each Hu protein has three RNA recognition motifs (RRM1-3). Hu proteins 
preferentially bind to AU rich RNA elements (ARE) where they can act as RNA stabilizers and 
regulators of polyadenylation and translation (Hinman and Lou, 2008; Mobarak et al., 2000; Zhu 
et al., 2006). Recently, 5 editing sites were discovered in HuD and HuB in a bioinformatic screen 
of deep-sequencing data (Enstero et al., 2010). The functional implication of editing is unknown. 
However, it is likely that editing of Hu proteins can alter the landscape of the brain transcriptome 
(Paz-Yaacov et al., 2010). 
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Nova-1 
Recently, another RNA binding protein, Nova-1, was found to be edited (Irimia et al., 2012). 
Nova-1 is a key regulator of alternative splicing of RNAs encoding synaptic proteins involved in 
neuronal activity in the central nervous system (CNS). Nova-1 binds pre-mRNAs in a sequence 
dependent manner and diversifies proteins by splicing regulation. Nova-1 null mice die 
postnataly from motor neuron death due to spinal and brainstem neuron apoptosis (Jensen et al., 
2000). The splicing regulation by Nova1/2 is well conserved from mammals to insects. Both 
Nova1/2 and the Drosophila melanogaster ortholog Pasilla (PS) binds to YCAY enriched 
regions located upstream of repressed exons and downstream of activated exons (Brooks et al., 
2011). RNA editing increases the Nova-1 half life by decreasing its susceptibility to proteasome 
degradation (Irimia et al., 2012). This stabilization of Nova-1 by RNA editing can create another 
layer of complexity in diversification of brain specific transcripts. 
 
Non-Coding Targets 
Coding targets undergo site selective editing whereas non-coding sites are promiscuously edited. 
Apart from coding targets tens of thousands non-coding editing sites are identified in human 
genome (Hundley and Bass, 2010; Levanon et al., 2004). Editing has various impacts on non-
coding targets. 
 
mRNA localization 
CTN-RNA is transcribed from the protein-coding mouse cationic amino acid transporter 2 
(mCAT2) gene harboring alternative promoter and poly (A) sites. The 3' UTR of CTN-RNA is 
edited and localizes to paraspeckles. However on stress, CTN-RNA is post transcriptionally 
cleaved to produce protein-coding mCAT2 mRNA (Prasanth et al., 2005). Nicolin 1 (NICN-1) 
mRNA is editing in its 3’ UTR. The mRNA has been suggested to be retained in the nucleus 
(Chen et al., 2008). p54nrb was found to bind inosine containing RNAs and suggested to 
mediated nuclear retention. Recently, a nuclear enriched non-coding RNA NEAT-1 has been 
found associated with this protein (Clemson et al., 2009). 
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Micro RNA pathway 
Editing affects endogenous small RNAs by hindering their processing by RNase III enzymes, 
changing the target specificity by altering their seed sequence, and by competing for double 
stranded RNAs with the dsRBPs involved in processing. 
miR 376a is the first miRNA demonstrating altered target specificity upon editing. The edited 
form targets phosphoribosyl pyrophosphate synthetase 1, (PRPS1) involved in uric acid 
metabolism. ADAR2 null mice show increased uric acid levels (Kawahara et al., 2007b). pre-
miR-151 and pri-miR-142 show impaired processing by Dicer and Drosha as a consequence of 
editing (Yang et al., 2006) ((Kawahara et al., 2007a). The enhanced efficacy of transgene 
silencing in C.elegans adr-1 and adr-2 knockout worms was the first indication of competition 
between ADARs and the RNAi machinery for dsRNA (Knight and Bass, 2002). Recently it was 
shown that MEFs derived from ADAR1 knockout mice have increased RNAi efficiency (Yang 
et al., 2005). Additionally, in Drosophila it was found editing inactive ADAR hinders RNAi 
raising the possibility of competitive dsRNA binding independent of editing (Heale et al., 2009).  
With the advent of new technologies, the discovery of potential new editing targets is 
progressing rapidly. The new validated editing substrates encode coatomer protein complex 
subunit alpha (COPA) as well as cyclin dependent kinase CDK13 (Maas et al., 2011).	  
Dysregulation of A to I editing has been found associated with a number of diseases, ranging 
from mental disorders to cancers (Paz et al., 2007). The following sections will give an overview 
on diseases that are strongly influenced by ADAR-mediated editing. 
 
Astrocytoma 
This glial cell tumor is classified on the basis of malignancy into four grades (I to IV). 
Glioblastoma multiforme (GBM) is a grade IV tumor with a survival rate of less than 18 months 
in children and adults (Stupp et al., 2005). Glial cells respond to external stimuli via neuronal 
receptors (Bergles et al., 2000; Gallo and Ghiani, 2000). Hypoediting of GluA2 at the Q/R site 
has been observed in GBM leading to increased Ca2+ influx and activation of the Akt pathway 
through phosphorylation (Ishiuchi et al., 2007). Also in pediatric astrocytoma the malignancy 
increases with a decrease in editing. GBM cells show strong migratory activity which is reduced 
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upon ADAR2 expression. Furthermore a decrease in GluK2 editing at the I/V and Y/C sites is 
observed in different brain regions (Cenci et al., 2008a). Since both GluA2 and GluK2 are edited 
by ADAR2, ADAR2 overexpression strongly inhibits cell proliferation and slows down the cell 
cycle. Mutation in the ADAR2 deaminase domain does not affect tumor malignancy proving the 
necessity of editing in tumor progression (Cenci et al., 2008a). In this type of tumor ADAR2 is 
expressed at a normal level, while ADAR1 and ADAR3 are overexpressed leading to the 
assumption that higher concentrations of ADAR1 and ADAR3 may inhibit the activity of 
ADAR2 (Cenci et al., 2008a). 
In pediatric astrocytoma high levels of interferon induced ADAR1 p150 are found. 
Overexpression of ADAR1 might again interfere with ADAR2 activity (Cenci et al., 2008a; 
Chen et al., 2000). 
 
Amyotrophic Lateral Sclerosis 
Amyotrophic Lateral Sclerosis (ALS) is characterized by slow degeneration of upper and lower 
motor neurons with a consequent loss of voluntary movement (Rothstein, 2009). Different 
mechanisms are proposed to be the underlying causes of this disease. Decreased editing at the 
Q/R site leading to increased Ca2+ influx has been observed in mice displaying late onset ALS 
(Kuner et al., 2005). The editing efficiency at the GluA2 Q/R site also decreases dramatically in 
ALS patients (Kawahara et al., 2004). Consistent with reduced Q/R site editing, a significant 
decrease in ADAR2 expression has been observed in spinal motor neurons of ALS patients 
(Hideyama et al., 2011). However, no decline in editing of Q/R in upper motor neurons was 
observed.  
Additionally, the flip-flop alternative splicing pattern of GluA2, downstream of the R/G editing 
site is pushed towards flip-bearing transcripts in ALS patients (Kawahara and Kwak, 2005). The 
flip form of GluA2 promotes assembly of slowly desensitizing AMPA receptors (Tomiyama et 
al., 2002).  
Clearing of glutamate from the synaptic cleft is accomplished through glutamate transporters that 
prevent repeated firing and excitotoxicity. The astroglial EAAT2 glutamate transport is 
responsible for clearing glutamate from the cleft. ALS patients show 50% decreased EAAT2 
protein levels as editing generates a cryptic polyadenylation site leading to intron 7 retention 
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(Flomen and Makoff, 2011). Depletion of EAAT2 leads to neuronal death in transgenic mice 
(Rothstein et al., 1996).  
 
Prader-Willi Syndrome 
The Prader-Willi locus is genomically imprinted and only expressed from the paternally 
inherited chromosome, while the maternal copy is transcriptionally silenced (Constancia et al., 
2004). Loss of expression or mutation of the paternal 15q11-q13 locus therefore leads to the 
formation of the Pader-Willi disease phenotype. Patients have growth defects in both sexes due 
to growth hormone deficiency, and cognition problems (Butler, 2011). Amongst several other 
transcripts the small C/D box snoRNA MBII-52 is located within the Prader-Willi locus. This 
snoRNA contains 18 nucleotides that are complementary to the editing site C of the serotonin 5-
HT2c receptor. When expressed in nucleoli the 5-HT2c pre-mRNA can even be targeted for 2’-O-
methylation (Vitali et al., 2005). Loss of MBII-52 causes an increase in editing. Mice with a 
deleted PWS imprinted control region show enhanced locomotor activity and aberrant 
discriminative behavior (Doe et al., 2009). Altered 5-HT2CR editing can also lead to phenotypes 
that mimic PWS. Mice expressing the fully edited VGV form of the serotonin receptor also 
exhibit PWS-like phenotypes such as hyperphagia, hypotonia, increased metabolism, and slim 
stature (Morabito et al., 2010). Molecularly, this isoform exhibits blunted G-protein coupling, 
reduced constitutive activity and enhanced serotonergic neurotransmission possibly as a 
consequence of increased surface expression (Kawahara et al., 2008; Morabito et al., 2010).  
 
Transient Forebrain Ischemia 
Cereberal ischemia in CA1 pyramidal neurons is caused by reduced oxygen supply, primarily as 
a consequence of heart attacks or occlusions of arteries. Neuronal damage is caused due to 
increased Ca2+ influx because of increased GluA2Q expression (Liu et al., 2004). Increase in 
calcium activates Cdk5 which phosphorylates NMDA receptors (Liu et al., 2004). 
Phosphorylation, in turn, prolongs opening of NMDA receptors which can activate nitric oxide 
synthase leading to the formation of toxic peroxynitrite that induces neuronal death (Bossy-
Wetzel et al., 2004; Fiskum et al., 1999). During experimental induction of ischemia in rat brain 
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ADAR2 expression is reduced. Consistently, recovery from ischemia can be accomplished 
through increased ADAR2 expression (Peng et al., 2006).  
Downregulation of R/G site editing has been observed during spinal cord injury (Steffen et al.). 
Reduced editing at this site may limit cell death progression by suppressing postsynaptic 
excitation. Thus, editing might influence recovery after SCI (Barbon et al., 2010). Reduced 
editing at the R/G site was also observed in rat prefrontal cortex upon treatment with 
phencyclidene (PCP) that instigates schizophrenia like behavior (Barbon et al., 2007).  
 
Epilepsy  
Epilepsy is a common neurological disorder characterized by seizures caused by neuronal 
hyperexcitability (Bozzi et al., 2012). Decreased editing of the AMPA receptor Q/R site leads to 
calcium permeable channels. Mice heterozygous for an editing deficient GluA2 allele develop 
seizures and die at 3 weeks of age while complete absence of GluA2 expression does not 
provoke seizures (Brusa et al., 1995).  
Increased editing at the R/G site of the GluA2 transcripts and also of Kv1.1 have also been linked 
to seizures (Vollmar et al., 2004). Editing at the R/G site enhances glutamate response of the 
receptor and modulates neuronal excitability (Lomeli et al., 1994). The editing-induced I/V 
change in Kv1.1 channels lies in the S6 segment. This is the target site of many drugs blocking 
the channel (Decher et al., 2010). Interestingly, the Kv channel blocker 4-aminopyridine (4-AP) 
also induces seizure like events in rats. RNA editing, in turn, reduces the affinity of 4-AP and 
serves as a compensatory mechanism against epileptic seizures (Streit et al., 2011).  
 
Psychiatric Disorders 
Changes in the editing pattern of 5-HT2C pre-mRNA have been linked to different psychiatric 
disorders such as schizophrenia, depression, and bipolar disorder (Table 1). Editing leads to 
reduced G protein activation resulting in decreased basal activity (Niswender et al., 1999). 
However, the observed correlations do not allow a clear-cut conclusion. Sample sizes are 
typically small and the investigated samples are rarely well controlled and matched, therefore 
giving a heterogeneous picture. For instance, overexpression of the edited VSV receptor isoform 
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has been observed in patients suffering from schizophrenia and bipolar disorders (Dracheva et 
al., 2008). Previously, in two different studies on suicide victims suffering schizophrenia, a 
significantly under edited B site and a hyper edited A site has been observed (Niswender et al., 
2001; Sodhi et al., 2001). Analysis on suicide victims suffering major depression, in contrast, 
revealed an increase in editing at the C and C’ site accompanied by decreased D site editing. 
Treatment with fluoxetine, a serotonin selective uptake inhibitor, causes opposing effects on 
editing of these sites indicating site specific serotonin dependent regulation (Gurevich et al., 
2002). Deregulation of A to I editing in schizophrenia and bipolar disorder (type I) patients and 
underediting of I/V site in GRIK2 resulting in high calcium influx has also been related to over 
the expression of ADAR2 isoforms with diminished catalytic activity a (Silberberg et al., 2012; 
Silberberg and Ohman, 2011). However, increase in ADAR1 expression has also been found 
suggested as an inhibitor of ADAR2 activity (Simmons et al., 2010).  
 
Diabetes 
A possible link between RNA editing and type 2 diabetes has been proposed. Mice chronically 
fed a high-fat diet exhibit an elevated level of ADAR2, but not ADAR1 transcripts and therefore 
elevated editing levels of primary ADAR2 substrates, such as: ADAR2 and GluA2 transcripts in 
pancreatic islets and β-cell lines. Ionotropic glutamate receptors are responsible for insulin 
secretion (Gan et al., 2006). Furthermore, selective knockdown of ADAR2 impairs secretion in 
rat insulinoma cells (INS-1). Silencing of ADAR2 decreases expression of Munc 18-1 and 
synaptogamin -17. These molecules play a essential role in vesicle exocytosis (Yang et al., 
2010). 
 
Prostate Cancer 
It is a common death cause in men over 70 years old. Two editing events D695G and D819G 
were observed in androgen receptors reducing their functionality towards ligands (Martinez et 
al., 2008). The miR-99 family is strongly deregulated in prostate cancers. miR-99b is edited in 
the seed sequence whereas mature miR-99a is edited in tissue specific manner as brain, liver, 
testis and skeletal muscles (Galeano et al., 2011) 
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Outlook 
Current studies on RNA editing have clearly shown that adenosine deamination is most abundant 
in the central nervous system where it plays a major role in the diversification of the 
transcriptome. Three major processes seem to be primarily affected by A to I editing: first, many 
receptors and channels are modulated in their primary response and sensitivity to stimuli. 
Second, in many cases receptor assembly and retention in the ER seems to be affected by RNA 
editing. Finally, cytoskeletal components required for both outgrowth of neurons but also to the 
structuring of the cortical cytoskeleton and the anchoring of receptors is affected by RNA 
editing. It is one of the challenges to understand how these three processes are interconnected 
possibly being regulated through neuronal activity that may feed back on the process of RNA 
editing itself. 
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TABLE 1: Table showing different editing substrates and implications of editing are indicated. 
Receptor Editing site Function Diseases 
GluR-2 Q607 R Calcium impermeable 
ER exit efficiency reduction 
ALS, Epilepsy, 
Glioblastoma 
multiforme, Pediatric 
astrocytoma, 
GluR-2 R764G Enhanced rate of desensitization 
Modulation of alternative splicing 
Spinal cord injury 
(Steffen et al.), 
Epilepsy 
Schizophrenia on drug 
administration  
Serotonin receptor 
5HT2C 
I156V 
I156M 
N158S 
N158G 
N158D 
I160V 
 
Modulation of surface expression of 
the receptor 
Reduced G protein coupling 
Decreased Erk signaling 
Schizophrenia 
Bipolar disorder 
Depression 
Anxiety 
PraderWillisyndrome 
 
Kv1.1 I400V Faster recovery from inactivation. 
Reduced potency of channel 
blockers 
Epilepsy 
Gabra-3 I342M Reduced stability of α3 subunit Migraine 
FLNa Q2341R Kv4.2 K+ channel 
Presenilins 
metabotropic Glu R (4a, 
5a/b, 7a/b, 8a) 
 
CyFIP2 K320E 
  
Nova-1 S383G Increase in protein stability 
 
Ca(v)1.3 I1606M 
Q1607R 
Y1609C 
 
Decrease in calmodulin mediated 
calcium dependent inhibition CDI 
and faster recovery  from 
inactivation 
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ADAR Regulation 
Different mechanisms were proposed to decipher modes of regulation. Both ADAR1 and 
ADAR2 are expressed in all tissues but ADAR3 is expressed predominantly in brain (Melcher et 
al., 1996a).  
 
Developmental regulation in mice  
The developmentally regulated expression of ADAR1 and ADAR2 starts at mouse E10.0 (Wang 
et al., 2000a). Moreover the highest expression of ADAR1 is detected in the mouse heart at E10 
stage. ADAR1 is negatively regulated by miR-1 which is critical for heart development (Lim et 
al., 2005). ADARs are not only differentially expressed in different tissues but also cell specific. 
Both ADAR1 and ADAR2 are detectible in neurons but not in astrocytes (Jacobs et al., 2009). 
The protein expression of ADAR1 and ADAR2 remain constant from E15 to adult but the 
editing activity of ADARs increase significantly with development (Wahlstedt et al., 2009a). 
ADAR3, in contrast, is specific to post-mitotic cells in certain parts of the central nervous system 
(Chen et al., 2000) 
 
Localization 
The ADAR1 gene is transcribed from three different promoters. One is interferon inducible 
resulting in the translation of a long ADAR1 isoform i.e. ADARp150. The other two promotors 
show constitutive expression leading to the formation of ADAR1s (ADARp110). ADAR1L is 
detected mainly in the cytoplasm (Desterro et al., 2003). The nucleo-cytoplasmic shuttling of 
ADAR1p150 suggests that its targets, possibly including a different class of dsRNA substrates as 
endogenous repeat associated siRNA (esiRNAs) or viral RNA may be localized to the 
cytoplasm. ADAR1 might thereby serve as an antiviral defense mechanism (Yang et al., 2005). 
The nuclear localization signal lies in the third dsRBD of ADAR1 (Eckmann et al., 2001). In 
addition, ADAR1p150 is exported to the cytoplasm by the CRM1-RanGTP-mediated mechanism 
due to a functional nuclear export signal in the N-terminal Zα domain in full-length (Poulsen et 
al., 2001). Recently, however, the nuclear cytoplasmic shuttling of ADAR1p110 that lacks this 
Zα domain has been reported.. Interaction with the protein exportin-5 is mediated via dsRNA 
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binding and may be responsible for the CRM1-independent nuclear export of ADAR1. Although 
binding of dsRNA to the third dsRBD appears to facilitate nuclear export of ADAR1, it inhibits 
nuclear import of the complex. Transportin-1, which binds to the third dsRBD, has been 
identified as the import receptor for ADAR1 (Fritz et al., 2009).  
Nuclear import of ADAR2 and ADAR3 appears to be controlled by importin α family members: 
ADAR2 by importin α4 and α5, whereas ADAR3 in transported by importin α1, which 
recognizes the N-terminal R domain (Maas and Gommans, 2009a). In Caenorhabditis elegans 
ADBP-1 (ADR-2 binding protein 1) up regulates ADR-2 causing nuclear retention (Ohta et al., 
2008). In an adbp-1 mutant strain, A-to-I RNA substrates were not edited, indicating that ADBP-
1 is required for efficient editing. No homolog of ADBP-1 has been found in mammalian 
systems. 
Finally, ADAR1p110 and ADAR2 accumulate in the nucleolus. The localization of ADAR1p110 
and ADAR2 in this compartment  is dependent on functional dsRBDs. Nucleolar localization has 
been proposed to occur through their binding to rRNA or to small nucleolar RNA. ADARs may 
be stored temporarily in the nucleolus but move out to the nucleoplasm as substrate dsRNAs 
appear. Inhibition of ribosomal RNA synthesis also increases the efficiency of ADAR2 pre-
mRNA editing (Desterro et al., 2003; Sansam et al., 2003). However, the significance of the 
nucleolar localization of ADAR1p110 remains largely unknown. 
 
Splicing 
Alternative splicing contributes significantly to the regulation of ADARs. The RNA binding 
domain is encoded by a large exon and the deaminase domain is split among three exons. The 5’ 
UTR allows a distinction between mammalian ADARs and other vertebrates.  In human and 
mouse the 5’ UTRs of ADAR1 and ADAR2 comprise of 2 exons with no alternative splice 
variants but in fish and chicken it is split in 3 exons exhibiting various splice isoforms. Apart 
from this ADAR2 activity has been regulated by self editing and a number of alternative splicing 
events (Rueter et al., 1999). In rat, self editing of the ADAR2 transcript leads to a 47nt insertion 
shifting the translation start site to methionine 25 generating a protein isoform with decreased 
enzymatic activity. This 47nt insertion can also be found in other species to variable extents 
ranging from 80% in mouse brain to 15% in human brain and zebra fish (Slavov and Gardiner, 
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2002). Alternative splicing occurs near the catalytic deaminase domain encoded by exon 4-6. 
This involves the inclusion of an AluJ-containing exon 5a (human), extension of exon 5 (mouse) 
and protein truncation by skipping of exon 7 (chicken). The human protein has decreased activity 
due to exon inclusion whereas the mouse protein exhibits increased activity (Lai et al., 1997). 
Another mammalian specific ~8.5kb alternative ADAR2 transcript is generated by intron 9 
retention. This longer transcript can also affect translational efficiency (Gerber et al., 1997). 
Recently, a novel exon was discovered within intron 7 of ADAR2 containing multiple stop 
codons in all 3 frames. The transcript produced is targeted by NMD consequently leading to a 
negative regulation of ADAR expression (Agranat et al., 2010). Another novel exon (0) 
generates an ADAR2 isoform with an R domain as it extends the open reading frame by 49amino 
acids. The R-rich domain is closely related to the ssRBM of ADAR3; therefore, this new isoform 
is designated as ADAR2 R (Maas and Gommans, 2009b). 
 
 
Fig. 1.8: Genomic organization of human ADAR genes. Exons are represented to scale by boxes; introns, 
not to scale, by lines. Filled boxes are coding, and open boxes are non-coding; alternative promoters are 
depicted as striped boxes in front of their corresponding first exons. Gray boxes can be expressed alternately 
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as exons or introns. Alternatively, spliced exons are indicated. Genomic sizes spanning 5′UTRs, coding 
regions and 3′UTRs are indicated in kilobases.  (adapted from (Orlandi et al., 2011).  
 
Post-Translational modification 
A post-translational regulatory mechanism that controls ADAR2 activity has recently been 
revealed. ADAR2 is phosphorylated at Ser 26 and Ser31. Peptidyl prolyl isomerase NIMA 
interacting proteins (Pin1) binds phosphorylated ADAR2 ensuring its nuclear localization and 
stability. Depletion of Pin1 mislocalizes ADAR2 to the cytoplasm resulting in reduced editing at 
the GluR2 Q/R and R/G sites. The NEDD4 E3 ubiquitin ligase WWP2 binds ADAR2 through 
recognition motifs located at the N and C termini. WWP2 negatively regulates ADAR2 by 
catalyzing polyubiquitination followed by degradation (Marcucci et al., 2011). However, human 
ADAR2 is predicted to be phosphorylated at Ser26 and Thr740. Additionally, Ser59, Tyr65and 
Thr304 are also suspected to be phosphorylated by cyclin dependent kinase 1 (Cdk 1) (Orlandi et 
al., 2011). 
ADAR1 is predicted to be phosphorylated at 10 sites comprising of 599–614 (6 P-sites) and 
amino acids 808–825 (4 P-sites) (Orlandi et al., 2011). One posttranslational modification is 
SUMOylation affecting the editing activity of ADAR1. The human ADAR1 protein can be 
modified by SUMO1 (small ubiquitin-like modifier 1) on lysine 418, thereby reducing the 
editing activity (Desterro et al., 2005). SUMO1 colocalizes with ADAR1 in the nucleolus. 
Therefore, upon conjugation, SUMO1 might stimulate ADAR1 localization to the nucleolus, 
thereby separating ADAR from its targets. SUMO1 expression has been detected in embryonic 
stem cells; it is therefore a possible candidate as a negative regulator during early development. 
 
ADAR3 
ADAR3 is able to decrease the efficiency of ADAR1 and ADAR2, at least in vitro (Chen et al., 
2000). This phenomenon relies upon both its dsRBDs and its single-stranded RNA-binding R-
domain and likely results from sequestering of ADAR substrates. ADAR3 may therefore be 
involved in controlling editing by ADAR1 and ADAR2 in the central nervous system. 
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IP6  
IP6 is important for proper folding of ADAR (Macbeth et al., 2005). In neural tissue at E 8.5 the 
expression of Ipk2 required for IP6 production increases significantly (Frederick et al., 2005; 
Verbsky et al., 2005). Mice deficient for Ipk2 die at E9.5 with abnormal folding of the neural 
tube, indicating that IP6 is important during early embryogenesis (Macbeth et al., 2004). This 
implies that IP6 is normally present during development and not the limiting factor that 
decreases the activity of the ADAR enzymes during early development. 
         
 
Autoinhibition 
The N terminal segment of ADAR2 along with dsRBD1 is inhibiting editing activity since 
ADAR2 with a N terminal deletion is able to edit a 15bp long RNA substrate harboring an R/G 
stem loop. Addition of this N terminal region in trans inhibits ADAR2 catalytic activity 
(Macbeth et al., 2004). 
 
Protease cleavage of ADAR2 
Deregulation of GluA2 editing at the Q/R site increases calcium influx leading to prolonged 
opening of NMDA receptors activating a calpain protease. This protease cleaves ADAR2 
between the two dsRBM inhibiting ADAR2 activity (Mahajan et al., 2011). 
 
 
 
Fig. 1.9: Image of IP6 buried in the binding site of 
ADAR2. (from (Macbeth et al., 2005)) The zinc ion 
(magenta sphere) and the E396 residue are coordinating 
the nucleophilic water (aqua sphere). Underneath the Ip6 
molecule is visible (yellow sticks) interacting with 
conserved residues (Green) of the active site via hydrogen 
bonds, which in case of W523 and W687 are mediated by 
water. 
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Other factors 
ADAR2 expression is positively regulated by the transcriptional activator CREB1 (cyclic 
adenosine monophosphate response element-binding) protein during experimental induction of 
ischemia in the rat brain (Peng et al., 2006). Recently thiamine deficiency has also been found as 
a negative regulator of ADAR2 expression by modulating activity of transcription factors as NF-
kB (Lee et al., 2010). 
  
Specific Aims 
Deregulation of RNA editing has been found associated with various disorders. Although, 
different plausible mechanisms were proposed the underlying mode of regulation is still not 
clear. The aim of this project was therefore to employ a yeast screen to identify mammalian 
cDNAs that encode factors that inhibit RNA editing in a heterologous reporter assay. 
Subsequently these factors (presumably proteins) should be tested for their activity in a 
mammalian system. Finally, candidate proteins, that inhibit RNA editing in mammalian cells 
should be studied in more detail to understand their mechanism of action. 
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Creation of a W303 AULA2 yeast strain 
Vector expressing HIS3 gene as a auxotrophy marker gene containing amber stop codon being at 
the same time an editing site for positive selection was based on pUC18 LEU2:HIS3. This vector 
has HIS3 gene inserted in LEU2 gene. This insertion disrupts the open reading frame of LEU2 
gene vector used for disruption of LEU2 gene in Saccharomyces cerevisiae. Firstly the XhoI 
restriction site was introduced via mutgenesis of 101st nucleotide of his3 gene from thymine to 
guanosine. Next the KanMX4 gene was introduced. KanMX4 was cut out of pFA6-KanMX4 
vector using SmaI and SacI restriction sites and after blunting introduced into previously blunted 
NsiI restriction site downstream of HIS3 gene. Amber editing substrate has been obtained by 
cloning of annealed complementary oligonucleotides containing XhoI restriction sites and 
introducing it into pUC18 LEU2:HIS3-KanMX4 vector. Vector for a negative selection carrying 
URA3 as a auxotrophy marker was constructed on a base of vector carrying HIS3 after the initial 
HIS3 279base pair. In order to do that URA3 was amplified from YCplac33 construct and cloned 
into HIS3 gene using MscI and NheI sites removing at the same time 296 bp of the HIS3 gene. 
The ura3 expression is under the control of HIS3 promotoer and the URA3 expression also 
initiates through the methionine encoded by HIS3. 
 
Plasmid Isolation from yeast 
Single colony was picked and grown overnight in a selective medium. The cultures were 
centrifuged and the pellet was incubated with 15 microlitre zymolyase 20T, 10microlitre 100mM 
DTT with 30µL water at 37o C for 1 hr. Add 20µlitre 10%SDS. Freeze in liquid nitrogen. The 
lysate was thawed at 60 o C for 5 minutes with vigorous shaking. The plasmid was isolated by 
adding 200µL of P1 buffer (50mMTris–HCl pH8.0,10mMEDTA). The lysate was incubated with 
200 µL of P2 buffer (1%SDS;0.2MNaOH) for 5 minutes till the content becomes clear. Followed 
by incubation at -20oC for 10 minutes after the addition 200µL of P3 (3M KAc pH5.5). 
Centrifuged at maximum speed for 10minutes. The 500µL clear supernatant was incubated with 
1000µL of ethanol for 10 minutes at -20 o C. DNA was pelted by spinning at maximum speed for 
10 minutes and washed with 70% ethanol for 5 minutes. The pellet was air dried and suspended 
in 50µL water.  
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Transformation 
1 colony was suspended in 1ml YPD. Vortex vigorously to disperse clumps and transfer to 
150ml YPD. Incubate at 30 o C for 16-18hrs to stationary phase till O.D600>1.5 with shaking at 
250rpm. Transferred the overnight culture to 1L YPD at O.D600=0.2-0.3. Incubate at 30oC for 3 
hours with shaking at 250rpm. Place cells in 50ml falcons and centrifuge at 1000g for 5minutes 
at room temperature. Discard the supernatant and resuspended in 50ml sterile water. Pool cells in 
one tube and centrifuge at 1000g for 5 minutes at rom temperature. Decant supernatant and 
resuspended cells in 8ml 1XT.E. For library scale transformation 0.5mg of HeLA cDNAlibrary 
in pJB4 vector bearing Trp2 as marker gene, 20mg of salmon sperm DNA (sonicated for 
7.5minutes) were added to 8ml yeast competent cells of W303AULA2 strain with integerated 
editable stem loop and rat ADAR2.60ml PEG/LiAc (40%PEG4000, 1XT.E and 1XLiAc) was 
added and vortexed vigorously. Incubate at 30oC for 30 minutes at 200rpm. Heat shock for 15 
minutes at 42oC. Chilled on ice for 1-2 minutes. Centrifuge at 1000g for 5minutes. Remove 
supernatant and resuspended in 10ml 1XT.E. 100µL of the suspended cells were plated on 
respective plates.  
 
Cloning of yeast screen candidates into tissue culture expression vector 
Yeast screen candidates were cloned into one of the pcDNA3.1(-)-6Myc-NLS vectors using 
already preexisting EcoRI site from the yeast expression vector.. Cloning was performed via 
PCR using 5’ primer annealing further upstream used previously for amplifying the library hits 
for sequencing or specific primer containing EcoRI restriction site and 3’ primer  bearing the 
restriction site in the amplified sequence (KpnI). Additionally, full length of DDX-15 and SFRS-
9 gene were cloned into pcDNA3.1(-)-6Myc, pcDNA3.1(-)-6Myc-NLS EcoRI and KpnI 
restriction sites respectively. 
 
Tissue culture  
Tissue culture cell lines; human embryonic kidney cells (HeK293), HeLa cervical cancer cells 
and HeK293 stably transformed with Flag-tagged rADAR2 were cultivated in cell culture dishes 
at 37°C, 5% CO2 and constant humidity. The medium used was DMEM (Dulbecco’s modified 
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Eagle’s Medium), high glucose (4,5g/l) with addition of heat inactivated fetal bovine serum 
(10%), 2mM L-glutamine and 1X penicillin/streptomycin  solution (100x stock = 10000 
Units/ml penicillin, 10mg/ml streptomycin). rADAR2 stable cell lines were grown in a presence 
of 300µg/ml G418 (geneticin). Adhesive cell culture was passaged by exposing the cells to the 
digestion of 1X trypsin EDTA in PBS solution (10x stock = 5mg/ml trypsin, 2,2mg/ml EDTA) 
for 5-10 minutes at room temperature and afterwards inactivated with serum containing medium. 
For longer maintenance of the cell lines the cells were kept at -80°C in 10% DMSO (dimethyl 
sulfoxide) and 90% fetal bovine serum. All media and reagents used for tissue culture were 
produced by PAA, Austria. 
 
Transfection 
Tissue culture cell lines were transfected using Nanofectin reagent (PAA, Austria) according to 
the manufacturer’s instructions. After 72 hours of incubation the cells were processed to obtain 
RNA, protein extracts or were stained to visualize protein expression. Cotransfections of RNAG 
and vectors expressing screen candidates were performed in 1:6 ratio with the latter in an optimal 
amount suggested by the manufacturer. 
 
Creation of cell line stably expressing rADAR2  
Flag-tagged pcDNA3 rat ADAR2 (gift from Marie Ohmann) bearing neomycin resistance was 
transfected in HEK293 cells. Stables were selected with G418 (450µg/ml) for two weeks. 
Positive clones were checked by immunostaining for stable expression of ADAR2. Expression of 
ADAR was detected by primary polyclonal rabbit anti-Flag antibody  (Sigma) followed by goat 
anti-rabbit Alexa 488 antibody. 
 
Tissue culture protein extracts 
Tissue culture cells were washed with 1XPBS, detached from the surface with a cell scraper, 
transferred to an Eppendorf tube and collected via short centrifugation (10s at full speed). Cells 
resuspended in an appropriate amount (depending on a size of the dish) NET-2 buffer (150mM 
NaCl, 80mM Tris pH 7.4, 0.05% NP-40) were sonicated 3x 15s with 30% output and 50% pulse 
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keeping in between on ice for another 15s. The cell lysate was spun down twice at 4°C for 10 
minutes at full speed to get rid of insoluble proteins transferring the supernatant to a new tube 
each time. The remaining lysate was mixed with 2× SDS sample buffer (220mM Tris-HCl pH 
6.8, 1.8% SDS, 29% glycerol, 0.03% bromophenol-blue, 0.03% β-mercaptoethanol), boiled for 5 
minutes, centrifuged for 5 minutes and kept at -20°C until use. 
 
In situ staining 
Transfected cells grown on acid-etched coverslips after 32 to 48 hours were washed once with 
1×PBS and fixed for 5 minutes with a fixing solution (2% paraformaldehyde, 1×PBS, 0.05% 
Triton X-100). The next washing step was followed by a one minute methanol-permeabilisation-
step and another washing step. In order to visualize expressed proteins an immunocytology was 
performed. The fixed cells were blocked with 10% horse serum solution in 1XPBST (137mM 
NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.76mM KH2PO4, pH 7.4, 0.2% Tween-20). The cells were 
kept in primary antibody for 2 hours at room temperature or over night at 4°C in a moist 
chamber, washed 3 times with 2.5% horse serum solution in 1XPBST, kept in secondary 
antibody for 1 hour at room temperature in a moist chamber and after that still washed 3 times 
with 2.5% horse serum 1XPBST solution. For visualization of chromatin, preparations were 
mounted with Antifade (1g p-phenylenediamine/100ml phosphate buffer (150mM NaCl, 10mM 
KH2PO4, 10mM Na2HPO4), pH to 8.0 with carbonate buffer (500mM NaHCO3, 500mM 
Na2CO3); mix 1 part with 8 parts of glycerol) containing DAPI.  
 
Microscopical analysis 
Microscopic images were captured on a Zeiss fluorescence microscope equipped with an ORCA 
cooled charged-coupled device camera (Hamamatsu Middlesex, CA). Images were imported into 
Photoshop 4 (Adobe Systems, Mountain View, CA) with the help of a QED plug-in module 
(QED-Imaging, Pittsburgh, PA). 
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FACS analysis 
The flow cytometry data was collected on a FACScalibur (Becton & Dickinson) using the 
CellQuest 3.3 software at the BioOptics department of the Institute of Molecular Pathology, 
Vienna, Austria. The data was further analysed with the FlowJo 6.3.1 software. 
 
Cloning of FACS reporter system 
In order to investigate influence of ADAR2 activators in the tissue culture an A to I editing 
substrate was cloned between red fluorescent protein (RFP) and green fluorescent protein (GFP), 
used as a constitutively expressed control and as an editing efficiency marker respectively, in 
RNLG. (Schoft et al., 2007) Modified GluR-B R/G sequence, flanked with XhoI sites and with 
addition of two nucleotides to keep GFP in frame with it, was amplified via PCR and cloned into 
polylinker of RNLG using HindIII and BamHI restriction sites. Additionally to RNAG vector a 
construct with ’pre-edited’ version of the editing substrate containing tryptophan (W) codon as a 
positive control named RNWG has been prepared. 
 
FACS data analysis 
Each time readouts of 30000 cells were taken. The red and green fluorescence readouts of each 
cell were in effect plotted with help of FlowJo 6.3.1 software of on a graph with logarithmic 
scale with red fluorescence on y axis and green fluorescence on x axis. For statistical purposes 6 
different gates were taken with very broad window for the green fluorescence and very narrow 
for the red one to observe changes of the green fluorescence compared to fairly stable red 
fluorescence. The gates were chosen above a region of untransfected cells background and below 
a region where cell density started to drop down. The mean green florescence values from each 
gate calculated using Excel software (Microsoft) were divided by mean red fluorescence values 
to become normalized relative fluorescence values, which were plotted again on the graph on x 
axis against the chosen gates on y axis. 
	   	  	   Materials	  &	  Methods	  
	  
	  
42	  
RNA isolation 
The layer of cells growing on a dish was washed with 1XPBS and RNA was isolated directly 
from the dish using guanidinium thiocyanate-phenol-chloroform extraction with TRIzol or 
TriFast reagents (Invitrogen or Peqlab respectively) according to manufacturer’s protocols and 
after 96% ethanol/3M NaOAc precipitation and 70% ethanol washing step were kept in 
deionized water treated with DEPC at -20°C. 
 
Reverse transcription 
The cDNA was synthesized with RevertAid M-MuLV Reverse Transcriptase (Fermentas) 
according to the manufacturer’s instructions using random hexamers. 1/4 of the heat inactivated 
RT-reactions were used as templates for PCR reactions. 
 
Quantification of editing by sequencing 
Editing was quantified by dividing the height of G peak to the sum of A and G peak. All 
measurements were made in Adobe photoshop CS5. 
 
Immunoprecipitation assay 
The cell extracts for immunoprecipitation were prepared in NET-2 buffer  (150mM NaCl, 80mM 
Tris pH 7.4, 0.05% NP-40) or NP-40 lysis buffer (150mM NaCl, 50mM Tris pH 8.0, 1.0% NP-
40, 0.05% Sodium deoxy cholate, 0.01%SDS ) were sonicated 2x 15s with 30% output and 40% 
pulse keeping in between on ice for another 15s. 3-5mg of the protein A sepharose beads were 
coupled with 9E11 anti-myc antibody for myc pull down. Same amount of beads were coupled 
with rabbit anti-flag antibody. Similar amount of beads were used as control for IP The lysate 
was incubated on a rotating wheel for 3h at 4°C and washed three times in 500µl NET-2 or NP-
40 buffer, high salt buffer (500mM NaCl, 50mM Tris pH 7.5 0.1% NP-40, 0.05% Sodium 
deoxycholate) and low salt buffer (50mM Tris pH 7.05 0.1% NP-40, 0.05% Sodium 
deoxycholate). A small aliquot of it was mixed with 2xSDS sample buffer as an input control. 
After last washing the excess of the buffer was removed and the beads were resuspended in 80µl 
of 2x SDS sample buffer, boiled for 5 minutes, centrifuged for 5 minutes. The co-
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immunoprecipitation was analyzed by western blotting. The flag tagged ADAR was detected by 
primary rabbit polyclonal anti-flag antibody (Sigma) and alkaline phosphatase conjugated 
secondary anti-rabbit antibody (Sigma). The myc-tagged candidates were detected by 
monoclonal anti-myc 9E10 antibody (available in our lab) followed by alkaline phosphatase 
conjugated secondary anti-mouse antibody (Sigma). 
 
RNA isolation from C.elegans 
C.elegans strains were obtained from Caenorhabditis Genetics Center (CGC). VC2277 (DDX-
15+/-) with pharyngeal GFP were picked and progeny was segregated to gfp+ DDX-15+/- and non-
gfp sterile DDX-15-/- adults. Homozygous glh2-/- worms were also obtained from CGC. 24 
worms were collected in 100µL water. The worms were vortexed at 4oC for 30 minutes after 
adding 500µL of beads and 500µL of Trifast (Peqlab). Shake at 55oC after adding 200µL 
chloroform. Spin for 10 minutes. Aqueous phase was mixed with 250µL isopropanol with 1µL 
glycogen. Incubated at -80oC for 20 minutes and centrifuged for 20 minutes to pellet DNA. The 
RNA was further subjected to DNase I digestion. 
 
 Construction of shRNA Vectors 
To generate shRNA expression cassettes targeting candidate proteins the pLKO.1 lentiviral 
vector system was used (Moffat et al., 2006) as described by Addgene 
(http://www.addgene.org/plko). Briefly, specific oligonucleotides (Sigma) corresponding to the 
following Broad TRC RNAi shRNA library (The RNAi Consortium) sequences were introduced 
into the Age I – EcoR I sites of pLKO.1 (Addgene plasmid # 10878): 
Cells transfected with non-targeting shRNA vectors , activating RISC and the RNAi pathway, 
but not targeting any human gene, were used as negative controls in knockdown experiments. All 
shRNA expression cassettes were sequence verified. 
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Table 2.1: Table listing the shRNA used in the screen 
	  
Oligo	   Sequence	  
RPS-14-
sh1_S	  
ccggCCGAGATGAATCCTCACCATACTCGAGTATGGTGAGGATTCATCTCGGTTTTTg	  
RPS-14-
sh1_AS	  
aattcAAAAACCGAGATGAATCCTCACCATACTCGAGTATGGTGAGGATTCATCTCGG	  
RPS-14-
sh2_S	  
ccggCCTTGCCCGCTCGGGTATGAACTCGAGTTCATACCCGAGCGGGCAAGGTTTTTg	  
RPS-14-
sh2_AS	  
aattcAAAAACCTTGCCCGCTCGGGTATGAACTCGAGTTCATACCCGAGCGGGCAAGG	  
SFRS-9-
sh3_S	  
ccggCCTGCGTAAACTGGATGACACCTCGAGGTGTCATCCAGTTTACGCAGGTTTTTg	  
SFRS-9-
sh3_AS	  
aattcAAAAACCTGCGTAAACTGGATGACACCTCGAGGTGTCATCCAGTTTACGCAGG	  
SFRS-9-
sh4_S	  
ccggTGGAAGAAATGGTTATGATTACTCGAGTAATCATAACCATTTCTTCCATTTTTg	  
SFRS-9-
sh4_AS	  
aattcAAAAATGGAAGAAATGGTTATGATTACTCGAGTAATCATAACCATTTCTTCCA	  
DDX-15-
sh5_S	  
ccggGTTGGTTCGATAATGGCCTTTCTCGAGAAAGGCCATTATCGAACCAACTTTTTg	  
DDX-15-
sh5_AS	  
aattcAAAAAGTTGGTTCGATAATGGCCTTTCTCGAGAAAGGCCATTATCGAACCAAC	  
DDX-15-
sh6_S	  
ccggACTGTTCTAATGAGGTCCTATCTCGAGATAGGACCTCATTAGAACAGTTTTTTg	  
DDX-15-
sh6_AS	  
aattcAAAAAACTGTTCTAATGAGGTCCTATCTCGAGATAGGACCTCATTAGAACAGT	  
 
Viral Particle Production and Target Cell Infection 
Described shRNA-pLKO.1 constructs were co-transfected with the packaging plasmid pPax2 
(Addgene plasmid # 12260) and the envelop plasmid pMD2.G (Addgene plasmid #12259) into 
human embryonic kidney 293FT cells using Lipofectamine 2000 (Invitrogen). Virus was 
harvested 72 h post-transfection and concentrated using a PEG virus precipitation kit 
(BioVision). Infections of stable cells expressing the candidate proteinswere carried out in the 
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presence of 10µg/ml hexadimethrine bromide (a.k.a. polybrene, Sigma). Following transduction, 
cells were selected with 1 µg/ml puromycin.  
 
Gradient SDS PAGE and Blum’s Silver staining 
Samples were separated on a 7.5% - 17% gradient SDS-PAGE gel at 1200V/h. After the run 
Blum’s silver staining protocol was performed (Helmut Blum, 1987). Protein bands of interest 
were cut out and stored in 1% acetic acid. 
 
Mass spectrometry 
Analysis of peptides by nano-LC-MS/MS: Cut protein bands of interest were prepared for mass 
spectrometric analysis by reduction with 10 mM DTT and alkylation with 0,01g/ml 
Iodacetamide in Ammonium bicarbonate buffer, followed by tryptic digestion. Peptides were 
separated on an UltiMate 3000 HPLC system (Dionex, Thermo Fisher Scientific). Digests were 
loaded on a trapping column (PepMap C18, 5µm particle size, 300 µm i.d. x 5mm, Dionex) 
equilibrated with 0.1% TFA (trifluoric acetic acid) and separated on an analytical column 
(PepMap C18, 3 µm, 75 µm i.d. x 150mm, Dionex) applying a 30’ linear gradient from 2.5% up 
to 40% ACN with 0.1% formic acid followed by a washing step with 80% ACN and 10% TFE 
(trifluoroethanol). The HPLC was directly coupled to an LTQ-Orbitrap Velos mass spectrometer 
(Thermo Fisher Scientific) equipped with a nanoelectrospray ionization source (Proxeon, 
Thermo Fisher Scientific). The electrospray voltage was set to 1500 V. The mass spectrometer 
was operated in the data-dependent mode: 1 full scan (m/z: 400-1800, resolution 60000) with 
lock mass enabled was followed by maximal 20 MS/MS scans. The lock mass was set at the 
signal of polydimethylcyclosiloxane at m/z 445.120025. Monoisotopic precursor selection was 
enabled; singly charged signals were excluded from fragmentation. The collision energy was set 
at 35%, Q-value at 0.25 and the activation time at 10 msec. Fragmented ions were set onto an 
exclusion list for 30 s. 
Data interpretation: Raw spectra were interpreted by Mascot 2.2.04 (Matrix Science) using 
Mascot Daemon 2.2.2.. Spectra were searched against the human nr-database with the following 
parameters: the peptide tolerance was set to 2 ppm, MS/MS tolerance was set to 0.8 Da, 
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carbamidomethylcysteine was set as static modification, oxidation of methionine as a variable 
modification. Trypsin was selected as protease and two missed cleavages were allowed. 
MASCOT results were loaded into Scaffold (Ver. 3.00.02; Proteome Software). Peptide 
identifications were accepted if they could be established at a probability greater than 95%. as 
assigned by the Protein Prophet algorithm. Protein identifications were accepted if they could be 
established at a probability greater than 99%. Additionally, at least two identified peptides per 
protein were required. 
 
Polyacrylamide gel electrophoresis (SDS PAGE) 
Protein separation by molecular weight was performed in a polyacrylamide gel matrix. A SDS 
gel is composed of a resolving gel (x% 30:1 acrylamide/bis-acrylamide according to the size of 
the proteins to be resolved, 375mM Tris-HCl pH 8.8, 0.1% SDS) and a stacking gel 
(concentrates negatively charged proteins to a thin boundary; 3.6% acrylamide (30:1 
acrylamide/bis-acrylamide), 110mM Tris-HCl pH 6.8, 0.1% SDS, 13% glycerol). The proteins 
were mixed with 2× SDS sample buffer (220mM Tris-HCl pH 6.8, 1.8% SDS, 29% glycerol, 
0.03% bromophenol-blue, 0.03% β-mercaptoethanol), boiled for 5 minutes, centrifuged for 5 
minutes and loaded onto the gel. Electrophoresis was carried out in 1× SDS running buffer 
(25mM Tris-HCl, 190mM glycine, 0.1% SDS). 20mA electric current was applied per gel. 
 
Western Blotting 
After electrophoresis, the proteins were transferred to a polyvinylidene fluoride membrane (GE 
Water & Process Technologies) via tank-blotting. For that, the membrane activated in methanol 
and equilibrated in transfer buffer (20mM Tris-HCl, 150mM glycine) was placed on the gel and 
all air bubbles were removed. The gel and membrane were placed between two Whatman papers 
and two sponges, and that sandwich was then put into the tank, which was filled up with transfer 
buffer. The transfer was carried out at room temperature with icepacks in the apparatus at 360-
450mA for 80 minutes. Afterwards the membrane was blocked with 5% dry skim milk in TBST 
(25mM Tris, pH 7.4, 3.0mM KCl, 140mM NaCl and 0.05% Tween 20) for 20 minutes at room 
temperature. The primary antibody was diluted in 0.5% milk in TBST and applied to the 
membrane. The membrane was shaken in the antibody solution for one to two hours at room 
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temperature or overnight at 4°C. It was then washed three times for 10 minutes with 0.5% milk 
in TBST. The secondary antibody was diluted in 0.5% milk and the blot was again incubated for 
one hour. This was followed by three washing steps (10 minutes each, 0.5% milk in TBST). The 
proteins on the blot were either detected by chemiluminescence or NBT/BCIP chromogen 
precipitation. For the chemiluminescence, the secondary antibody had to be coupled to horse 
raddish peroxidase. For the detection the PIERCE supersignal solution was used according to the 
manufacturers instruction. For the chromogen detection, the secondary antibody had to be 
coupled to alkaline phosphatase. In the presence of an alkaline phosphatase enzyme, the 
chromogen NBT/BCIP produces a purple precipitate. The detection was carried out as 
recommended by the manufacturer.  
 
Cycle sequencing	  
Sequencing was performed with use of BigDye® Terminator v3.1 cycle sequencing kit (Applied 
Biosystems) according to manufacturer’s instructions and afterwards by the Department of 
Systematic and Evolutionary Botany at the Faculty of Life Sciences, University of Vienna. 
 
Cell Fractionation 
Cells growing in 10cm dish were rinsed twice with icecold 1XPBS. Harvested cells in 1ml ice 
cold 1XPBS by scraping and centrifuged at 1000rpm for 10minutes.Cells were resuspended by 
gentle pipetting in 200µL of lysis buffer A (10mMTris pH8.0,140mM NaCl, 1.5mM 
MgCl2,0.5%NP40)Incubated on ice for 5-7 minutes and centrifuged at +4oC for 
3minutes.Supernatant has cytoplasmic fraction. RNA was extracted by TRIzol.The nuclear pellet 
was given two additional washes with lysis buffer A and final wash with lysis buffer A 
containing 1% Tween-20 and 0.5% sodium deoxycholate acid. Purified nuclear pellet was 
resuspended in 1ml TRIzol. 
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Poly A RNA FISH 
Cells were fixed with 3-4% paraformaldehyde in 1XPBS pH7.4 for 15 minutes, Washed with 
1XPBS three times. Cells were permeabilized with 0.5% Triton X100 in 1XPBS for 5-10minutes 
on ice. Cells were washed again in 1XPBS three times 10 minutes each. Cells were rinsed in 
2XSSC. Hybridization buffer containing 2µL of yeast tRNA (10mg/ml),2µLof 20XSSC,4µL of 
50%Dextran sulphate was added to 1µL of oligo (polyA or poly T labelled with fluorescein dT), 
5µL of 100% deionized formamide (25% final concentration) and 6µL of DEPC treated water. 
The entire mixture was mixed and placed on one slide. Coverslips containing the cells are 
inverted on the slide and sealed with rubber cement and incubated in a moist chamber in water 
bath at 42oC. Floated off the coverslips with 2XSSCand washed in 2XSSC for 30 minutes at 
room temperature. Cells were washed in 0.5XSSc for 15 minutes at room temperature. 
Coverslips are washed in 4XSSC for 10 minutes twice. The DNA was stained by DAPI (1:1000 
in antifade solution). 
 
Bacterial Expression of Inhibitors 
RPS-14 and SFRS-9 were cloned into pET28a vector after cutting them from pcDNA3.1 vector 
using EcoRI and HindIII restriction sites. DDX-15 was amplified from the already cloned full 
length cDNA in mammalian vector using primers bearing EcoRI and XhoI restriction sites. The 
resultant full length DDX-15 was cloned into pET 28a vector. 
The inhibitors cloned in pET28a were transformed in C41 cells. Next day fresh colonies were 
inoculated in 2ml Kannamycin containing media. The culture were grown till O.D.600 =0.6 and 
then induced with 1mMIPTG for 3 hrs. Cell pellet was obtained by spinning them for 5 minutes 
full speed at 14000 rpm. The pellets were resuspended in 2XSDS buffer sonicated for 1 minute 
at 60% energy with 50% pulse. The protein extracts were boiled and run on SDS PAGE. The 
expression of ptrotein was detected by commassie staining. After verification of protein 
expression in small culture large scale purification done. 5ml of overnight preculture was used to 
inoculate fresh 500ml cultures. The culture was grown until O.D.600 =0.6 is reached. The culture 
was induced with 1mMIPTG for 3 hrs. Cells were pelleted by spinning at 14000 rpm for 10 
minutes at 4oC. The cell pellet was suspended in lysis buffer (50mMTris pH7.5, 500mMNaCl, 
1mMDTT and 1% Triton X100). The cells were sonicated for 2minutes at 70% energy with 50% 
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pulse with intervals of 30seconds, 1 minute and 30 seconds respectively. Keeping the cells on 
ice. The sonicated cells were centrifuged for 20 minutes at 20,000rpm for 20 minutes. The lysate 
was subjected to His purification using Nickle (His affinity purification column GE Health 
Care). After washing the unbound proteins elution was performed using gradient of imidazole 
20mM, 100mM and 250mM imidazole. 
 
Flag purification 
 The cells expressing overexpressed protein were washed with ice cold 1XPBS (137mM NaCl, 
2.7mM KCl, 10mM Na2HPO4, 1.76mM KH2PO4, pH 7.4). The cells were scraped in 1ml 1XPBS 
and were sonicated 2x 15s with 30% output and 40% pulse keeping in between on ice for another 
15s. The lysate was centrifuged for 10minutes full speed and incubated with Flag coupled beads 
(sigma) for 2 hrs. The beads were washed 3 times with lysis buffer and eluted in 100µL of lysis 
buffer after incubating it with 15µg of Flag peptide (sigma). 
 
In-vitro editing 
200b.p. of CyFIP2 was amplified from genomic DNA. The amplified fragment was cloned next 
to the T7 promotoer in KS- vector bearing SacI and HindIII restriction sites. The substrate was 
subjected to in vitro transcription by incubating 1µL of DNA with 4.5µL water, 4µL of 5X 
buffer, 2µL of 100mM DTT, 2.5µL 10mMrNTPS, 1µLRNasein, 1µL T7 polymerase.  
The purified ADAR and proteins were incubated in editing buffer (40 mM Tris–HCl pH 8, 5% 
glycerol, 25 mM KCl, 1.1 mM MgCl2, 1 mM DTT, 5 mM EDTA, 0.2 mM ATP, 0.16 U/µl 
RNasin (Fermentas). The reaction was incubated at 30°C for 30 min. Edited RNA was 
phenol/chloroform extracted and precipitated. Editing efficiency was checked by making gene 
specific oligo mediated cDNA followed by Tru1 restriction digestion. 
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PRIMERS 
The following primers were used in this study 
Name Sequence 5‘ – 3‘ Purpose 
MJ1136 GGTGGAGTTCAAGTCCATCTACATG
G 
5’ primer for RT-PCR of 
RNAG (binds to 3`end of 
RFP) 
MJ1137 GTGCAGATGAACTTCAGGGTCAGC 3’ primer for RT-PCR of 
RNAG (binds to 5` end of 
GFP) 
MJ1601 CCATCTAGATGGGATCTTGCTATATT
GCCC 
Reverse3’Primer for the 3’ 
UTR of the cflar gene 
MJ2256 ATCATGGCCAAAGCTACATATAAGG
AACGTG 
Forward primer to amplify 
URA3 without start codon 
and clone it in stem-loop-
HIS3 constructs, contains 
BalI (MscI) site. 
MJ2257 ATACGCTAGCTTAGTTTTGCTGGCC
GCAT 
Reverse primer to amplify 
URA3 with stop codon 
and clone it in stem-loop-
HIS3 constructs, contains 
NheI restriction site. 
MJ2362 GCCTGACTGGCTGAAATCG Forward primer for pJG4-
5 or pB42AD for 
amplification of cDNA 
insert upstream of EcoRI 
cloning site 
MJ2577 TCCCAATTGGACCATGGGGTGGCCC
AC 
5ʼ primer containing MfeI 
restriction site for NLS 
cloning from NLS GFP in 
pGEX2T into pcDNA3.1(-
)-6Myc expression vector 
MJ2578 CATGAATTCGTCTTCTACCTTTCTCT
TCTT 
5ʼ primer containing 
EcoRI restriction site for 
NLS cloning from NLS 
GFP in pGEX2T into 
pcDNA3.1(-)-6Myc 
expression vector 
MJ2579 CATGAATTCCGTCTTCTACCTTTCTC
TTCTT 
5ʼ primer containing 
EcoRI restriction site for 
NLS cloning from NLS 
GFP in pGEX2T into 
pcDNA3.1(-)-6Myc 
expression vector with 
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addition of one nucleotide 
upstream of restriction 
site 
MJ2580 CATGAATTCGCGTCTTCTACCTTTCT
CTTCTT 
5ʼ primer containing 
EcoRI restriction site for 
NLS cloning from NLS 
GFP in pGEX2T into 
pcDNA3.1(-)-6Myc 
expression vector with 
addition of two 
nucleotides upstream of 
restriction site 
MJ2583 TTGGTACCTCTGGCAAGGTAGACAA
GCCGAC 
3’ primer for cDNA library 
amplification from  
pB42AD containing KpnI 
MJ2584 GCGAAGCTTGGCTCGAGTTAGGTGG
GTGG 
5ʼ primer for GluR-B R/G 
stem-loop with amber 
stop codon cloning to 
RNLG vector containing 
HindIII 
MJ2585 GCGAAGCTTGGCTCGAGTTGGGTG
GGTGG 
5ʼ primer for GluR-B R/G 
stem-loop with Trp codon 
cloning to RNLG vector 
containing HindIII 
MJ2586 AGGGATCCCTCGAGAGCTGGGTAG
GT 
3’ primer for cloning GluR-
B R/G stem-loop with 
BamHI 
MJ2652a AGATCTCTTTTGAGGACCGCAAGG Forward primer for 
amplifying human FLNA 
MJ2653a TGGTCAATTTCTGTGACATAGCACTC
C 
Reverse primer for 
amplifying human FLNA 
MJ2712 GACCCAAGCTGGCTAGCGT 5’ oligo for pcDNA 
amplification 
MJ2726 TCTACCTAATGGATGGAAATGTCAGT
AAC 
Forward RT-PCR CyFip2 
primer 
MJ2727 ATCCCGGATCTGAACCATCTG Reverse RT-PCR CyFip2 
primer 
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MJ2807 
TAATCTCGAGGAGGTGGATGGGCCA
GCG 
CFLAR forward primer 
with xhoI restriction site 
MJ2891 
AAAGGTGATGTAGTATAATTTGTTTT
ATTG 
Forward primer to amplify 
zc239.6 in C elegans 
MJ2892 
CCTAAATCGAGTTGAAACCCCAAG Reverse  primer to amplify 
zc239.6 in C elegans 
MJ2909 
AGAAGAATTCATGGCACCTCGAAAG
GGGAAGG 
RPS-14 forward primer 
MJ2910 
 
GCTTGGTACCTCTGGCAAGGTAGAC
AAGCC 
RPS-14 reverse primer 
with Kpn1 site 
MJ2917 
GAGGGAATTCATGTCCAAGCGGCAC
CGGTTGG 
Forward primer for human 
amplification. Size 
2388b.p. 
MJ2918 
 
GAATGGTACCTCAGTACTGTGAATAT
TCCTTGGATTG 
reverse primer for human 
amplification. Size 
2388b.p. 
MJ2921 
GCGGGAATTCATGTCGGGCTGGGC
GGACGA 
Forward primer for SFRS-
9 human cloning with 
EcoRI site 
MJ2922 
CCTGGGTACCTCAGTAGGGCCTGAA
AGGAG 
Reverse primer for human 
SFRS-9 amplification. 
Size 666b.p. 
 
 
Antibodies 
The following antibodies were used in this study: 
Name Target Source Dilution Company 
9E10 Myc-tag Mouse 1:3 (WB), 1:1 (IP, Cyt) Homemade 
Anti-FLAG Flag-tag Rabbit 1:1000 (WB), 1:300 (Cyt) Sigma 
Anti-Rabbit rabbit (secondary antibody, 
coupled to horseradish 
peroxidase) 
Goat 1:10000 (WB) Axell 
Anti-Rabbit Rabbit (secondary antibody, 
coupled to alkaline 
phosphatase) 
Goat 1:1000 (WB) Pierce 
Anti-Mouse Mouse (secondary antibody, 
coupled to alkaline 
phosphatase) 
Goat 1:1000 (WB) Sigma 
Alexa Fluor 
568 Anti-
Mouse 
Mouse (secondary antibody) Goat 1:400 (Cyt) Invitrogen 
Alexa Fluor 
488 Anti-
Rabbit 
Rabbit (secondary antibody) Goat 1:400 (Cyt) Invitrogen 
(WB = Western Blotting, Cyt = in situ staining 
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RESULTS 
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Results of t                       Transformation assay 
To screen for inhibitors of editing the test strain AULA2 described above was transformed with a 
HeLA cDNA library, expressing HeLa cDNAs from a TRP2 vector. 1.0x106 transformed 
colonies were screened on 5-FOA (5-fluoroorotic acid) medium. Approximately 2x102 colonies 
appeared on the selective plates. The colonies (a total of 200) were picked for further analysis. 
 
Hits obtained in the screen 
Out of 200 hits the plasmid DNA of 134 haploid strains from the screen were sequenced 
successfully. Of these 134 hits many sequences encoded RNA binding proteins. 32 sequences 
were 3’UTR. 6 candidates aligned to non-annotated, unresolved DNA contigs and 3 aligned to 
the mitochondrial genome. The remaining 97 hits were aligning to ribosomal proteins (23), 
mitochondrial ribosomal proteins (2), RNA binding proteins (6), transcription associated proteins 
(4), mitochondrial proteins (9), transmembrane proteins (2), cytoskeleton associated proteins (5), 
chromatin related proteins (2), translation associated proteins (2), kinases (3), and protein -
folding, -degradation and -targeting proteins (12). 
 
TABLE 3.1.1: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the contig is given in following column  
No. Name  
1 ch13 contig 
2 chromosome 2 genomic contig 
3 chromosome 17 genomic contig 
4 chromosome1 contig 
5  chromosome3 contig 
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TABLE 3.1.2: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the 3’UTR is given in following column  
No. Name  
1 Copine III (CPNE3) 3'UTR 
2 Heterogeneous nuclear ribonucleoprotein H3 (2H9) (HNRPH3)exon+3'UTR 
3 SPRY domain containing 3 (SPRYD3) (exon+3'UTR) 
4 Guanylate kinase 1 (GUK1)  exon +3'UTR 
5 Protein phosphatase 1, regulatory (inhibitor) subunit 14B (PPP1R14B)3'UTR 
6 Tripartite motif-containing 38 (TRIM38)3'UTR 
7 Oxysterol binding protein-like 1A (OSBPL1A)3'UTR 
8 Met proto-oncogene (hepatocyte growth factor receptor)(Skuse et al.)3'UTR 
9 RAB17, member RAS oncogene family (RAB17) 3'UTR 
10 Coiled-coil domain containing 102A (CCDC102A)exon +3'UTR 
11 KIAA1147 (3'UTR) 
12  (ETF1) Eukaryotic translation termination factor 1(3'UTR) 
13 HnRNPA3 (3'UTR + SOME EXON) 
14 p21 protein (Cdc42/Rac)-activated kinase 4 (PAK49 3'UTR 
15 Phosphoserine aminotransferase 1 (PSAT1) 3'UTR 
16 Actin, gamma 1 (ACTG1) (exon +3'UTR) 
17 KHSRP (3'UTR)KH-type splicing regulatory protein  
18 HnRNPA3 (3'UTR + SOME EXON) 
19 SHC1 Src homology 2 domain-containing-transforming protein C1(3'UTR) 
20 SHC1 (3'UTR) 
21 PTPN3 (3'UTR) (protein tyrosine phosphatase, non-receptor type 3) 
22 TUBA1B (exon +3'UTR) 
23 RPL7A (has 3'UTR +lastexon) 
24 Chromobox homolog 6 (CBX6) 3'UTR 
25 Germ cell-less homolog 1 (Drosophila)-like (GMCL1L 
26  (ETF1) Eukaryotic translation termination factor 1(3'UTR) 
27 Parkinson disease (autosomal recessive, early onset)7 (PARK7)exon+3'utr 
28 RAB17, member RAS oncogene family (RAB17) 3'UTR 
29 Vitamin K epoxide reductase complex, subunit 1-like1 (VKORC1L1) 
30 Arginyl aminopeptidase (aminopeptidase B)-like 1 (RNPEPL1) 
32 RPL28 exon +3'UTR 
 
 
	   	   Results	  
	  
	  
56	  
TABLE 3.1.3: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded ribosomal protein is given in one column while the predicted 
function of the protein is given next to it. 
No. Name  Function 
1 RPL-13a belongs to the L13P family of ribosomal proteins 
2 RPL-18a  belongs to the L18AE family of ribosomal proteins 
3 RPS-18 Located at the top of the head of the 40S subunit. 
4 RPL-34 Belongs to the ribosomal protein L34e family 
5 RPL-6  binds to  the Tax-responsive enhancer element. 
6 RPL-7A  belongs to the L7AE family of ribosomal proteins.  
7 RPL-27A belongs to the ribosomal protein L15P family. 
8 RPS-14 belongs to the ribosomal protein S11P family. 
9 RPL-10A belongs to the ribosomal protein L1P family. 
10 RPL-34 Belongs to the ribosomal protein L34e family 
11 
Ribosomal protein, large, 
P0 (RPLP0)  
12 RPS-21  
           
13 RPL-10  
14 RPS-18 small ribosomal subunit protein 
15 RPS-3A  Belongs to the ribosomal protein S3Ae family 
16 
Ribosomal protein L29 
(RPL-29) 60S ribosomal protein L29 . 
17 
ribosomal protein L27 (RPL-
27) large ribosomal subunit protein 
18 
Ribosomal protein S15 
(RPS-15) 40S ribosomal protein S15 (RIG protein). 
19 
Ribosomal protein S6 
(RPS-6)   role in controlling cell growth and proliferation. 
20 RPS-26  belongs to the S26E family of ribosomal proteins 
21 
Ribosomal protein S23 
(RPS-23) Belongs to the ribosomal protein S12P family 
22 
Ribosomal protein L34 
(RPL-34)   
23 RPL-10A belongs to the ribosomal protein L1P family. 
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TABLE 3.1.4 Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded mitochondrial ribosomal protein is given in one column while 
the predicted function of the protein is given next to it. 
No. Name  Function 
1 
Mitochondrial ribosomal 
protein L22 (MRPL22) 
 
Mitochondrial large ribosomal subunit protein 
 
 2 
Mitochondrial ribosomal 
protein S18C (MRPS18C) 
Mitochondrial  small ribosomal subunit protein 
 
 
	  
TABLE 3.1.5: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded RNA binding protein is given in one column while the predicted 
function of the protein is given next to it. 
No. Name  Function 
1 
SERPINE1 mRNA binding 
protein 1 (SERBP1) May play a role in the regulation of mRNA stability 
2 
LSM7 homolog, U6 small 
nuclear RNA 
associatedLSM7 binds to the 3'-terminal U-tract of U6 snRNA. 
3 
DHX15 (DEAH  box 
polypeptide 15 DHX15) ATP-dependent RNA helicase implicatedinsplicing 
4 
small nuclear 
ribonucleoprotein 
polypeptide G (SNRPG)   
5 
SFRS-9 serine/arginine-rich 
splicing factor 9 
The protein encoded by this gene is a member of the 
serine/arginine (SR)-rich family of pre-mRNA splicing 
factors, which constitute part of the spliceosome.  
6 
nucleolar protein 
NOP5/NOP58 
(NOP5/NOP58), mRNA   
7 
SRA stem-loop-interacting 
RNA-binding protein 
 
RNA-binding protein that acts as a nuclear receptor 
corepressor. Probably acts by binding the SRA RNA, 
and repressing the SRA-mediated nuclear receptor 
coactivation.  
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TABLE 3.1.6: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded chromatin associated protein is given in one column while the 
predicted function of the protein is given next to it 
No. Name  Function 
1 
Poly (ADP-ribose) polymerase 
family, member 1 (PARP1) 
 
A chromatin-associated enzyme, poly(ADP-
ribosyl)transferase, which modifies various nuclear 
proteins by poly(ADP-ribosyl)ation.  
2 
DSN1, MIND kinetochore 
complex component, homolog  
 
Part of the MIS12 complex which is required for normal 
chromosome alignment and segregation and 
kinetochore formation during mitosis. 
	  
TABLE 3.1.7: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded transcription associated protein is given in one column while 
the predicted function of the protein is given next to it. 
No. Name  Function 
1 znf286  transcriptional regulation. 
2 
hmgn2 (high-mobility group 
nucleosomal binding domain 
2) 
unfolding higher-order chromatin structure and 
facilitating the transcriptional activation of mammalian 
genes 
3  Peroxiredoxin 4 (PRDX4) 
 regulatory role in the activation of the transcription 
factor NF-kappaB. 
4 NdkB 
Major role in the synthesis of nucleoside triphosphates 
other than ATP. Negatively regulates Rho activity by 
interacting with AKAP13/LBC. 
	  
TABLE 3.1.8: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded protein folding, targeting and degradation associated 
candidates is given in one column while the predicted function of the protein is given next to it 
No. Name  Function 
 
1 
CCT4 (chaperonin 
containing TCP1, subunit 4  
 
Molecular chaperone. Known to play a role, in the 
folding of actin and tubulin. 
 
 
2 
Chaperonin containing 
TCP1, subunit 3 (gamma) 
(CCT3),  
 
Molecular chaperone. Known to play a role, in the 
folding of actin and tubulin.  
 
	   	   Results	  
	  
	  
59	  
3 
heat shock 70kDa protein 8 
(HSPA8) 
 
This protein binds to nascent polypeptides to facilitate 
correct folding.  
 
 
4 
naca nascent polypeptide-
associated complex subunit 
alpha (NAC-alpha) 
 
Prevents inappropriate targeting of non-secretory 
polypeptides to the ER 
 
5 
heat shock protein 90kDa 
alpha (cytosolic) class A 
member 1 (HSP90AA1) 
 
HSP90AA1, an inducible form 
 
6 
chaperonin containing TCP1, 
subunit 3 (gamma) (CCT3),  
 
Molecular chaperone. Known to play a role, in the 
folding of actin and tubulin.  
 
7 
signal peptidase complex 
subunit 2 homolog (S. 
cerevisiae) (SPCS2) 
 
Component of the microsomal signal peptidase 
complex which removes signal peptides from nascent 
proteins as they are translocated into the lumen of the 
endoplasmic reticulum 
 
8 
prolylcarboxypeptidase 
(angiotensinase C) (PRCP) 
 
Cleaves C-terminal amino acids linked to proline in 
peptides  
9 
proteasome (prosome, 
macropain) subunit, alpha 
type, 6 (PSMA6) 
 
Cleavage of peptide bonds with very broad specificity. 
 
10 
ubiquitin-activating enzyme 
E1 (UBE1) 
 
Activates ubiquitin by first adenylating with ATP its 
carboxy-terminal glycine residue yieldS an ubiquitin-E1 
thioester and free AMP. 
 
11 
RAB34, member RAS 
oncogene family 
 
Protein transport. Involved in the redistribution of 
lysosomes to the peri-Golgi region 
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12 
RAN, member RAS 
oncogene family (RAN) 
 
 Required for the import of protein into the nucleus and 
also for RNA export. Involved in chromatin 
condensation and control of cell cycle 
 
PSMC1 proteasome 
(prosome, macropain) 26S 
subunit, ATPase, 1 
This gene encodes one of the ATPase subunits, a 
member of the triple-A family of ATPases which have a 
chaperone-like activity.  
 
TCP1 
 molecular chaperone that is a member of the 
chaperonin containing TCP1 complex (CCT), also 
known as the TCP1 ring complex (TRiC) 
 
TABLE 3.1.9: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded mitochondrial protein is given in one column while the 
predicted function of the protein is given next to it. 
No. Name Function 
 
1 
ATP synthase F0 subunit 6 
 
 
 
2 
succinate dehydrogenase complex, 
subunit Biron sulfur(Ip) (SDHB) 
 
 
3 pyruvate dehydrogenase (lipoamide) 
alpha 1 (PDHA1 
 
catalyzes the overall conversion of pyruvate to 
acetyl-CoA and CO(2) 
 
 
4 
cyt c oxidase subunitIII 
 
 
5 isocitrate dehydrogenase 3 (NAD+) 
beta (IDH3B) 
 
The protein encoded by this gene is the beta 
subunit of one isozyme of NAD(+)-dependent 
isocitrate dehydrogenase. 
 
6 cyt c oxidase subunitII Subunit 2 (CO II) transfers the electrons from 
cytochrome c to the catalytic subunit 1.  
 
7 Lactate dehydrogenase B ldhB 
 
LDHs are tetrameric enzymes catalyzing the 
pyruvate conversion to L-lactate 
 
8 ATP5L (ATP synthase, H+ 
transporting, mitochondrial F0 
complex, subunit G ) 
 
Mitochondrial ATP synthase catalyzes ATP 
synthesis,  
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TABLE 3.2: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded histone protein is given in one column while the predicted 
function of the protein is given next to it. 
No. Name Function 
1 H3 histone, family 3B 
(H3.3B) (H3F3B 
 
 This gene contains introns and its mRNA is 
poyadenylated, unlike most histone genes. The protein 
encoded is a member of the histone H3 family. [ 
2 Histone H2A type 1 
 
 
3 
H2A histone family, member 
Z 
 This gene encodes a replication-independent member 
of the histone H2A family that is distinct from other 
members of the family.  
 
TABLE 3.2.1: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded cytoskeletal protein is given in one column while the predicted 
function of the protein is given next to it. 
No. Name Function 
 
1 
actin, gamma 1 (ACTG1)  
 
Actin, gamma 1, encoded by this gene, is a 
cytoplasmic actin found in nonmuscle cells. 
 
 
2 
(DYNLL1) dynein, light 
chain, LC8-type 1  
 
May play a role in changing or maintaining the spatial 
distribution of cytoskeletal structures. 
Binds and inhibits the catalytic activity of neuronal nitric 
oxide synthase. 
 
 
3 discs, large homolog 5 
(Drosophila) (DLG5) 
 
It is proposed to function in the transmission of 
extracellular signals to the cytoskeleton 
 
4 
profilin 1 (PFN1) 
 
Binds to actin and affects the structure of the 
cytoskeleton. At high concentrations, profilin prevents 
the polymerization of actin, whereas it enhances it at 
low concentrations. By binding to PIP2, it inhibits the 
formation of IP3 and DG 
5 thymosin, beta 4, X-linked 
(TMSB4X 
 
Plays an important role in the organization of the 
cytoskeleton (By similarity). Binds to and sequesters 
actin monomers (G actin) and therefore inhibits actin 
polymerization. 
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TABLE 3.2.2: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded cell cycle kinase is given in one column while the predicted 
function of the protein is given next to it. 
No. Name Function 
1 CDK4 
 
The activity of this kinase is restricted to the G1-S 
phase, which is controlled by the regulatory subunits 
D-type cyclins  
2 cdc2 (CDK1 or p34 protein 
kinase) 
 
 
It is required in higher cells for entry into S-phase and 
mitosis.  
3 Cell division cycle 123 
homolog (S. cerevisiae) 
Cdc123 
 
Involved in cell cycle and cell division. 
	  
TABLE 3.2.3: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded translation associated protein is given in one column while the 
predicted function of the protein is given next to it 
No. Name Function 
1 mars tRNA 
 
belongs to the class I family of tRNA synthetases. 
 
2 ef1alpha 
 
 
3 arginyl aminopeptidase 
(aminopeptidase B)-like 1 
(RNPEPL1) 
 
 
4 
EEF1G eukaryotic 
translation elongation factor 
1 gamma 
This gene encodes a subunit of the elongation factor-1 
complex, which is responsible for the enzymatic 
delivery of aminoacyl tRNAs to the ribosome. 	  
TABLE 3.2.4: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded transmembrane protein is given in one column while the 
predicted function of the protein is given next to it. 
No. Name Function 
1 tmem66 
 
 
Highly expressed in macrophages 
 
 
2 transmembrane protein 183A (TMEM183A) 
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TABLE 3.2.5: Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a primary yeast 
screen. The name of the encoded protein is given in one column while the predicted function of 
the protein is given next to it 
No. Name Function 
1 basigin (Ok blood group) 
(BSG 
 
 
belongs to the class I family of tRNA synthetases. 
 
2 chm1B  
 
 
These proteins are components of ESCRT-III 
(endosomal sorting complex required for transport III), 
a complex involved in degradation of surface receptor 
proteins and formation of endocytic multivesicular 
bodies (MVBs). 
 
3 ornithine decarboxylase 
antizyme 1 (OAZ1) 
 
catalyzes the conversion of ornithine to putrescine  
 
4 macrophage migration 
inhibitory factor 
(glycosylation-inhibiting 
factor MIF  
 
gene encodes a lymphokine involved in cell-mediated 
immunity, immunoregulation, and inflammation. It plays 
a role in the regulation of macrophage function in host 
defense through the suppression of anti-inflammatory 
effects of glucocorticoids 
 
5 GSTM4 glutathione S-
transferase M4  
 
Conjugation of reduced glutathione to a wide number of 
exogenous and endogenous hydrophobic electrophiles 
 
6 SPATS2 spermatogenesis 
associated, serine-rich 2 
 
7 Yip1 domain family, 
member 6 
 
 
8 NUDT5 
 
NUDT5, eliminate toxic nucleotide derivatives from the 
cell and regulate the levels of important signaling 
nucleotides and their metabolites 
 
9 ferritin, light polypeptide 
(FTL), mRNA 
 
Stores iron in a soluble, non-toxic, readily available 
form. Important for iron homeostasis. Iron is taken up in 
the ferrous form and deposited as ferric hydroxides 
after oxidation 
 
10 cutA divalent cation 
tolerance homolog 
 
May forms part of a complex of membrane proteins 
attached to acetylcholinesterase (AChE). 
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11 S100 calcium binding 
protein A6 (S100A6) 
 
 
This protein may function in stimulation of Ca2+-
dependent insulin release, stimulation of prolactin 
secretion, and exocytosis 
 
12 vitamin K epoxide 
reductase complex, subunit 
1-like1 (VKORC1L1) 
 
 
13 small nucleolar RNA host 
gene (non-protein coding) 1 
(SNHG1)non-protein coding 
 
 
14 glycosyltransferase 8 
domain containing 2 
(GLT8D2) 
 
Glycosyltransferase 8 domain-containing protein 2  
 
15 glycoprotein hormones, 
alpha polypeptide (CGA 
 
glycoprotein hormones alpha chain precursor 
 
16 FTH1 ferritin, heavy 
polypeptide 1 
This gene encodes the heavy subunit of ferritin, the 
major intracellular iron storage protein in prokaryotes 
and eukaryotes. 
17 PARK7 parkinson protein 7 The product of this gene belongs to the peptidase C56 
family of proteins. It acts as a positive regulator of 
androgen receptor-dependent transcription. 
18 PPA1 pyrophosphatase 
(inorganic) 1 
The protein encoded by this gene is a member of the 
inorganic pyrophosphatase (PPase) family. PPases 
catalyze the hydrolysis of pyrophosphate to inorganic 
phosphate, which is important for the phosphate 
metabolism of cells.  
 
 
 
 
 
 
	  
3.3	   Confirmation	  of	  yeast	  strains	  obtained	  in	  the	  screen	  
To exclude false positive colonies and to compare candidates to each other the plasmids were 
retransformed into the test strain which was monitored for growth on FOA. In the secondary 
screen a group of 12 candidates was obtained. Candidates are listed in table 3.3 
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TABLE3.3:  Proteins encoded by cDNAs obtained as inhibitors of ADAR2 in a secondary 
yeast screen. The name of the encoded protein is given in one column while the predicted 
function of the protein is given next to it. 
No. Name Function 
1 CDC123  
2 FTH1 ferritin, heavy 
polypeptide 1 
This gene encodes the heavy subunit of ferritin, the 
major intracellular iron storage protein in prokaryotes 
and eukaryotes. 
 3 SEC13 homolog (S. 
cerevisiae) 
The protein encoded by this gene belongs to the 
SEC13 family of WD-repeat proteins. It is a constituent 
of the endoplasmic reticulum and the nuclear pore 
complex. It required for vesicle biogenesis from 
endoplasmic reticulum during the transport of proteins. 
4 RAN, member RAS 
oncogene family 
RAN (ras-related nuclear protein) is a small GTP 
binding protein belonging to the RAS superfamily that 
is essential for the translocation of RNA and proteins 
through the nuclear pore complex 
5 PPA1 pyrophosphatase 
(inorganic) 1 
The protein encoded by this gene is a member of the 
inorganic pyrophosphatase (P Pase) family. PPases 
catalyze the hydrolysis of pyrophosphate to inorganic 
phosphate, which is important for the phosphate 
metabolism of cells.  
6 SHC (Src homology 2 
domain containing) 
transforming protein 1 
3’utr 
7 DDX-15  DEAH (Asp-Glu-
Ala-His) box polypeptide 15 
The protein encoded by this gene is a putative ATP-
dependent RNA helicase implicated in pre-mRNA 
splicing. 
8 
SFRS-9 serine/arginine-rich 
splicing factor 9 
The protein encoded by this gene is a member of the 
serine/arginine (SR)-rich family of pre-mRNA splicing 
factors, which constitute part of the spliceosome.  
10 RPS-14 ribosomal protein 
S14 
Small ribosomal subunit protein S14 
11 RPS26 ribosomal protein 
S26 
Small ribosomal subunit protein S26 
12 TCP1  molecular chaperone that is a member of the 
chaperonin containing TCP1 complex (CCT), also 
known as the TCP1 ring complex (TRiC) 
 
3.4 Secondary screen: Inhibition of editing in tissue culture cells 
The candidate clones, expression of which led to an increase in editing in yeast cells had to be 
verified in a mammalian system. Therefore, the cDNAs encoding the 12 best hits were cloned 
into a tissue culture expression vector that allowed their expression as a myc-epitope-NLS 
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fusion-protein and transfected in a HEK293 cell line that was stably expressing rat ADAR2 for 
indirect and direct assessment of their ability to inhibit editing. 
cDNAs isolated from the yeast screen that only encoded a partial protein were cloned in two  
versions: as the original protein fragment recovered from the screen and as full length proteins. 
Non-coding candidates were cloned as recovered from the yeast screen.  
Successfull expression was tested by Western blotting using an atni-myc antibody. 
Sequences cloned out of frame  only expressed polypeptides slightly larger than the myc- and 
NLS sequence. Moreover, cytological staining of HeLa cells expressing the myc-tagged 
candidates proved their predominant nuclear localisation. Transfection efficiency was ranging 
from 20 to 50% and varied slightly throughout the experiments. 
 
A FACS reporter system for quantification of editing levels 
The GluA2 amber editing site harboring a stop codon that was employed in the primary yeast 
screen was introduced in a vector between the ORFs of RFP and GFP separated by a short linker 
harboring an NLS [see Figure 3.4.] (Schoft et al., 2007). The RFP expression from this vector is 
constitutive but the GFP expression is editing-dependent as editing will convert the stop codon to 
a tryptophan codon. The vector harboring the stem-loop stop codon was termed RFP-NLS-
AMBER-GFP (RNAG), while a pre-edited version in which the stop codon was replaced by a 
tryptophan codon was termed RNWG. This reporter allows a semi quantitative assessment of 
editing levels: strong editing leads to increased GFP expression while inhibition of editing 
reduces GFP expression relative to RFP expression. Thus fluorescence ratios can be measured in 
cells stably expressing rat ADAR2 that had been co-transfected with the RFP-GFP reporter 
plasmid and the plasmids expressing the candidate inhibitors of editing. Fluorescence ratios were 
measured by flow cytometry (FACS). 
For a graphic depiction of the FACS data, the red fluorescence was plotted on a 
logarithmically scaled y axis, while the green fluorescence was plotted on the x axis. If both RFP 
and GFP are expressed in equal amounts the readout of each single cell would lie on the diagonal 
of the graph. This is the case if the ‘pre-edited’ version RNWG is expressed.  ADAR2 stable 
HEK293 cells were used to determine editing levels. A decrease in editing would shift cells 
towards the left along the y-axis. 
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Fig 3.4.1:Schematic representation of the editing substrate. The  RFP and GFP fusion construct was 
established with the same editable stem loop that was used in the original yeast screen. The stem loop harboring a 
stop codon is separating RFP and GFP ORFs. In the absence of editing only RFP will be produced. Both RFP and 
GFP will be produced as a consequence of editing  
	  
ADAR	  
	  
	  
	  
	  ADAR	  
	   	   Results	  
	  
	  
68	  
 
 
 
Fig3.4.2:	   FACS graphs of cells transfected with various reporters. Left panel shows from top to bottom: 
untransfected control cells; cells expressing RFP; cells expressing GFP; cells expressing a vector 
constitutively expressing a fusion of RFP and GFP. Right panel from top to bottom: cells expressing the 
reporter RNAG construct; cells expressing RNWG, the ‘pre-edited’ version of RNAG; cells cotransfected 
with RNAG and hsADAR1; and cells cotransfected with RNAG and rADAR2. Cotransfection of either ADAR 
leads to a shift of cells to the right along the x-axis indicating increased GFP expression. 
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3.5	   Testing	  candidate	  cDNAs	  for	  inhibition	  of	  editing	  in	  the	  FACS	  reporter	  system	  
Selected candidates were tested in three independent experiments three times in the FACS 
reporter assay. Co-transfection of the reporter RNAG plasmid with the plasmids expressing the 
candidate cDNAs reduces transfection efficiency of either plasmid. Therefore, as an appropriate 
control the RNAG plasmid was transfected with an empty ‘candidate’ vector only expressing 
myc-NLS. Transfection efficiencies were in the range of 20-50%. Initially HeLA cells were used 
for shortlisting the candidates [Fig. 3.5.1]. 
To evaluate the FACS results a statistical approach was applied. Cells showing a solid RFP 
expression above background were divided into six gates depending on the strength of their RFP 
expression [Fig. 3.4.2 & 3.5.5]. This way, narrow pools in red fluorescence were compared to 
wide changes in green fluorescence intensity. For each cell in a gate green fluorescence values 
were divided by the red fluorescence values. The mean values of this calculation together with 
the standard deviation were plotted for each gate on the x axis of a two dimensional graph. Since 
HeLA does not have prominent editing activity, no strong editing inhibition was observed.  
 
 
 
 
 
 
 
 
 
•  
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Fig 
3.5.1: The 
region above the untransfected cells 
was divided into six 
equal portions or gates. Mean values of the three repeat was plotted by dividing red versus green fluorescence of all 
candidates in six different gates. The control is shown with a blue line. In each case the values of candidates are 
compared to the control. The standard deviation from the mean value of the three repeats is shown by horizontal 
capped line. SFRS-9, RPS-14, DDX-15 and TCP1 show shift towards left indicating decrease in green to red ratio 
(editing) as compared to control.  
 
However candidates like SFRS-9, DDX-15 and RPS-14 showed editing inhibition more 
prominently than others. Later onwards, the effective candidates were tested in stable ADAR2 
HeK293 cells clone . Different stable clones were made. We selected HeK ADAR2 stable clone 
3. [Fig. 3.5.2 -3.5.3]. 
 
  
Fig. 3.5.2.: Comparison of editing levels in the CyFIP2 pre mRNA in HeK cell line stably expressing 
rADAR2 (edited adenosine marked with an asterisk). The cDNA obtained via reverse transcription was 
amplified using MJ2726 and MJ2727 primers and sequenced with MJ2726 primer. The electrophorograms 
show different editing levels in different clones. 
 
	   	   Results	  
	  
	  
71	  
 
 
Fig.3.5.3: Immunostaining of different clones of HeK293 cells stably expressing flag-ratAdar2 Immunostaining 
was performed with anti-Flag antibody detecting rADAR2 and Alexa Fluor 488 antibody and Alexa Fluor 568 
antibodies for detection. 
 
This more sensitive method allowed to identify RPS-14, SFRS-9 and DDX-15 as inhibitors 
of editing. Since only small fragments of DDX-15 and SFRS-9 were obtained from the screen so 
full length versions of these candidates were cloned in the same vector [Fig. 3.5.4.]. The RPS-14 
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encoding cDNA was obtained full length from the screen. The full length proteins as compared 
to fragments show significant reduction in editing indicating that the full length proteins are also 
capable to efficiently inhibit editing [Fig. 3.5.5].  
 
 
	  
Fig 3.5.4: Schematic overview of fragments and the corresponding full length proteins SFRS-9 (25.5kDa) bears 
two RNA recognition motifs (RRM) and protein interacting serine arginine rich domain (RS). From the screen a 
part of RRM2 was obtained indicated by a red box. DDX-15 (90.93kDa)bears a N terminal DNA/RNA helicase 
domain.(DEAH), Helicase C terminal (Helicase C). Additionally DDX-15 harbors a helicase associated domain 
(HA2) and domain of unknown function (DUF1605). The DDX-15 fragment obtained from the screen contains HA2 
and DUF1605 marked by a red box. Full length RPS-14 (16.27kDa) was obtained from the screen and have a 
conserved  ribosomal S11 superfamily domain. 
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Fig 3.5.5.: FACS 
result in ADAR2 
stable HeK293 
cells. Mean 
values of red 
versus green 
fluorescence of 
all candidates in 
six different gates. In each case the values of candidates are compared to 
the control (blue). Full length RPS-14 showed a significant decrease in editing. DDX-15 fragment is shown in 
yellow whereas the full length DDX-15 indicated in green. Full length DDX-15 show stronger editing inhibition 
than the fragment obtained from the screen as compared to the control. SFRS-9 fragment is shown in light pink 
whereas the full length SFRS-9 (dark pink) show significant decrease in green to red ratio. Additionally, one graph 
from FACS analysis with chosen gates is shown. 
 
 
3.6 Determination of editing inhibition on different substrate 
Measuring fluorescence values of RFP and GFP expression by FACS is an indirect way to 
determine editing levels. Therefore, to verify these results by a more direct assay, editing levels 
were determined by sequencing of cDNAs generated from transcripts of the reporter stem loop. 
Furthermore, the influence of the candidates on the editing efficiency of endogenous substrates 
was studied. Additionally, attempts to elucidate the mode of action of the isolated inhibitors of 
editing were made. 
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3.6.1 Direct determination of editing levels of the RNAG stem loop in stable ADAR2 
expressing HeK293 cells 
To directly measure the editing inhibition induced by transfection of the cDNAs encoding 
the candidates, editing levels of the amber site in RNAG transcripts was investigated. RNA 
isolated from stable ADAR2 HeK293 cells that were co-transfected with the RNAG reporter 
plasmid and plasmids expressing the candidates was reverse transcribed Afterwards the editing 
site was amplified and sequenced. Sequencing results showed a decrease in editing upon co-
expression of the candidates. The protein fragments of DDX-15 and SFRS-9 show a decrease in 
editing as compared to the empty vector [Fig. 3.6.1]. However , the full length proteins exhibit 
stronger editing inhibition as compared to  the fragments [Fig 3.6.2]  
	  	  	  	  	  	  	  	  	  
 
Fig 3.6.1: Sequence comparison of the RNAG transcript edited in stable ADAR2 HeK293 cells with or 
without the expression of candidates i.e. fragments of proteins obtained from the screen (edited adenosine 
marked with an asterisk) The cDNA obtained via reverse transcription was amplified using MJ1136 and 
MJ1137 primers and sequenced with MJ1136 primer. The electrophorograms show editing of RNAG in 
stable ADAR2 HEK293 cells and the graphs show the result of 2 repeats. DDX-15 and SFRS-9 fragments 
show a moderate decrease in editing. The editing site is marked by an asterisk. 
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Fig. 3.6.2: Sequence comparison of the RNAG transcript edited in stable ADAR2 HeK293 cells with or 
without the expression of full length candidates (edited adenosine marked with an asterisk) The cDNA 
obtained via reverse transcription was amplified using MJ1136 and MJ1137 primers and sequenced with 
MJ1136 primer. The electrophorograms show editing of RNAG in stable ADAR2 HeK293 cells and the 
graphs show the result of 2 repeats. DDX-15, RPS-14 and SFRS-9 show a moderate decrease in editing. The 
editing site is marked by an asterisk. 
 
3.7 Editing of endogenous substrates in the cell line stably expressing rADAR2 
The above mentioned system relies on the transient co-transfection of both the  RNAG substrate 
plasmid and the plasmid expressing the inhibitors into the same cell. Moreover, the hairpin 
expressing the editable amber stop codon only remotely resembles endogenous substrates. 
Therefore we wanted to determine the effect of the candidate inhibitors on endogenous editing 
substrates. The best choice for studying the influence of inhibitors on editing modulation would 
be a cell line with a homogeneous ADAR2 expression, showing significant editing. Since editing 
sites can frequently be found in the vicinity of splice sites and since the speed of splicing may 
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affect the extent of editing, three different substrates were chosen that differ with respect to their 
context to splice sites. CyFIP2 pre mRNA harbors an editing site that is located far from a splice 
site. The filamin A (FLNa) pre-mRNA has an editing site located at the -2 position relative to the 
next downstream 5’ splice site. Finally, in the CFLAR RNA the editing site is located in the 
3’UTR.  
Sequencing of RT-PCR products of CyFip2 demonstrated a statistically significant 
decrease in editing upon transfection of inhibitors as compared to control. Co-expression of RPS-
14, DDX-15 and SFRS-9 resulted in a decrease of editing by 15%, 7%, and 9% respectively. 
[Fig. 3.7.1.] 
 
 
Fig. 3.7.1: Comparison of editing levels determined by direct sequencing of RT-PCR products of the 
CyFIP2 pre mRNA. Editing levels were determined after transfection of a cell line stably expressing 
rADAR2 with vectors expressing the candidate inhibitors of editing RPS-14, DDX-15, and SFRS-9, as 
indicated (the edited adenosine marked with an asterisk). The cDNA obtained via reverse transcription was 
*	  
*	  
*	  
*	  
*	   *	  
*	  
*	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amplified using MJ2726 and MJ2727 primers and sequenced with MJ2726 primer. The electrophorograms 
show a decrease in editing in two repeats. RPS 14 leads to the strongest reduction in editing. 
 
Sequencing of RT-PCR products of FLNa showed a statistically significant decrease in 
editing upon transfection of plasmids expressing RPS-14 and DDX-15 as compared to controls. 
In contrast, co-expression of SFRS-9 shows no significant editing modulation in FLNa. [Fig. 
3.7.2.] 
 
Fig. 3.7.2.: Comparison of editing levels in the FLNa pre mRNA after transfection of a cell line stably 
expressing rADAR2 with vectors expressing candidate inhibitors of editing (edited adenosine marked with 
an asterisk). The cDNA obtained via reverse transcription was amplified using MJ2652a and MJ2653a 
primers and sequenced with MJ2653a primer. The electrophorograms show a decrease in editing upon 
overexpression of RPS-14 and DDX-15. Overexpression of SFRS-9, in contrast, even led to a slight increase 
in editing. 
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Sequencing of RT-PCR products derived from the CFLAR pre-mRNA showed a statistically 
significant decrease in editing upon transfection of SFRS-9. Overexpression of RPS-14 and 
DDX-15, in contrast, showed no significant inhibition of editing [see Figure 3.7.3]. 
 
Fig. 3.7.3: Comparison of editing levels in the CFLAR 3’ UTR after transfection of a cell line stably expressing 
rADAR2 with vectors expressing putative inhibitors of editing (edited adenosine marked with an asterisk). The 
cDNA obtained via reverse transcription was amplified using MJ1604 and MJ2807 primers and sequenced with 
MJ2807a primer. The electrophorograms show a decrease in editing upon overexpression of SFRS-9. 
	  
Substrate-specific inhibition of RNA editing 
The candidate proteins isolated in this screen all did inhibit RNA editing. However, the extent of 
inhibition varied considerably between the different substrates investigated. A direct comparison 
of the activity of the three candidate proteins on the editing of four different substrates (RNAG, 
FLNa, CyFIP2, and CFLAR) shows a substrate-specific effect exerted by some candidates. 
While the FLNa pre mRNA was only moderately affected by the three candidates the CFLAR 3’ 
*	  
*	  
*	  
*	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UTR was most strongly affected by the SFRS-9 protein. Editing of the artificial stem-loop was 
mildly affected by all three factors while the CyFIP2 pre-mRNA was most affected by SFRS-9 
and RPS-14 overexpression. Thus, it seems that different factors can affect editing in a site 
specific manner, possibly by specifically interfering with RNA-binding to specific sites (see 
discussion) [see Figure3.7.4]	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.7.4 Graph showing variable editing inhibition on different substrates. The significant editing 
inhibition is marked by an asterisk. CyFIP2 and the artificial substrate RNAG undergoes significant editing 
inhibition on overexpression of RPS-14, DDX-15 and SFRS-9. Significant FLNa editing inhibition  was 
observed on overexoression of RPS-14 and DDX-15. SFRS-9 overexpression leads to a slight increase in 
FLNa editing. Significant editing inhibiton of CFLAR was only observed on overexpression of SFRS-9. RPS-
14 and DDX-15 overexpression in contrast cause a slight increase in editing of the CFLAR 3’UTR. The 
corresponding P values are indicated in a box. 
 
3.8 Knockdown of candidate proteins  
Overexpression of candidate inhibitors of RNA editing did lead to a modest but 
reproducible decrease in editing. However, cellular levels of the candidate proteins might 
already be high. Therefore, to determine whether silencing of the candidate proteins would 
P VALUES 
CyFIP2 
RPS-14=0.00941 
DDX-15=0.0008 
SFRS-9=0.022 
FLNa 
RPS-14=0.00566 
DDX-15=0.0013 
SFRS-9=0.65 
CFLAR 
RPS-14=0.015 
DDX-15=0.955 
SFRS-9=0.015 
STEM LOOP (RNAG) 
RPS-14=0.016 
DDX-15=6.63E-05 
SFRS-9=0.006241 
 
 
 
 
 
 
	   	   Results	  
	  
	  
80	  
have an inverse effect on editing knockdown experiments were performed. To silence the 
candidate proteins we took advantage of the efficient lentiviral shRNA delivery system 
(Moffat et al., 2006) For each candidate protein two shRNAs were designed and tested for 
their effect on editing levels. Sequencing of RT-PCR products of the CyFIP2 pre mRNA 
showed a statistically significant increase in editing upon silencing of SFRS-9 and RPS-14. 
Delivery of shRNAs directed against DDX-15, however, showed no increase in editing as 
silencing failed in the case of DDX-15. Silencing of RPS-14 was also not so efficient and 
showed minor impact about 5% on editing [see Figure 3.8.1].  
 
 
Fig. 3.8.1: Comparison of editing in the CyFip2 pre mRNA upon silencing of RPS-14, DDX-15, or SFRS-9 in 
a cell line stably expressing rADAR2. (The edited adenosine is marked with an asterisk). Silencing of RPS-14 
and SFRS-9 leads to an increase in editing. Silencing of DDX-15 was inefficient and therefore had no effect on 
RNA editing. 
 
To test whether the shRNA treatment did indeed lead to a silencing of the candidate proteins we 
generated stable cell lines expressing the myc-tagged versions of the candidates. These cell lines 
were treated with lentiviral mediated shRNA transfection. The presence of the myc-tagged 
proteins was then determined using an anti-myc tag antibody. As can be seen in Figure 3.8.2-
3.8.4. Silencing of SFRS-9 and RPS-14 worked efficiently, while DDX-15 could not be silenced. 
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This finding is consistent with the changes observed upon sequencing of endogenous CyFIP2 
substrates that showed a clear increase in editing upon shRNA treatments against SFRS-9 and 
RPS-14, but not for DDX-15 shRNA treatment.  
 Fig 3.8.2: Immunostaining of RPS-14 expressing U2OS 
cells transfected with lentiviral shRNA vectors. Cells 
stably expressing myc tagged RPS-14 were stably 
transfected with lentivirus expressing two different 
shRNAs and control (non-target).The non-target control 
had no effect on RPS-14 expression. shRNA1 was found 
and shRNA2 were not so efficient in silencing RPS-14.. 
Immunostaining was performed with anti-Myc antibody 
detecting Myc-tagged proteins and Alexa Fluor 568 
antibody for detection. Scale bar: 20µm 
 
 
 
 
 
 Fig 3.8.3: Immunostaining of DDX-15 expressing HeK293 
cells transfected with lentiviral shRNA vectors. Cells stably 
expressing myc tagged DDX-15 were stably transfected with 
lentivirus expressing two different shRNAs and control (non-
target).The non-target control and the two shRNAs direcrted 
against DDX-15 had no effect on DDX-15 expression. 
Immunostaining was performed with anti-Myc antibody 
detecting Myc-tagged proteins and Alexa Fluor 568 antibody 
for detection. Scale bar: 20µm 
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Fig 3.8.4: Immunostaining of SFRS-9 
expressing HeK293 cells transfected with lentiviral 
shRNA vectors. Cells stably expressing myc tagged 
SFRS-9 were stably transfected with lentivirus 
expressing two different shRNAs and control (non-
target).The non-target control showed no effect on 
SFRS-9 expression. Out of the two shRNAs direcrted 
against SFRS-9. shRNA3 had no effect on SFRS-9 
expression. shRNA4 showed efficient silencing of SFRS-
9. Immunostaining was performed with anti-Myc 
antibody detecting Myc-tagged proteins and Alexa 
Fluor 568 antibody for detection. Scale bar: 20µm 
 
3.9 DDX-15 activity is conserved in C. elegans 
ADAR activity is found in all metazoan. The nematode C. elegans also exhibits editing of 
several structured 3’ UTRs (Morse and Bass, 1999). C. elegans expresses two ADAR genes adr-
1 and adr-2. Similarly, two of the three inhibitors identified in this study can also be found in the 
C. elegans genome: SFRS-9 and DDX-15. Of these, a viable deletion in the ddx-15 gene is 
available from the C. elegans genetics center. C.elegans DDX-15 is 70% similar between human 
and C.elegans.Therefore, to test whether C .elegans DDX 15 would also negatively influence 
RNA editing. Editing levels of the 3’UTR of zc239.6 were determined for the offspring of 
heterozygous hermaphrodites. Thus, wild type, heterozygous, and homozygous deletions of ddx-
15 could be compared directly. Sequencing of RT-PCR products showed a statistically 
significant increase in editing of zc239.6 3’UTR in DDX-15 knockout worm as compared to 
control and heterozygous worms. To test whether loss of any helicase would lead to an increase 
in editing a deletion of the germ-line helicase glh-2 was included as a control. Interestingly, 
deletion of glh-2 did not lead to an increase in RNA-editing [see Figure 3.9.1 A]. 
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Fig. 3.9.1: Comparison of editing levels of C.elegans 3’UTR (zc239.6). A) Editing levels were compared by 
direct sequencing of RT PCR products of the zc239.6 3’ UTR. cDNA was amplified from wildt type (wt), glh-2 
heterozygotes (glh-2+/-), glh-2 deletions (glh-2-/-), ddx-15 heterozygotes (ddx-15+/-) and homozygous ddx-15 
deletions (ddx-15-/-)- Genomic DNA was sequenced alongside for comparison. The edited adenosine is marked 
with an asterisk. The cDNA obtained via reverse transcription was amplified using MJ2891 and MJ2892 primers 
and sequenced with MJ2891 primer. The electrophorograms show an increase in editing in the homozygous ddx-
15 deletion in two biological repeats.  
 
 
 
	   	   Results	  
	  
	  
84	  
 
Fig 3.9.1B) A graph showing a quantification of editing levels shown in A). The ddx-15 deletion shows a clear 
increase in editing. 
 
	  3.10	   Interaction of inhibitors of editing with ADAR2 
To elucidate the mode of action by which the potential inhibitors of editing might affect the 
activity of rADAR2, we tested whether a direct interaction between the inhibitors and ADAR2 
could be detected. To do this HeK293 cells stably expressing ADAR2 were transiently 
transfected with plasmids expressing the myc-tagged candidates. Lysates generated from these 
cells were used for immunoprecipitation experiments. In these experiments RPS-14 could be 
coprecipitated with rADAR2 while the converse was not the case. This suggests a weak 
interaction between the two proteins. Interestingly, this interaction was resistant to RNAse 
treatment, suggesting a direct protein-protein interaction, at least when both factors are 
overexpressed [Fig. 3.10.1-3.10.3].  
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Fig. 3.10.1: Co-immunoprecipitation of myc-RPS-14 with rADAR2. Cells transfected with the appropriate 
constructs were cultured for 72 hours and afterwards the cell lysate was used for the IP experiment. The Western 
Blot was detected with anti-myc antibody to detect myc-RPS-14 and anti-Flag antibody detecting flag-tagged 
rADAR2. Blots are shown: input showing extracts of transfected HeK293cells to visualize the presence of rADAR2 
or RPS-14 in stable cell lines. Pull down experiments were either done with anti-flag, anti-myc, or uncoupled beads. 
Although the myc-tagged polypeptides are visible after the IP, there is no sign of rADAR2 being pulled down along 
with RPS-14. Nonetheless, RPS-14 can get coprecipitated with ADAR2 in a flag pull-down. Arrowheads mark the 
bands for ADAR2 and arrows indicate RPS-14 bands. 
 
In contrast to the above demonstrated interaction of RPS-14 with ADAR2 no interaction 
could be detected between ADAR2 and DDX-15 [see Figure 3.10.2]. 
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Fig. 3.10.2: Co-immunoprecipitation of myc-DDX-15 with rADAR2. Cells transfected with the appropriate 
constructs were cultured for 72 hours and afterwards the cell lysate was used for the IP experiment. The Western 
Blot was detected with anti-myc antibody to detect myc-DDX-15 and anti-Flag antibody detecting flag-tagged 
rADAR2. Blots are shown: input showing extracts of transfected HeK293cells to visualize the presence of rADAR2 
or DDX-15 in stable cell lines. Pull down experiments were either done with anti-flag, anti-myc, or uncoupled 
beadss. Although the myc-tagged polypeptides are visible after the IP, there is no sign of rADAR2 being pulled 
down along with DDX-15. Conversely, no DDX-15 can be precipitated with ADAR2. Arrowheads mark the bands 
for ADAR2 and arrows indicate RPS-14 bands. 
 
Finally, co-precipitation experiments of extracts derived from cells expressing myc-SFRS-9 and 
flag-ADAR2 showed a solid interaction between the two factors. Both flag-ADAR2 could be 
precipitated with myc-SFRS-9 but also SFRS-9 could be precipitated together with flag-ADAR2. 
Both precipitates were resistant to RNAse treatment suggesting a solid interaction between the 
two overexpressed proteins [see Figure 3.10.3].	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Fig. 3.10.3: Co-immunoprecipitation experiment to detect an interaction between rADAR2 with myc-tagged 
SFRS-9. Cells transfected with appropriate constructs were cultured for 72 hours and afterwards the cell lysate was 
used for the IP experiment. The Western Blot was detected with anti-myc antibody to detectmyc-SFRS-9 and anti-
flag antibody detecting flag-tagged rADAR2. Blots are shown: the input, lysates of transfected and native 
HeK293cells showing expression of rADAR2and myc-tagged SFRS-9. Immunoprecipitation of flag-ADAR2 allows a 
coprecipitation of myc-SFRS-9. Conversely, precipitation of myc-SFRS-9 allows coprecipitation of flag-
ADAR2.Interactions are resistant to RNAse treatment. Arrowheads indicate ADAR and arrows indicate SFRS-9. 
Asterik (*) indicate heavy chain. 
 
 3.11 Specific localization of overexpressed inhibitors 
 
At the same time the localization of the overexpressed inhibitors was investigated. In 
particular we were interested to determine whether candidates colocalize with ADAR2. Indeed, 
overexpressed RPS-14 localizes with ADAR2 to nucleoli. SFRS-9 partially colocalize with 
ADAR2 in nucleoli but also exhibits a nuclear speckle associated staining pattern. DDX-15 does 
not co-localize with ADAR2 and show a distinct nuclear speckle pattern. [Fig.3.11.1]. 
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Fig. 3.11.1: Immunostaining of HeK293 cells stably expressing flag-ratAdar2 transfected with vectors expressing 
myc-tagged inhibitors of editing. The cells transfected with appropriate constructs were cultured for 72 hours and 
afterwards the immunostaining was performed with anti-Flag antibody detecting rADAR2, anti-Myc antibody 
detecting Myc-tagged candidates and Alexa Fluor 488 antibody and Alexa Fluor 568 antibodies for detection. Scale 
bar: 20µm 
 
3.12 Mass Spectrometry of DDX-15 
To further determine the proteomic interaction profile of the inhibitors of editing we did 
mass-spectrometric analysis of proteins that would co-precipitate with the myc-tagged inhibitors 
of editing (Cornelia Handl). To do this, cells stably expressing the myc-tagged inhibitors were 
lysed and used for precipitation with anti-myc protein A sepharose beads. Precipitated proteins 
were separated on SDS gradient gels and subjected to silver staining. In these experiments only 
myc-DDX-15 showed clear protein bands that were co-purified. Distinct bands were excised 
from a gel [see Figure 3.12.1] and subjected to mass spectrometric analysis [see table 2]. DDX-
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15 showed a strong interaction with a transcriptional repressor of NF kappa B. Interestingly, 
this factor is also predicted to harbor a double-stranded RNA-binding motif. Moreover, RNA 
helicase A was also found to interact with DDX-15. RNA helicase A has previously been 
reported as editing inhibitor. 
 
 
Fig. 3.12.1: Immunostaining of HeK293 cells stably expressing myc-DDX-15 transfected with vectors expressing 
myc-tagged inhibitors of editing. The immunoprecipitated proteins were resolved on a SDS-gradient gels. The bands 
differing from the control were excised (labeled A –E) and subjected to mass spectrometric analysis. 
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Table 2: Table demonstrating mass spectrometric analysis.results 
DDX-15 interacting protein 
number 
of 
assigne
d 
spectra 
sample: 
Mw, 
source 
Mw 
(kDa) Function 
putative pre-mRNA-splicing 
factor ATP-dependent RNA 
helicase DHX15 [Homo 
sapiens] 
 
373 85.2 91 
Pre-mRNA processing 
factor involved in 
disassembly of 
spliceosomes after the 
release of mature mRNA 
NF-kappa-B-repressing factor 
isoform 1 [Homo sapiens] 59 77.3 79 transcriptional repressor  
NudC domain containing 1, 
isoform CRA_a [Homo 
sapiens] 
23 52.3 57  
mitochondrial heat shock 60kD 
protein 1 variant 1 [Homo 
sapiens] 
18 52.3 61 Chaperonin 
KIAA0002 [Homo sapiens] 10 52.3 59  
T-complex protein 1 subunit 
alpha isoform a [Homo 
sapiens] 
8 52.3 60 
Molecular chaperone; 
assists the folding of 
proteins upon ATP 
hydrolysis 
U4/U6 snRNP-associated 61 
kDa protein [Homo sapiens] 5 52.3 55 Splicing 
spliceosomal protein SAP 155 
[Homo sapiens] 5 108.8 146 Splicing 
ATP-dependent RNA helicase 
A [Homo sapiens] 5 108.8 141 
Unwinds double-
stranded DNA and RNA 
in a 3' to 5' direction 
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DISCUSSION 
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4.1 Modulators of ADAR activity 
Although the mechanism of ADAR-mediated RNA-editing is known cellular regulators of 
ADAR-mediated editing still need to be discovered.  
The first evidence that ADAR may require a cofactor came with the discovery that site 
selective editing activity requires a balanced proportion of ADAR, substrate and some unknown 
factors (Dabiri et al., 1996). As ADARs are involved in co- and post-transcriptional processes, 
this suggests that these enzymes are part of a very complex RNP architecture that forms on 
nascent transcripts, which have to be edited, spliced and in the end exported. Recently, a direct 
interaction between ADAR2 and the C-terminal domain (CTD) of RNA polymerase II has been 
shown. The CTD is necessary for ADAR2 to auto-edit its transcript (Laurencikiene et al., 2006). 
This would indicate a possible existence of factors influencing co-transcriptional RNA editing. 
Apart from the above mentioned facts, an up regulation of editing activity during 
development was demonstrated with constant levels of ADARs (Wahlstedt et al., 2009a). This 
fact also points in the same direction and argues for the existence of potential cellular modulators 
of ADARs. Moreover, other evidences like post translational modification (Marcucci et al., 
2011), alternative splice isoforms (Rueter et al., 1999) and heterodimerization (Cenci et al., 
2008b; Chen et al., 2000) indicate regulation of editing activity at the transcriptional and 
translational level.  
Three attempts were made to screen for factors influencing editing activity. First, the Peter 
A. Beal laboratory performed a screen in yeast for mutations in ADAR2 and editing substrates 
that would change editing activity. In their study, they placed the editing site (part of a stop 
codon) directly upstream of a β-galactosidase reporter gene (Pokharel and Beal, 2006). Second, 
an in vivo editing analysis based on luciferase system was developed in the Stefan Maas lab. 
This system is based on a reporter stem loop placed immediately before the renilla luciferase for 
quantitative assessment of ADAR2 activity (Gommans et al., 2010). The third in vivo system 
was developed in Drosophila where the reporter stem loop is bearing an editable stop codon 
upstream of GFP. This system enabled spatiotemporal editing assessment and variable editing 
patterns in different individuals (Jepson et al., 2012). Until now, no cellular proteins have been 
identified as modulators of ADAR activity. 
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 rADAR2 eff                    4.2 rADAR2 efficiently edits in yeast system 
The basic yeast strain used in this screen carried an auxotrophy gene, preceded by an editing site. 
It was based on the idea that editing of an adenosine, which was a part of a stop codon, would 
allow this gene to be expressed and therefore impede strain growth on a negative selection 
medium. The advantage of using yeast for our screen over a mammalian system was a rather 
quick and inexpensive way to screen millions of genes in various cDNA libraries. The absence of 
endogenous ADAR homologues helped to avoid editing variation exerted by different splice 
isoforms. Each of these advantages had unfortunately its drawbacks. Using Saccharomyces 
cerevisiae as a model would help to quickly screen a large number of genes, but these genes had 
to be later confirmed in the mammalian system to avoid yeast-borne false positives. Also, the 
absence of ADAR in yeast meant a possible absence of other molecules interacting with them 
posing a threat, that even a true ADAR interactor, expressed in this screen, could remain 
undetectable. Despite all these drawbacks and knowing that no system is perfect and able to 
detect everything, we decided to proceed. 
The editing screen was based on a common yeast two-hybrid screen. The goal was to adapt 
it in purpose to detect differences in editing modulation via monitoring growth rate of yeast 
strain on negative selection media. This aspect already turned out to be difficult showing 
discrepancies in growth rates, clumping of yeast strains on FOA plates and loss of ADAR2 
activity. However this problem was resolved by retransforming the plasmids of potential 
candidates obtained from previous transformation into the original strain again. In brief, the yeast 
metabolism is still quite complex and with a screen based on most basic and essential functions 
like cell growth and proliferation, these kind of problems may not be trivial. One had to 
understand that some of the screen results may be false positives, since there would be a heavy 
pressure on the cell to promote the cells boosting up cell cycle and counteracting the selection. 
Additionally, because the screen was not based on protein-protein interaction, there was no fail-
safe control ensuring that all positives are the result of such an interaction. 
The expression system used for rADAR2 expression was a tetracycline inducible one. For 
the purpose of the screen, which is the identification of inhibitors of ADAR2 editing activity, 
good ADAR expression was essential. This was achieved by a controlled DOX induction of 
rADAR2 expression.  
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The screen g                    4.3 The screen gives rise to inhibitors of rADAR2 activity 
For the screen a yeast strain bearing a stem loop and ADAR2 was transformed with a HeLA 
cDNA library. This kind of library was used knowing that ADARs are less active in cell lines as 
compared to tissues. The performed screen has covered 1.0x106 clones of the cDNA library, 
which was roughly one third the amount of the clones in the library. In the primary screen 200 
clones, which were showing growth on 5FOA plate were isolated. Out of these, 134 were 
sequenced. We also found that ADAR had been silenced in many of our clones. Therefore, to 
eliminate false positives the individual plasmids were retransformed in the original strain bearing 
the stem loop and ADAR2. Out of the above mentioned 134 plasmids only 12 were able to grow 
on FOA plates. ADAR expression was also induced via doxycycline induction. 
After exclusion of false positives, one third turned out to be RNA binding proteins. The 
finding of RNA binding proteins and their fragments was not surprising as RNA binding proteins 
can compete with ADAR2 in binding to editing substrate. Obtaining protein fragments shouldn’t 
be a surprise as the way the cDNA library was cloned by random fragmentation, not by reading 
frame dependent, amplification. One should also not underestimate the bias created by using 
GluR-B R/G-derived editing substrate and expression of rADAR2. Although ADARs are able to 
edit this site by themselves, purely hypothetically, some of the factors affecting ADAR2 activity 
might be also site-specific, discriminating against those that cannot bind the site. Also, many 
binding studies were made on ADAR1 and may not apply to the obtained rADAR2 results. 
In order to confirm the effect of candidates on ADAR activity, a mammalian editing 
reporter system was established. A red and green fluorescent protein with GluR-B R/G-derived 
editing site in between was utilised and measured via FACS. This method was used to obtain 
statistical data about the influence of chosen candidates on editing in a very fast way. Although 
the FACS reporter system has proven to be a efficient tool to distinguish between candidates 
influencing editing, a few drawbacks of this method have emerged. Firstly, it was highly 
dependent on transfection efficiency, and even with stable transfection rate of 30-50% many 
candidates could have been lost in this way. This reporter system allowed efficient selection of 
the candidates inhibiting ADAR activity at cellular level. Three candidates out of 12 showed a 
decrease in editing. Two candidates were protein fragments. Full length proteins showed stronger 
editing inhibition. The discrepancy between the FACS results and bulk sequencing data had to be 
taken into consideration. The inhibition of editing was better visible in bulk sequencing than 
	   	   Discussion	  
	  
	  
95	  
FACS graphs of RNAG construct. One reason for this discrepancy is high editing of RNAG 
which leads to no dramatic shift towards RFP. [Fig.3.5.5.]. The inhibitory effect is more 
prominent in case of CyFip2 than RNAG indicating substrate specificity. Different substrates in 
context to their location in messenger RNA were taken into consideration. The difference in 
editing inhibition varies with the substrate. This shows different substrates behave differently 
with same modulator [Fig 3.7.4]. These results show that modulation of RNA editing is far more 
complex. The chosen substrates or modulating candidate can change the entire picture. 
 
Candidate proteins 
Following RNA binding proteins were obtained from the screen. 
 
Candidates 
RPS-14 
The ribosomal proteins are encoded by complex gene families that include at least 1 active 
intron-containing gene and multiple processed pseudogenes. Human gene contains 5 exons and 
spans 5.9 kb (Rhoads et al., 1986) encoding 151aminoacids. RPS-14 gene appears to have been 
stringently conserved during evolution. High similarity exists between the C termini of 
mammalian RPS-14 and yeast ribosomal protein 59 (Chen et al., 1986).The basic stretch of C 
terminal protrude from the body of protein (Antunez de Mayolo and Woolford, 2003) is involved 
in ~200nt endonucleolytic cleavage of 3’end of 20Spre-RNA to 18S mature 18SrRNA and 
functional 40S subunit (Jakovljevic et al., 2004). Rapid degradation of rRNA and ribosomal 
proteins destined for 40S subunit on depletion of RPS-14 (Moritz et al., 1990). Two antisense 
RNA α-250and α-280 are transcribed from the first intron transcribed from RNA polymerase I 
stimulate S14 mRNA transcription, whereas free ribosomal protein S14 inhibits it (Tasheva and 
Roufa, 1995). Recently, RPS-14 has been identified through RNA interference screen as a 
candidate gene for 5q myelodysplastic syndrome entailing erythroid defect (Ebert et al., 2008). 
The 5q knockout mouse has defective bone marrow progenitor development and bone marrow 
cells expressing high amounts of p53 with increased apoptosis. The 5q- mouse is rescued by 
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crossing p53 deficient mice and significantly rescued the erythropoietic defect (Barlow et al., 
2010) 
RPS-14 being a RNA binding protein can be speculated to bind to the RNA substrate 
competitively. But the co-immunoprecipitation studies [see Figure 3.10.1] show protein-protein 
interaction between RPS-14 and ADAR2 in a RNA independent fashion. Moreover, RPS-14 and 
ADAR2 co-localize in the nucleoli supporting the observed interaction [see Figure 3.11.1]. 
 
DDX-15      
DEXH/D-box proteins comprise a family of RNA helicase and RNA helicase-like proteins 
involved in RNA metabolism from transcription to degradation. DDX-15 is highly conserved 
protein from human to yeast. Human DDX-15 is 99% similar to mouse DDX-15 and 75% similar 
to uncharacterized C.elegans protein (F56D2.6) and 67% similar to S.cerevisiae (Prp43p) protein 
Endogenous DDX-15 accumulates in U snRNP containing nuclear speckles. DDX-15 has a 
modular structure consisting of a helicase core (DEAH-box) and the N- and C-terminal 
extensions. DDX-15 has a unique N-terminal region of 160 amino acids that bears no significant 
similarity to other helicases (Fouraux et al., 2002). The yeast homolog of DDX-15 Prp43p is 
required for the release of the lariat intron from the spliceosome. Prp43p is also important for 
ribosomal synthesis, Depletion of Prp43p leads to accumulation of 35S pre-rRNA and strikingly 
reduces levels of all downstream pre-rRNA processing intermediates (Mayas et al., 2010) 
DDX-15 does not show direct interaction with ADAR2 both in co-immunoprecipitation studies 
and co-localization studies [see Figure 3.10.2 and 3.11.1]. Mass spectrometric analysis of DDX-
15 indicate NF-κB and RNA helicase A. NF-κB is proposed to bind double stranded RNA. RNA 
helicase A which also came as DDX-15 interactor was shown to inhibit RNA editing previously 
(Bratt and Ohman, 2003). Apart from mammalian DDX-15, the helicase knockout worm 
exhibited dramatic increase in editing proving the conservation of editing inhibition [see Figure 
3.9.1 A&B].  
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SFRS-9 
SFRS-9 belongs to the family of SR family of splicing regulatory proteins. The 1.35-kb 
transcript encodes 25.5kDa protein exhibiting highest expression in pancreas, followed by 
kidney, placenta, and heart (Stoss et al., 1999). SFRS-9 ias highly conserved from human to 
C.elegans. Human SFRS-9 is 98% identical to mouse SFRS-9, and 46% to C.elegans (rsp 3). 
Recently, it is found that SFRS-9 is associated with SCA31 (spinocerebellar ataxia 31) .SCA31 
is caused due to insertion of 2.5–3.8 kb long consisting of (UGGAA)n. SFRS-9 bind to penta-
nucleotide repeat leading to RNA-mediated gain-of-function mutation (Sato et al., 2009). 
Additionally, SRp30c is a modulator of SMN exon 7 inclusion (Young et al., 2002). 
SFRS-9 has two RNA binding motifs. Therefore competitive binding to the RNA substrate can 
be a possibility. However, the RNA independent protein protein interaction of SFRS-9 and 
ADAR2 by co-immunoprecipitation studies [see Figure 3.10.3] contradicts it. The partial co-
localization of SFRS-9with ADAR2 in the nucleoli also supports the interaction (see Figure 
3.11.1). Moreover, silencing of endogenous SFRS-9 showed 11% increase in editing verifying 
the observed editing inhibition [see Figure 3.8.1]. 
 
CONCLUSION 
Until now, different mechanisms were proposed to decipher ADAR regulation From the above 
mentioned yeast screen, three RNA binding proteins were identified. These RNA binding 
proteins showed editing inhibition in mammalian system. Silencing of the endogenous proteins 
also confirmed editing inhibition.  
 
	   	   References	  
	  
	  
98	  
REFERENCES
	   	   References	  
	  
	  
	  
99	  
Agranat, L., J. Sperling, and R. Sperling. 2010. A novel tissue-specific alternatively spliced form 
of the A-to-I RNA editing enzyme ADAR2. RNA Biol. 7:253-262. 
Antunez de Mayolo, P., and J.L. Woolford, Jr. 2003. Interactions of yeast ribosomal protein 
rpS14 with RNA. J Mol Biol. 333:697-709. 
Aphasizheva, I., G.E. Ringpis, J. Weng, P.D. Gershon, R.H. Lathrop, and R. Aphasizhev. 2009. 
Novel TUTase associates with an editosome-like complex in mitochondria of 
Trypanosoma brucei. RNA. 15:1322-1337. 
Athanasiadis, A., A. Rich, and S. Maas. 2004a. Widespread A-to-I RNA editing of Alu-
containing mRNAs in the human transcriptome. PLoS Biol. 2:e391. 
Athanasiadis, A., A. Rich, and S. Maas. 2004b. Widespread A-to-I RNA Editing of Alu-
Containing mRNAs in the Human Transcriptome. PLoS Biol. 2:e391. 
Backus, J.W., D. Schock, and H.C. Smith. 1994. Only cytidines 5' of the apolipoprotein B 
mRNA mooring sequence are edited. Biochim Biophys Acta. 1219:1-14. 
Barbon, A., F. Fumagalli, L. Caracciolo, L. Madaschi, E. Lesma, C. Mora, S. Carelli, T.A. 
Slotkin, G. Racagni, A.M. Di Giulio, A. Gorio, and S. Barlati. 2010. Acute spinal cord 
injury persistently reduces R/G RNA editing of AMPA receptors. Journal of 
neurochemistry. 114:397-407. 
Barbon, A., F. Fumagalli, L. La Via, L. Caracciolo, G. Racagni, M.A. Riva, and S. Barlati. 2007. 
Chronic phencyclidine administration reduces the expression and editing of specific 
glutamate receptors in rat prefrontal cortex. Experimental neurology. 208:54-62. 
Barlow, J.L., L.F. Drynan, D.R. Hewett, L.R. Holmes, S. Lorenzo-Abalde, A.L. Lane, H.E. Jolin, 
R. Pannell, A.J. Middleton, S.H. Wong, A.J. Warren, J.S. Wainscoat, J. Boultwood, and 
A.N. McKenzie. 2010. A p53-dependent mechanism underlies macrocytic anemia in a 
mouse model of human 5q- syndrome. Nat Med. 16:59-66. 
Bass, B. 2002a. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem. 
71:817 - 846. 
Bass, B.L. 2002b. RNA editing by adenosine deaminases that act on RNA. Annual review of 
biochemistry. 71:817-846. 
Bass, B.L., and H. Weintraub. 1987. A developmentally regulated activity that unwinds RNA 
duplexes. Cell. 48:607-613. 
	   	   References	  
	  
	  
	  
100	  
Bass, B.L., and H. Weintraub. 1988. An unwinding activity that covalently modifies its double-
stranded RNA substrate. Cell. 55:1089-1098. 
Ben-Ari, Y., J.L. Gaiarsa, R. Tyzio, and R. Khazipov. 2007. GABA: a pioneer transmitter that 
excites immature neurons and generates primitive oscillations. Physiol Rev. 87:1215-
1284. 
Benne, R., J. Van den Burg, J.P. Brakenhoff, P. Sloof, J.H. Van Boom, and M.C. Tromp. 1986. 
Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains 
four nucleotides that are not encoded in the DNA. Cell. 46:819-826. 
Bergles, D.E., J.D. Roberts, P. Somogyi, and C.E. Jahr. 2000. Glutamatergic synapses on 
oligodendrocyte precursor cells in the hippocampus. Nature. 405:187-191. 
Bezanilla, F. 2004. RNA editing of a human potassium channel modifies its inactivation. Nat 
Struct Mol Biol. 11:915-916. 
Bhalla, T., J.J. Rosenthal, M. Holmgren, and R. Reenan. 2004. Control of human potassium 
channel inactivation by editing of a small mRNA hairpin. Nat Struct Mol Biol. 11:950-
956. 
Blow, M., P.A. Futreal, R. Wooster, and M.R. Stratton. 2004. A survey of RNA editing in human 
brain. Genome Res. 14:2379-2387. 
Bossy-Wetzel, E., M.V. Talantova, W.D. Lee, M.N. Scholzke, A. Harrop, E. Mathews, T. Gotz, 
J. Han, M.H. Ellisman, G.A. Perkins, and S.A. Lipton. 2004. Crosstalk between nitric 
oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and 
p38-activated K+ channels. Neuron. 41:351-365. 
Bozzi, Y., S. Casarosa, and M. Caleo. 2012. Epilepsy as a neurodevelopmental disorder. Front 
Psychiatry. 3:19. 
Bratt, E., and M. Ohman. 2003. Coordination of editing and splicing of glutamate receptor pre-
mRNA. Rna. 9:309-318. 
Brooks, A.N., L. Yang, M.O. Duff, K.D. Hansen, J.W. Park, S. Dudoit, S.E. Brenner, and B.R. 
Graveley. 2011. Conservation of an RNA regulatory map between Drosophila and 
mammals. Genome research. 21:193-202. 
Brusa, R., F. Zimmermann, D. Koh, D. Feldmeyer, P. Gass, P. Seeburg, and R. Sprengel. 1995. 
Early-Onset Epilepsy and Postnatal Lethality Associated with an Editing-Deficient GluR-
B Allele in Mice. Science. 270:1677 - 1680. 
	   	   References	  
	  
	  
	  
101	  
Burns, C., H. Chu, S. Rueter, L. Hutchinson, H. Canton, E. Sanders-Bush, and R. Emeson. 1997. 
Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 
387:303 - 308. 
Butler, M.G. 2011. Prader-Willi Syndrome: Obesity due to Genomic Imprinting. Curr Genomics. 
12:204-215. 
Cantara, W.A., P.F. Crain, J. Rozenski, J.A. McCloskey, K.A. Harris, X. Zhang, F.A. Vendeix, 
D. Fabris, and P.F. Agris. 2011. The RNA Modification Database, RNAMDB: 2011 
update. Nucleic Acids Res. 39:D195-201. 
Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M.A. Billeter. 1988. Biased 
hypermutation and other genetic changes in defective measles viruses in human brain 
infections. Cell. 55:255-265. 
Catterall, W.A., E. Perez-Reyes, T.P. Snutch, and J. Striessnig. 2005. International Union of 
Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-
gated calcium channels. Pharmacological reviews. 57:411-425. 
Cenci, C., R. Barzotti, F. Galeano, S. Corbelli, R. Rota, L. Massimi, C. Di Rocco, M.A. 
O'Connell, and A. Gallo. 2008a. Down-regulation of RNA editing in pediatric 
astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol 
Chem. 283:7251-7260. 
Cenci, C., R. Barzotti, F. Galeano, S. Corbelli, R. Rota, L. Massimi, C. Di Rocco, M.A. 
O'Connell, and A. Gallo. 2008b. Down-regulation of RNA editing in pediatric 
astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol 
Chem. 283:7251-7260. 
Chan, L. 1992. Apolipoprotein B, the major protein component of triglyceride-rich and low 
density lipoproteins. J Biol Chem. 267:25621-25624. 
Chen, C.X., D.S. Cho, Q. Wang, F. Lai, K.C. Carter, and K. Nishikura. 2000. A third member of 
the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and 
double-stranded RNA binding domains. Rna. 6:755-767. 
Chen, H., X. Zhu, P. Cong, M.P. Sheetz, F. Nakamura, and J. Yan. 2011. Differential mechanical 
stability of filamin A rod segments. Biophysical journal. 101:1231-1237. 
Chen, I.T., A. Dixit, D.D. Rhoads, and D.J. Roufa. 1986. Homologous ribosomal proteins in 
bacteria, yeast, and humans. Proc Natl Acad Sci U S A. 83:6907-6911. 
	   	   References	  
	  
	  
	  
102	  
Chen, L.L., J.N. DeCerbo, and G.G. Carmichael. 2008. Alu element-mediated gene silencing. 
Embo J. 27:1694-1705. 
Chen, Z., T.L. Eggerman, and A.P. Patterson. 2001. Phosphorylation is a regulatory mechanism 
in apolipoprotein B mRNA editing. Biochem J. 357:661-672. 
Chester, A., J. Scott, S. Anant, and N. Navaratnam. 2000. RNA editing: cytidine to uridine 
conversion in apolipoprotein B mRNA. Biochim Biophys Acta. 1494:1-13. 
Clemson, C.M., J.N. Hutchinson, S.A. Sara, A.W. Ensminger, A.H. Fox, A. Chess, and J.B. 
Lawrence. 2009. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is 
essential for the structure of paraspeckles. Mol Cell. 33:717-726. 
Constancia, M., G. Kelsey, and W. Reik. 2004. Resourceful imprinting. Nature. 432:53-57. 
Dabiri, G.A., F. Lai, R.A. Drakas, and K. Nishikura. 1996. Editing of the GLuR-B ion channel 
RNA in vitro by recombinant double-stranded RNA adenosine deaminase. Embo J. 
15:34-45. 
Daniel, C., H. Wahlstedt, J. Ohlson, P. Bjork, and M. Ohman. 2011. Adenosine-to-inosine RNA 
editing affects trafficking of the gamma-aminobutyric acid type A (GABA(A)) receptor. 
J Biol Chem. 286:2031-2040. 
Decher, N., A.K. Streit, M. Rapedius, M.F. Netter, S. Marzian, P. Ehling, G. Schlichthorl, T. 
Craan, V. Renigunta, A. Kohler, R.C. Dodel, R.A. Navarro-Polanco, R. Preisig-Muller, 
G. Klebe, T. Budde, T. Baukrowitz, and J. Daut. 2010. RNA editing modulates the 
binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium 
channels. Embo J. 29:2101-2113. 
Desterro, J.M., L.P. Keegan, E. Jaffray, R.T. Hay, M.A. O'Connell, and M. Carmo-Fonseca. 
2005. SUMO-1 modification alters ADAR1 editing activity. Mol Biol Cell. 16:5115-
5126. 
Desterro, J.M., L.P. Keegan, M. Lafarga, M.T. Berciano, M. O'Connell, and M. Carmo-Fonseca. 
2003. Dynamic association of RNA-editing enzymes with the nucleolus. J Cell Sci. 
116:1805-1818. 
Dick, I.E., M.R. Tadross, H. Liang, L.H. Tay, W. Yang, and D.T. Yue. 2008. A modular switch 
for spatial Ca2+ selectivity in the calmodulin regulation of CaV channels. Nature. 
451:830-834. 
	   	   References	  
	  
	  
	  
103	  
Dillon, C., and Y. Goda. 2005. The actin cytoskeleton: integrating form and function at the 
synapse. Annu Rev Neurosci. 28:25-55. 
Doe, C.M., D. Relkovic, A.S. Garfield, J.W. Dalley, D.E. Theobald, T. Humby, L.S. Wilkinson, 
and A.R. Isles. 2009. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c 
pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum Mol Genet. 18:2140-
2148. 
Dracheva, S., N. Patel, D.A. Woo, S.M. Marcus, L.J. Siever, and V. Haroutunian. 2008. 
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol 
Psychiatry. 13:1001-1010. 
Drago, A., and A. Serretti. 2009. Focus on HTR2C: A possible suggestion for genetic studies of 
complex disorders. Am J Med Genet B Neuropsychiatr Genet. 150B:601-637. 
Dwivedi, Y., H.S. Rizavi, H. Zhang, R.C. Roberts, R.R. Conley, and G.N. Pandey. 2009. 
Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role 
of ERK kinase 1 (MEK1). Int J Neuropsychopharmacol. 12:1337-1354. 
Ebert, B.L., J. Pretz, J. Bosco, C.Y. Chang, P. Tamayo, N. Galili, A. Raza, D.E. Root, E. Attar, 
S.R. Ellis, and T.R. Golub. 2008. Identification of RPS14 as a 5q- syndrome gene by 
RNA interference screen. Nature. 451:335-339. 
Eckmann, C.R., A. Neunteufl, L. Pfaffstetter, and M.F. Jantsch. 2001. The human but not the 
Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and 
displays the characteristics of a shuttling protein. Mol Biol Cell. 12:1911-1924. 
Eggington, J.M., T. Greene, and B.L. Bass. 2011. Predicting sites of ADAR editing in double-
stranded RNA. Nat Commun. 2:319. 
Enstero, M., O. Akerborg, D. Lundin, B. Wang, T.S. Furey, M. Ohman, and J. Lagergren. 2010. 
A computational screen for site selective A-to-I editing detects novel sites in neuron 
specific Hu proteins. BMC Bioinformatics. 11:6. 
Enz, R. 2002. The actin-binding protein Filamin-A interacts with the metabotropic glutamate 
receptor type 7. FEBS Lett. 514:184-188. 
Feagin, J.E., J.M. Abraham, and K. Stuart. 1988. Extensive editing of the cytochrome c oxidase 
III transcript in Trypanosoma brucei. Cell. 53:413-422. 
Feng, Y., M.H. Chen, I.P. Moskowitz, A.M. Mendonza, L. Vidali, F. Nakamura, D.J. 
Kwiatkowski, and C.A. Walsh. 2006. Filamin A (FLNA) is required for cell-cell contact 
	   	   References	  
	  
	  
	  
104	  
in vascular development and cardiac morphogenesis. Proc Natl Acad Sci U S A. 
103:19836-19841. 
Feuillette, S., V. Deramecourt, A. Laquerriere, C. Duyckaerts, M.B. Delisle, C.A. Maurage, D. 
Blum, L. Buee, T. Frebourg, D. Campion, and M. Lecourtois. 2010. Filamin-A and 
Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 
brains. Brain research. 1345:182-189. 
Fiskum, G., A.N. Murphy, and M.F. Beal. 1999. Mitochondria in neurodegeneration: acute 
ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab. 19:351-
369. 
Flomen, R., Knight, J., Sham, P., Kerwin, R., and Makoff, A. 2004. Evidence that RNA editing 
modulates splice site selection in the 5-HT2C receptor gene. Nuleic Acids Res. 32:2113-
2122. 
Flomen, R., and A. Makoff. 2011. Increased RNA editing in EAAT2 pre-mRNA from 
amyotrophic lateral sclerosis patients: Involvement of a cryptic polyadenylation site. 
Neurosci Lett. 
Fouraux, M.A., M.J. Kolkman, A. Van der Heijden, A.S. De Jong, W.J. Van Venrooij, and G.J. 
Pruijn. 2002. The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative 
DEAH-box RNA helicase. Rna. 8:1428-1443. 
Frederick, J.P., D. Mattiske, J.A. Wofford, L.C. Megosh, L.Y. Drake, S.T. Chiou, B.L. Hogan, 
and J.D. York. 2005. An essential role for an inositol polyphosphate multikinase, Ipk2, in 
mouse embryogenesis and second messenger production. Proceedings of the National 
Academy of Sciences of the United States of America. 102:8454-8459. 
Fritz, J., A. Strehblow, A. Taschner, S. Schopoff, P. Pasierbek, and M.F. Jantsch. 2009. RNA-
regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-
binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol Cell Biol. 
29:1487-1497. 
Fucini, P., C. Renner, C. Herberhold, A.A. Noegel, and T.A. Holak. 1997. The repeating 
segments of the F-actin cross-linking gelation factor (ABP-120) have an 
immunoglobulin-like fold. Nat Struct Biol. 4:223-230. 
Galeano, F., S. Tomaselli, F. Locatelli, and A. Gallo. 2011. A-to-I RNA editing: The "ADAR" 
side of human cancer. Semin Cell Dev Biol. 
	   	   References	  
	  
	  
	  
105	  
Gallo, V., and C.A. Ghiani. 2000. Glutamate receptors in glia: new cells, new inputs and new 
functions. Trends Pharmacol Sci. 21:252-258. 
Gan, Z., L. Zhao, L. Yang, P. Huang, F. Zhao, W. Li, and Y. Liu. 2006. RNA editing by ADAR2 
is metabolically regulated in pancreatic islets and beta-cells. J Biol Chem. 281:33386-
33394. 
Gerber, A., M.A. O'Connell, and W. Keller. 1997. Two forms of human double-stranded RNA-
specific editase 1 (hRED1) generated by the insertion of an Alu cassette. Rna. 3:453-463. 
Gerber, A.P., and W. Keller. 2001. RNA editing by base deamination: more enzymes, more 
targets, new mysteries. Trends Biochem Sci. 26:376-384. 
Gommans, W.M., J. McCane, G.S. Nacarelli, and S. Maas. 2010. A mammalian reporter system 
for fast and quantitative detection of intracellular A-to-I RNA editing levels. Anal 
Biochem. 399:230-236. 
Gott, J.M., and R.B. Emeson. 2000. Functions and mechanisms of RNA editing. Annu Rev 
Genet. 34:499-531. 
Green, W.R. 1986. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens 
by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral 
CTL generation. J Immunol. 136:308-312. 
Greger, I.H., P. Akamine, L. Khatri, and E.B. Ziff. 2006. Developmentally regulated, 
combinatorial RNA processing modulates AMPA receptor biogenesis. Neuron. 51:85-97. 
Greger, I.H., L. Khatri, X. Kong, and E.B. Ziff. 2003. AMPA receptor tetramerization is 
mediated by Q/R editing. Neuron. 40:763-774. 
Greger, I.H., L. Khatri, and E.B. Ziff. 2002. RNA editing at arg607 controls AMPA receptor exit 
from the endoplasmic reticulum. Neuron. 34:759-772. 
Guo, Y., S.X. Zhang, N. Sokol, L. Cooley, and G.L. Boulianne. 2000. Physical and genetic 
interaction of filamin with presenilin in Drosophila. Journal of cell science. 113 Pt 
19:3499-3508. 
Gurevich, I., H. Tamir, V. Arango, A.J. Dwork, J.J. Mann, and C. Schmauss. 2002. Altered 
editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide 
victims. Neuron. 34:349-356. 
Hamad, M.I., Z.L. Ma-Hogemeier, C. Riedel, C. Conrads, T. Veitinger, T. Habijan, J.N. Schulz, 
M. Krause, M.J. Wirth, M. Hollmann, and P. Wahle. 2011. Cell class-specific regulation 
	   	   References	  
	  
	  
	  
106	  
of neocortical dendrite and spine growth by AMPA receptor splice and editing variants. 
Development. 138:4301-4313. 
Hart, A.W., J.E. Morgan, J. Schneider, K. West, L. McKie, S. Bhattacharya, I.J. Jackson, and 
S.H. Cross. 2006. Cardiac malformations and midline skeletal defects in mice lacking 
filamin A. Hum Mol Genet. 15:2457-2467. 
Hartner, J.C., C. Schmittwolf, A. Kispert, A.M. Muller, M. Higuchi, and P.H. Seeburg. 2004. 
Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing 
enzyme ADAR1. J Biol Chem. 279:4894-4902. 
Hartner, J.C., C.R. Walkley, J. Lu, and S.H. Orkin. 2009. ADAR1 is essential for the 
maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 
10:109-115. 
Heale, B.S., L.P. Keegan, L. McGurk, G. Michlewski, J. Brindle, C.M. Stanton, J.F. Caceres, 
and M.A. O'Connell. 2009. Editing independent effects of ADARs on the miRNA/siRNA 
pathways. Embo J. 28:3145-3156. 
Helmut Blum, D.H.B., Hans J. Gross. 1987. Improved silver staining of plant proteins, RNA and 
DNA in polyacrylamide gels. Electrophoresis. 8:93-99. 
Hersberger, M., S. Patarroyo-White, K.S. Arnold, and T.L. Innerarity. 1999a. Phylogenetic 
analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary 
structure between the mooring sequence and the 3' efficiency element. J Biol Chem. 
274:34590-34597. 
Hersberger, M., S. Patarroyo-White, K.S. Arnold, and T.L. Innerarity. 1999b. Phylogenetic 
analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary 
structure between the mooring sequence and the 3' efficiency element. J Biol Chem. 
274:34590-34597. 
Hevers, W., and H. Luddens. 1998. The diversity of GABAA receptors. Pharmacological and 
electrophysiological properties of GABAA channel subtypes. Mol Neurobiol. 18:35-86. 
Hideyama, T., T. Yamashita, H. Aizawa, S. Tsuji, A. Kakita, H. Takahashi, and S. Kwak. 2011. 
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor 
neurons. Neurobiology of disease. 
	   	   References	  
	  
	  
	  
107	  
Higuchi, M., S. Maas, F. Single, J. Hartner, A. Rozov, N. Burnashev, D. Feldmeyer, R. Sprengel, 
and P. Seeburg. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice 
deficient in the RNA-editing enzyme ADAR2. Nature. 406:78 - 81. 
Higuchi, M., Single, F.N., Kohler, M., Sommer, B., Sprengel, R., Seeburg P.H. 1993. RNA 
editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure 
determines position and efficiency. Cell. 75:1361-1370. 
Hinman, M.N., and H. Lou. 2008. Diverse molecular functions of Hu proteins. Cell Mol Life Sci. 
65:3168-3181. 
Horsch, M., P.H. Seeburg, T. Adler, J.A. Aguilar-Pimentel, L. Becker, J. Calzada-Wack, L. 
Garrett, A. Gotz, W. Hans, M. Higuchi, S.M. Holter, B. Naton, C. Prehn, O. Puk, I. Racz, 
B. Rathkolb, J. Rozman, A. Schrewe, J. Adamski, D.H. Busch, I. Esposito, J. Graw, B. 
Ivandic, M. Klingenspor, T. Klopstock, M. Mempel, M. Ollert, H. Schulz, E. Wolf, W. 
Wurst, A. Zimmer, V. Gailus-Durner, H. Fuchs, M.H. de Angelis, and J. Beckers. 2011. 
Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice. J Biol 
Chem. 286:18614-18622. 
Hospattankar, A.V., K. Higuchi, S.W. Law, N. Meglin, and H.B. Brewer, Jr. 1987. Identification 
of a novel in-frame translational stop codon in human intestine apoB mRNA. Biochem 
Biophys Res Commun. 148:279-285. 
Hough, R.F., and B.L. Bass. 1997. Analysis of Xenopus dsRNA adenosine deaminase cDNAs 
reveals similarities to DNA methyltransferases. Rna. 3:356-370. 
Hoyer, D., J.P. Hannon, and G.R. Martin. 2002. Molecular, pharmacological and functional 
diversity of 5-HT receptors. Pharmacol Biochem Behav. 71:533-554. 
Huang, H., B.Z. Tan, Y. Shen, J. Tao, F. Jiang, Y.Y. Sung, C.K. Ng, M. Raida, G. Kohr, M. 
Higuchi, H. Fatemi-Shariatpanahi, B. Harden, D.T. Yue, and T.W. Soong. 2012. RNA 
editing of the IQ domain in Ca(v)1.3 channels modulates their Ca(2)-dependent 
inactivation. Neuron. 73:304-316. 
Hundley, H.A., and B.L. Bass. 2010. ADAR editing in double-stranded UTRs and other 
noncoding RNA sequences. Trends Biochem Sci. 35:377-383. 
Hutcheon, B., J.M. Fritschy, and M.O. Poulter. 2004. Organization of GABA receptor alpha-
subunit clustering in the developing rat neocortex and hippocampus. The European 
journal of neuroscience. 19:2475-2487. 
	   	   References	  
	  
	  
	  
108	  
Igo, R.P., Jr., S.D. Lawson, and K. Stuart. 2002. RNA sequence and base pairing effects on 
insertion editing in Trypanosoma brucei. Mol Cell Biol. 22:1567-1576. 
Irimia, M., A. Denuc, J.L. Ferran, B. Pernaute, L. Puelles, S.W. Roy, J. Garcia-Fernandez, and 
G. Marfany. 2012. Evolutionarily conserved A-to-I editing increases protein stability of 
the alternative splicing factor Nova1. RNA biology. 9. 
Ishiuchi, S., Y. Yoshida, K. Sugawara, M. Aihara, T. Ohtani, T. Watanabe, N. Saito, K. Tsuzuki, 
H. Okado, A. Miwa, Y. Nakazato, and S. Ozawa. 2007. Ca2+-permeable AMPA 
receptors regulate growth of human glioblastoma via Akt activation. J Neurosci. 
27:7987-8001. 
Jacobs, M.M., R.L. Fogg, R.B. Emeson, and G.D. Stanwood. 2009. ADAR1 and ADAR2 
expression and editing activity during forebrain development. Dev Neurosci. 31:223-237. 
Jakovljevic, J., P.A. de Mayolo, T.D. Miles, T.M. Nguyen, I. Leger-Silvestre, N. Gas, and J.L. 
Woolford, Jr. 2004. The carboxy-terminal extension of yeast ribosomal protein S14 is 
necessary for maturation of 43S preribosomes. Mol Cell. 14:331-342. 
Jensen, K.B., B.K. Dredge, G. Stefani, R. Zhong, R.J. Buckanovich, H.J. Okano, Y.Y. Yang, and 
R.B. Darnell. 2000. Nova-1 regulates neuron-specific alternative splicing and is essential 
for neuronal viability. Neuron. 25:359-371. 
Jepson, J.E., Y.A. Savva, K.A. Jay, and R.A. Reenan. 2012. Visualizing adenosine-to-inosine 
RNA editing in the Drosophila nervous system. Nat Methods. 9:189-194. 
Jin, Y., W. Zhang, and Q. Li. 2009. Origins and evolution of ADAR-mediated RNA editing. 
IUBMB Life. 61:572-578. 
Kawahara, Y., A. Grimberg, S. Teegarden, C. Mombereau, S. Liu, T.L. Bale, J.A. Blendy, and 
K. Nishikura. 2008. Dysregulated editing of serotonin 2C receptor mRNAs results in 
energy dissipation and loss of fat mass. J Neurosci. 28:12834-12844. 
Kawahara, Y., K. Ito, H. Sun, H. Aizawa, I. Kanazawa, and S. Kwak. 2004. Glutamate receptors: 
RNA editing and death of motor neurons. Nature. 427:801. 
Kawahara, Y., and S. Kwak. 2005. Excitotoxicity and ALS: what is unique about the AMPA 
receptors expressed on spinal motor neurons? Amyotrophic lateral sclerosis and other 
motor neuron disorders : official publication of the World Federation of Neurology, 
Research Group on Motor Neuron Diseases. 6:131-144. 
	   	   References	  
	  
	  
	  
109	  
Kawahara, Y., B. Zinshteyn, T.P. Chendrimada, R. Shiekhattar, and K. Nishikura. 2007a. RNA 
editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. 
EMBO Rep. 8:763-769. 
Kawahara, Y., B. Zinshteyn, P. Sethupathy, H. Iizasa, A.G. Hatzigeorgiou, and K. Nishikura. 
2007b. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. 
Science. 315:1137-1140. 
Keegan, L.P., A. Gallo, and M.A. O'Connell. 2001. The many roles of an RNA editor. Nat Rev 
Genet. 2:869-878. 
Keller, W., J. Wolf, and A. Gerber. 1999. Editing of messenger RNA precursors and of tRNAs 
by adenosine to inosine conversion. FEBS Lett. 452:71-76. 
Kim, D.D., T.T. Kim, T. Walsh, Y. Kobayashi, T.C. Matise, S. Buyske, and A. Gabriel. 2004. 
Widespread RNA editing of embedded alu elements in the human transcriptome. Genome 
Res. 14:1719-1725. 
Kishore, S., and S. Stamm. 2006. The snoRNA HBII-52 regulates alternative splicing of the 
serotonin receptor 2C. Science. 311:230-232. 
Knight, S.W., and B.L. Bass. 2002. The role of RNA editing by ADARs in RNAi. Mol Cell. 
10:809-817. 
Knoop, V. 2011. When you can't trust the DNA: RNA editing changes transcript sequences. 
Cellular and molecular life sciences : CMLS. 68:567-586. 
Kohler, M., N. Burnashev, B. Sakmann, and P.H. Seeburg. 1993. Determinants of Ca2+ 
permeability in both TM1 and TM2 of high affinity kainate receptor channels: diversity 
by RNA editing. Neuron. 10:491-500. 
Kuner, R., A.J. Groom, I. Bresink, H.C. Kornau, V. Stefovska, G. Muller, B. Hartmann, K. 
Tschauner, S. Waibel, A.C. Ludolph, C. Ikonomidou, P.H. Seeburg, and L. Turski. 2005. 
Late-onset motoneuron disease caused by a functionally modified AMPA receptor 
subunit. Proc Natl Acad Sci U S A. 102:5826-5831. 
Labasque, M., J. Meffre, G. Carrat, C. Becamel, J. Bockaert, and P. Marin. 2010. Constitutive 
activity of serotonin 2C receptors at G protein-independent signaling: modulation by 
RNA editing and antidepressants. Mol Pharmacol. 78:818-826. 
Lacinova, L. 2005. Voltage-dependent calcium channels. Gen Physiol Biophys. 24 Suppl 1:1-78. 
	   	   References	  
	  
	  
	  
110	  
Lad, Y., T. Kiema, P. Jiang, O.T. Pentikainen, C.H. Coles, I.D. Campbell, D.A. Calderwood, and 
J. Ylanne. 2007. Structure of three tandem filamin domains reveals auto-inhibition of 
ligand binding. The EMBO journal. 26:3993-4004. 
Lai, F., C.X. Chen, K.C. Carter, and K. Nishikura. 1997. Editing of glutamate receptor B subunit 
ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA 
adenosine deaminases. Mol Cell Biol. 17:2413-2424. 
Laurencikiene, J., A.M. Kallman, N. Fong, D.L. Bentley, and M. Ohman. 2006. RNA editing and 
alternative splicing: the importance of co-transcriptional coordination. EMBO Rep. 
7:303-307. 
Lee, S., G. Yang, Y. Yong, Y. Liu, L. Zhao, J. Xu, X. Zhang, Y. Wan, C. Feng, Z. Fan, J. Luo, 
and Z.J. Ke. 2010. ADAR2-dependent RNA editing of GluR2 is involved in thiamine 
deficiency-induced alteration of calcium dynamics. Mol Neurodegener. 5:54. 
Lehmann, K.A., and B.L. Bass. 1999. The importance of internal loops within RNA substrates of 
ADAR1. J Mol Biol. 291:1-13. 
Levanon, E.Y., E. Eisenberg, R. Yelin, S. Nemzer, M. Hallegger, R. Shemesh, Z.Y. Fligelman, 
A. Shoshan, S.R. Pollock, D. Sztybel, M. Olshansky, G. Rechavi, and M.F. Jantsch. 
2004. Systematic identification of abundant A-to-I editing sites in the human 
transcriptome. Nat Biotechnol. 22:1001-1005. 
Levanon, E.Y., M. Hallegger, Y. Kinar, R. Shemesh, K. Djinovic-Carugo, G. Rechavi, M.F. 
Jantsch, and E. Eisenberg. 2005. Evolutionarily conserved human targets of adenosine to 
inosine RNA editing. Nucleic Acids Res. 33:1162-1168. 
Li, J.B., E.Y. Levanon, J.K. Yoon, J. Aach, B. Xie, E. Leproust, K. Zhang, Y. Gao, and G.M. 
Church. 2009. Genome-wide identification of human RNA editing sites by parallel DNA 
capturing and sequencing. Science. 324:1210-1213. 
Licatalosi, D.D., and R.B. Darnell. 2010. RNA processing and its regulation: global insights into 
biological networks. Nat Rev Genet. 11:75-87. 
Lim, L.P., N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. 
Linsley, and J.M. Johnson. 2005. Microarray analysis shows that some microRNAs 
downregulate large numbers of target mRNAs. Nature. 433:769-773. 
	   	   References	  
	  
	  
	  
111	  
Liu, S., L. Lau, J. Wei, D. Zhu, S. Zou, H.S. Sun, Y. Fu, F. Liu, and Y. Lu. 2004. Expression of 
Ca(2+)-permeable AMPA receptor channels primes cell death in transient forebrain 
ischemia. Neuron. 43:43-55. 
Lomeli, H., J. Mosbacher, T. Melcher, T. Hoger, J.R. Geiger, T. Kuner, H. Monyer, M. Higuchi, 
A. Bach, and P.H. Seeburg. 1994. Control of kinetic properties of AMPA receptor 
channels by nuclear RNA editing. Science. 266:1709-1713. 
Lu, Q., K. Ding, M.P. Frosch, S. Jones, M. Wolfe, W. Xia, and G.W. Lanford. 2010. Alzheimer's 
disease-linked presenilin mutation (PS1M146L) induces filamin expression and gamma-
secretase independent redistribution. Journal of Alzheimer's disease : JAD. 22:235-245. 
Maas, S., A.P. Gerber, and A. Rich. 1999. Identification and characterization of a human tRNA-
specific adenosine deaminase related to the ADAR family of pre-mRNA editing 
enzymes. Proc Natl Acad Sci U S A. 96:8895-8900. 
Maas, S., C.P. Godfried Sie, I. Stoev, D.E. Dupuis, J. Latona, A.M. Porman, B. Evans, P. 
Rekawek, V. Kluempers, M. Mutter, W.M. Gommans, and D. Lopresti. 2011. Genome-
wide evaluation and discovery of vertebrate A-to-I RNA editing sites. Biochem Biophys 
Res Commun. 412:407-412. 
Maas, S., and W.M. Gommans. 2009a. Identification of a selective nuclear import signal in 
adenosine deaminases acting on RNA. Nucleic acids research. 37:5822-5829. 
Maas, S., and W.M. Gommans. 2009b. Novel exon of mammalian ADAR2 extends open reading 
frame. PLoS One. 4:e4225. 
Macbeth, M.R., A.T. Lingam, and B.L. Bass. 2004. Evidence for auto-inhibition by the N 
terminus of hADAR2 and activation by dsRNA binding. Rna. 10:1563-1571. 
Macbeth, M.R., H.L. Schubert, A.P. Vandemark, A.T. Lingam, C.P. Hill, and B.L. Bass. 2005. 
Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. 
Science. 309:1534-1539. 
Mahajan, S.S., K.H. Thai, K. Chen, and E. Ziff. 2011. Exposure of neurons to excitotoxic levels 
of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting 
on RNA 2, and loss of GLUR2 editing. Neuroscience. 189:305-315. 
Marcucci, R., J. Brindle, S. Paro, A. Casadio, S. Hempel, N. Morrice, A. Bisso, L.P. Keegan, G. 
Del Sal, and M.A. O'Connell. 2011. Pin1 and WWP2 regulate GluR2 Q/R site RNA 
editing by ADAR2 with opposing effects. Embo J. 30:4211-4222. 
	   	   References	  
	  
	  
	  
112	  
Marion, S., D.M. Weiner, and M.G. Caron. 2004. RNA editing induces variation in 
desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol 
Chem. 279:2945-2954. 
Maris, C., J. Masse, A. Chester, N. Navaratnam, and F.H. Allain. 2005. NMR structure of the 
apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 
complementary factor. RNA. 11:173-186. 
Martinez, H.D., R.J. Jasavala, I. Hinkson, L.D. Fitzgerald, J.S. Trimmer, H.J. Kung, and M.E. 
Wright. 2008. RNA editing of androgen receptor gene transcripts in prostate cancer cells. 
J Biol Chem. 283:29938-29949. 
Mayas, R.M., H. Maita, D.R. Semlow, and J.P. Staley. 2010. Spliceosome discards intermediates 
via the DEAH box ATPase Prp43p. Proc Natl Acad Sci U S A. 107:10020-10025. 
Mehler, M.F., and J.S. Mattick. 2007. Noncoding RNAs and RNA editing in brain development, 
functional diversification, and neurological disease. Physiol Rev. 87:799-823. 
Mehta, A., M.T. Kinter, N.E. Sherman, and D.M. Driscoll. 2000. Molecular cloning of apobec-1 
complementation factor, a novel RNA-binding protein involved in the editing of 
apolipoprotein B mRNA. Mol Cell Biol. 20:1846-1854. 
Melcher, T., S. Maas, A. Herb, R. Sprengel, M. Higuchi, and P.H. Seeburg. 1996a. RED2, a 
brain-specific member of the RNA-specific adenosine deaminase family. The Journal of 
biological chemistry. 271:31795-31798. 
Melcher, T., S. Maas, A. Herb, R. Sprengel, P. Seeburg, and M. Higuchi. 1996b. A mammalian 
RNA editing enzyme. Nature. 379:460 - 464. 
Mobarak, C.D., K.D. Anderson, M. Morin, A. Beckel-Mitchener, S.L. Rogers, H. Furneaux, P. 
King, and N.I. Perrone-Bizzozero. 2000. The RNA-binding protein HuD is required for 
GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite 
outgrowth in PC12 cells. Molecular biology of the cell. 11:3191-3203. 
Moffat, J., D.A. Grueneberg, X. Yang, S.Y. Kim, A.M. Kloepfer, G. Hinkle, B. Piqani, T.M. 
Eisenhaure, B. Luo, J.K. Grenier, A.E. Carpenter, S.Y. Foo, S.A. Stewart, B.R. 
Stockwell, N. Hacohen, W.C. Hahn, E.S. Lander, D.M. Sabatini, and D.E. Root. 2006. A 
lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-
content screen. Cell. 124:1283-1298. 
	   	   References	  
	  
	  
	  
113	  
Mombereau, C., Y. Kawahara, B.B. Gundersen, K. Nishikura, and J.A. Blendy. 2010. Functional 
relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like 
behaviors. Neuropharmacology. 59:468-473. 
Morabito, M.V., A.I. Abbas, J.L. Hood, R.A. Kesterson, M.M. Jacobs, D.S. Kump, D.L. Hachey, 
B.L. Roth, and R.B. Emeson. 2010. Mice with altered serotonin 2C receptor RNA editing 
display characteristics of Prader-Willi syndrome. Neurobiol Dis. 39:169-180. 
Morabito, M.V., and R.B. Emeson. 2009. RNA editing as a therapeutic target for CNS disorders. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology. 34:246. 
Moritz, M., A.G. Paulovich, Y.F. Tsay, and J.L. Woolford, Jr. 1990. Depletion of yeast 
ribosomal proteins L16 or rp59 disrupts ribosome assembly. J Cell Biol. 111:2261-2274. 
Morse, D.P., P.J. Aruscavage, and B.L. Bass. 2002. RNA hairpins in noncoding regions of 
human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that 
act on RNA. Proc Natl Acad Sci U S A. 99:7906-7911. 
Morse, D.P., and B.L. Bass. 1999. Long RNA hairpins that contain inosine are present in 
Caenorhabditis elegans poly(A)+ RNA. Proc Natl Acad Sci U S A. 96:6048-6053. 
Mukhopadhyay, D., S. Anant, R.M. Lee, S. Kennedy, D. Viskochil, and N.O. Davidson. 2002. 
C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type 
II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing 
enzyme. Am J Hum Genet. 70:38-50. 
Nelson, O., C. Supnet, H. Liu, and I. Bezprozvanny. 2010. Familial Alzheimer's disease 
mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and 
correlation with clinical phenotypes. Journal of Alzheimer's disease : JAD. 21:781-793. 
Nicholas, A., J.P. de Magalhaes, Y. Kraytsberg, E.K. Richfield, E.Y. Levanon, and K. Khrapko. 
2010. Age-related gene-specific changes of A-to-I mRNA editing in the human brain. 
Mech Ageing Dev. 131:445-447. 
Nishikura, K. 1992. Modulation of double-stranded RNAs in vivo by RNA duplex unwindase. 
Ann N Y Acad Sci. 660:240-250. 
Nishimoto, Y., T. Yamashita, T. Hideyama, S. Tsuji, N. Suzuki, and S. Kwak. 2008. 
Determination of editors at the novel A-to-I editing positions. Neurosci Res. 61:201-206. 
	   	   References	  
	  
	  
	  
114	  
Niswender, C., K. Herrick-Davis, G. Dilley, H. Meltzer, J. Overholser, C. Stockmeier, R. 
Emeson, and E. Sanders-Bush. 2001. RNA editing of the human serotonin 5-HT2C 
receptor: Alterations in suicide and implications for serotonergic pharmacotherapy. 
Neuropsychopharmacology. 24:478 - 491. 
Niswender, C.M., S.C. Copeland, K. Herrick-Davis, R.B. Emeson, and E. Sanders-Bush. 1999. 
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences 
constitutive activity. J Biol Chem. 274:9472-9478. 
Niswender, C.M., E. Sanders-Bush, and R.B. Emeson. 1998. Identification and characterization 
of RNA editing events within the 5- HT2C receptor. Ann N Y Acad Sci. 861:38-48. 
O'Connell, M.A., A. Gerber, and W. Keller. 1997. Purification of human double-stranded RNA-
specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA. 
J Biol Chem. 272:473-478. 
Ohlson, J., J.S. Pedersen, D. Haussler, and M. Ohman. 2007. Editing modifies the GABA(A) 
receptor subunit alpha3. Rna. 13:698-703. 
Ohta, H., M. Fujiwara, Y. Ohshima, and T. Ishihara. 2008. ADBP-1 regulates an ADAR RNA-
editing enzyme to antagonize RNA-interference-mediated gene silencing in 
Caenorhabditis elegans. Genetics. 180:785-796. 
Orlandi, C., A. Barbon, and S. Barlati. 2011. Activity Regulation of Adenosine Deaminases 
Acting on RNA (ADARs). Mol Neurobiol. 
Palladino, M.J., L.P. Keegan, M.A. O'Connell, and R.A. Reenan. 2000. A-to-I pre-mRNA 
editing in Drosophila is primarily involved in adult nervous system function and 
integrity. Cell. 102:437-449. 
Pan, Y., J. Weng, Y. Cao, R.C. Bhosle, and M. Zhou. 2008. Functional coupling between the 
Kv1.1 channel and aldoketoreductase Kvbeta1. The Journal of biological chemistry. 
283:8634-8642. 
Paz, N., E. Levanon, N. Amariglio, A. Heimberger, Z. Ram, S. Constantini, Z. Barbash, K. 
Adamsky, M. Safran, A. Hirschberg, M. Krupsky, I. Ben-Dov, S. Cazacu, T. Mikkelsen, 
C. Brodie, E. Eisenberg, and G. Rechavi. 2007. Altered adenosine-to-inosine RNA 
editing in human cancer. Genome Res. 17:1586 - 1595. 
Paz-Yaacov, N., E.Y. Levanon, E. Nevo, Y. Kinar, A. Harmelin, J. Jacob-Hirsch, N. Amariglio, 
E. Eisenberg, and G. Rechavi. 2010. Adenosine-to-inosine RNA editing shapes 
	   	   References	  
	  
	  
	  
115	  
transcriptome diversity in primates. Proceedings of the National Academy of Sciences of 
the United States of America. 107:12174-12179. 
Peng, P.L., X. Zhong, W. Tu, M.M. Soundarapandian, P. Molner, D. Zhu, L. Lau, S. Liu, F. Liu, 
and Y. Lu. 2006. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 
determines vulnerability of neurons in forebrain ischemia. Neuron. 49:719-733. 
Penn, A.C., and I.H. Greger. 2009a. Sculpting AMPA receptor formation and function by 
alternative RNA processing. RNA Biol. 6:517-521. 
Penn, A.C., and I.H. Greger. 2009b. Sculpting AMPA receptor formation and function by 
alternative RNA processing. RNA biology. 6:517-521. 
Petrecca, K., D.M. Miller, and A. Shrier. 2000. Localization and enhanced current density of the 
Kv4.2 potassium channel by interaction with the actin-binding protein filamin. J 
Neurosci. 20:8736-8744. 
Pittman, A.J., J.A. Gaynes, and C.B. Chien. 2010. nev (cyfip2) is required for retinal lamination 
and axon guidance in the zebrafish retinotectal system. Developmental biology. 344:784-
794. 
Pokharel, S., and P.A. Beal. 2006. High-throughput screening for functional adenosine to inosine 
RNA editing systems. ACS Chem Biol. 1:761-765. 
Polson, A., and B. Bass. 1994. Preferential selection of adenosines for modification by double-
stranded RNA adenosine deaminase. EMBO J. 13:5701 - 5711. 
Polson, A.G., B.L. Bass, and J.L. Casey. 1996. RNA editing of hepatitis delta virus antigenome 
by dsRNA-adenosine deaminase. Nature. 380:454-456. 
Popowicz, G.M., M. Schleicher, A.A. Noegel, and T.A. Holak. 2006. Filamins: promiscuous 
organizers of the cytoskeleton. Trends Biochem Sci. 31:411-419. 
Poulsen, H., J. Nilsson, C.K. Damgaard, J. Egebjerg, and J. Kjems. 2001. CRM1 mediates the 
export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. 
Molecular and cellular biology. 21:7862-7871. 
Powell, L.M., S.C. Wallis, R.J. Pease, Y.H. Edwards, T.J. Knott, and J. Scott. 1987. A novel 
form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 
50:831-840. 
	   	   References	  
	  
	  
	  
116	  
Prasanth, K.V., S.G. Prasanth, Z. Xuan, S. Hearn, S.M. Freier, C.F. Bennett, M.Q. Zhang, and 
D.L. Spector. 2005. Regulating gene expression through RNA nuclear retention. Cell. 
123:249-263. 
Price, R.D., D.M. Weiner, M.S. Chang, and E. Sanders-Bush. 2001. RNA editing of the human 
serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. The 
Journal of biological chemistry. 276:44663-44668. 
Rebagliati, M.R., and D.A. Melton. 1987. Antisense RNA injections in fertilized frog eggs reveal 
an RNA duplex unwinding activity. Cell. 48:599-605. 
Rhoads, D.D., A. Dixit, and D.J. Roufa. 1986. Primary structure of human ribosomal protein S14 
and the gene that encodes it. Mol Cell Biol. 6:2774-2783. 
Rosenberg, B.R., C.E. Hamilton, M.M. Mwangi, S. Dewell, and F.N. Papavasiliou. 2011. 
Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in 
transcript 3' UTRs. Nat Struct Mol Biol. 18:230-236. 
Rosenthal, J.J., and F. Bezanilla. 2002. Extensive editing of mRNAs for the squid delayed 
rectifier K+ channel regulates subunit tetramerization. Neuron. 34:743-757. 
Rothstein, J.D. 2009. Current hypotheses for the underlying biology of amyotrophic lateral 
sclerosis. Ann Neurol. 65 Suppl 1:S3-9. 
Rothstein, J.D., M. Dykes-Hoberg, C.A. Pardo, L.A. Bristol, L. Jin, R.W. Kuncl, Y. Kanai, M.A. 
Hediger, Y. Wang, J.P. Schielke, and D.F. Welty. 1996. Knockout of glutamate 
transporters reveals a major role for astroglial transport in excitotoxicity and clearance of 
glutamate. Neuron. 16:675-686. 
Rueter, S.M., T.R. Dawson, and R.B. Emeson. 1999. Regulation of alternative splicing by RNA 
editing. Nature. 399:75-80. 
Rula, E.Y., A.H. Lagrange, M.M. Jacobs, N. Hu, R.L. Macdonald, and R.B. Emeson. 2008. 
Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci. 
28:6196-6201. 
Ryan, M.Y., R. Maloney, R. Reenan, and R. Horn. 2008. Characterization of five RNA editing 
sites in Shab potassium channels. Channels. 2:202-209. 
Ryter, J.M., and S.C. Schultz. 1998. Molecular basis of double-stranded RNA-protein 
interactions: structure of a dsRNA-binding domain complexed with dsRNA. Embo J. 
17:7505-7513. 
	   	   References	  
	  
	  
	  
117	  
Sansam, C.L., K.S. Wells, and R.B. Emeson. 2003. Modulation of RNA editing by functional 
nucleolar sequestration of ADAR2. Proc Natl Acad Sci U S A. 100:14018-14023. 
Sato, N., T. Amino, K. Kobayashi, S. Asakawa, T. Ishiguro, T. Tsunemi, M. Takahashi, T. 
Matsuura, K.M. Flanigan, S. Iwasaki, F. Ishino, Y. Saito, S. Murayama, M. Yoshida, Y. 
Hashizume, Y. Takahashi, S. Tsuji, N. Shimizu, T. Toda, K. Ishikawa, and H. Mizusawa. 
2009. Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide 
repeats containing (TGGAA)n. Am J Hum Genet. 85:544-557. 
Schaub, M., and W. Keller. 2002. RNA editing by adenosine deaminases generates RNA and 
protein diversity. Biochimie. 84:791-803. 
Schenck, A., B. Bardoni, C. Langmann, N. Harden, J.L. Mandel, and A. Giangrande. 2003. 
CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase 
pathway to the fragile X protein. Neuron. 38:887-898. 
Schenck, A., B. Bardoni, A. Moro, C. Bagni, and J.L. Mandel. 2001. A highly conserved protein 
family interacting with the fragile X mental retardation protein (FMRP) and displaying 
selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad 
Sci U S A. 98:8844-8849. 
Schenck, A., A. Qurashi, P. Carrera, B. Bardoni, C. Diebold, E. Schejter, J.L. Mandel, and A. 
Giangrande. 2004. WAVE/SCAR, a multifunctional complex coordinating different 
aspects of neuronal connectivity. Developmental biology. 274:260-270. 
Schoft, V.K., S. Schopoff, and M.F. Jantsch. 2007. Regulation of glutamate receptor B pre-
mRNA splicing by RNA editing. Nucleic Acids Res. 35:3723-3732. 
Sheen, V.L., Y. Feng, D. Graham, T. Takafuta, S.S. Shapiro, and C.A. Walsh. 2002. Filamin A 
and Filamin B are co-expressed within neurons during periods of neuronal migration and 
can physically interact. Hum Mol Genet. 11:2845-2854. 
Silberberg, G., D. Lundin, R. Navon, and M. Ohman. 2012. Deregulation of the A-to-I RNA 
editing mechanism in psychiatric disorders. Human molecular genetics. 21:311-321. 
Silberberg, G., and M. Ohman. 2011. The edited transcriptome: novel high throughput 
approaches to detect nucleotide deamination. Curr Opin Genet Dev. 
Simmons, M., J.H. Meador-Woodruff, and M.S. Sodhi. 2010. Increased cortical expression of an 
RNA editing enzyme occurs in major depressive suicide victims. Neuroreport. 21:993-
997. 
	   	   References	  
	  
	  
	  
118	  
Simpson, L. 1987. The mitochondrial genome of kinetoplastid protozoa: genomic organization, 
transcription, replication, and evolution. Annu Rev Microbiol. 41:363-382. 
Singh, A., M. Gebhart, R. Fritsch, M.J. Sinnegger-Brauns, C. Poggiani, J.C. Hoda, J. Engel, C. 
Romanin, J. Striessnig, and A. Koschak. 2008. Modulation of voltage- and Ca2+-
dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-
terminal regulatory domain. The Journal of biological chemistry. 283:20733-20744. 
Singh, M., R.A. Kesterson, M.M. Jacobs, J.M. Joers, J.C. Gore, and R.B. Emeson. 2007. 
Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing 
enzyme ADAR2. J Biol Chem. 282:22448-22459. 
Singh, M., M.M. Singh, E. Na, K. Agassandian, M.B. Zimmerman, and A.K. Johnson. 2011. 
Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 
transgenic mice. Genes Brain Behav. 10:637-647. 
Singh, M., M.B. Zimmerman, T.G. Beltz, and A.K. Johnson. 2009. Affect-related behaviors in 
mice misexpressing the RNA editing enzyme ADAR2. Physiol Behav. 97:446-454. 
Skuse, G.R., A.J. Cappione, M. Sowden, L.J. Metheny, and H.C. Smith. 1996. The 
neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. 
Nucleic acids research. 24:478-485. 
Slavov, D., and K. Gardiner. 2002. Phylogenetic comparison of the pre-mRNA adenosine 
deaminase ADAR2 genes and transcripts: conservation and diversity in editing site 
sequence and alternative splicing patterns. Gene. 299:83-94. 
Smith, H.C., S.R. Kuo, J.W. Backus, S.G. Harris, C.E. Sparks, and J.D. Sparks. 1991. In vitro 
apolipoprotein B mRNA editing: identification of a 27S editing complex. Proc Natl Acad 
Sci U S A. 88:1489-1493. 
Sodhi, M.S., P.W. Burnet, A.J. Makoff, R.W. Kerwin, and P.J. Harrison. 2001. RNA editing of 
the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry. 6:373-379. 
Sommer, B., M. Kohler, R. Sprengel, and P.H. Seeburg. 1991. RNA editing in brain controls a 
determinant of ion flow in glutamate-gated channels. Cell. 67:11-19. 
Sowden, M., J.K. Hamm, and H.C. Smith. 1996. Overexpression of APOBEC-1 results in 
mooring sequence-dependent promiscuous RNA editing. J Biol Chem. 271:3011-3017. 
	   	   References	  
	  
	  
	  
119	  
Steffen, A., K. Rottner, J. Ehinger, M. Innocenti, G. Scita, J. Wehland, and T.E. Stradal. 2004. 
Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. The EMBO 
journal. 23:749-759. 
Stefl, R., F.C. Oberstrass, J.L. Hood, M. Jourdan, M. Zimmermann, L. Skrisovska, C. Maris, L. 
Peng, C. Hofr, R.B. Emeson, and F.H. Allain. 2010. The solution structure of the ADAR2 
dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell. 
143:225-237. 
Stefl, R., L. Skrisovska, M. Xu, R.B. Emeson, and F.H. Allain. 2005. Resonance assignments of 
the double-stranded RNA-binding domains of adenosine deaminase acting on RNA 2 
(ADAR2). J Biomol NMR. 31:71-72. 
Stefl, R., M. Xu, L. Skrisovska, R.B. Emeson, and F.H. Allain. 2006. Structure and specific 
RNA binding of ADAR2 double-stranded RNA binding motifs. Structure. 14:345-355. 
Stephens, O.M., H.Y. Yi-Brunozzi, and P.A. Beal. 2000. Analysis of the RNA-editing reaction 
of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site. 
Biochemistry. 39:12243-12251. 
Stoss, O., F.W. Schwaiger, T.A. Cooper, and S. Stamm. 1999. Alternative splicing determines 
the intracellular localization of the novel nuclear protein Nop30 and its interaction with 
the splicing factor SRp30c. J Biol Chem. 274:10951-10962. 
Streit, A.K., C. Derst, S. Wegner, U. Heinemann, R.K. Zahn, and N. Decher. 2011. RNA editing 
of Kv1.1 channels may account for reduced ictogenic potential of 4-aminopyridine in 
chronic epileptic rats. Epilepsia. 52:645-648. 
Stupp, R., M.J. van den Bent, and M.E. Hegi. 2005. Optimal role of temozolomide in the 
treatment of malignant gliomas. Curr Neurol Neurosci Rep. 5:198-206. 
Swartz, K.J. 2004. Towards a structural view of gating in potassium channels. Nature reviews. 
Neuroscience. 5:905-916. 
Tadross, M.R., I.E. Dick, and D.T. Yue. 2008. Mechanism of local and global Ca2+ sensing by 
calmodulin in complex with a Ca2+ channel. Cell. 133:1228-1240. 
Tasheva, E.S., and D.J. Roufa. 1995. Regulation of human RPS14 transcription by intronic 
antisense RNAs and ribosomal protein S14. Genes Dev. 9:304-316. 
Tian, N., Y. Yang, N. Sachsenmaier, D. Muggenhumer, J. Bi, C. Waldsich, M.F. Jantsch, and Y. 
Jin. 2011. A structural determinant required for RNA editing. Nucleic Acids Res. 
	   	   References	  
	  
	  
	  
120	  
Tomiyama, M., R. Rodriguez-Puertas, R. Cortes, A. Pazos, J.M. Palacios, and G. Mengod. 2002. 
Flip and flop splice variants of AMPA receptor subunits in the spinal cord of 
amyotrophic lateral sclerosis. Synapse. 45:245-249. 
Tonkin, L.A., L. Saccomanno, D.P. Morse, T. Brodigan, M. Krause, and B.L. Bass. 2002. RNA 
editing by ADARs is important for normal behavior in Caenorhabditis elegans. Embo J. 
21:6025-6035. 
Verbsky, J., K. Lavine, and P.W. Majerus. 2005. Disruption of the mouse inositol 1,3,4,5,6-
pentakisphosphate 2-kinase gene, associated lethality, and tissue distribution of 2-kinase 
expression. Proceedings of the National Academy of Sciences of the United States of 
America. 102:8448-8453. 
Vesely, C., S. Tauber, F.J. Sedlazeck, A. von Haeseler, and M.F. Jantsch. 2012. Adenosine 
deaminases that act on RNA induce reproducible changes in abundance and sequence of 
embryonic miRNAs. Genome research. 
Vitali, P., E. Basyuk, E. Le Meur, E. Bertrand, F. Muscatelli, J. Cavaille, and A. Huttenhofer. 
2005. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D 
small nucleolar RNAs. The Journal of cell biology. 169:745-753. 
Vollmar, W., J. Gloger, E. Berger, G. Kortenbruck, R. Kohling, E.J. Speckmann, and U. 
Musshoff. 2004. RNA editing (R/G site) and flip-flop splicing of the AMPA receptor 
subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis. 15:371-379. 
Wahlstedt, H., C. Daniel, M. Enstero, and M. Ohman. 2009a. Large-scale mRNA sequencing 
determines global regulation of RNA editing during brain development. Genome Res. 
19:978-986. 
Wahlstedt, H., C. Daniel, M. Enstero, and M. Ohman. 2009b. Large-scale mRNA sequencing 
determines global regulation of RNA editing during brain development. Genome Res. 
19:978-986. 
Wang, Q., J. Khillan, P. Gadue, and K. Nishikura. 2000a. Requirement of the RNA editing 
deaminase ADAR1 gene for embryonic erythropoiesis. Science. 290:1765-1768. 
Wang, Q., P.J. O'Brien, C.X. Chen, D.S. Cho, J.M. Murray, and K. Nishikura. 2000b. Altered G 
protein-coupling functions of RNA editing isoform and splicing variant serotonin2C 
receptors. J Neurochem. 74:1290-1300. 
	   	   References	  
	  
	  
	  
121	  
Wolf, J., A.P. Gerber, and W. Keller. 2002. tadA, an essential tRNA-specific adenosine 
deaminase from Escherichia coli. Embo J. 21:3841-3851. 
Yamanaka, S., K.S. Poksay, K.S. Arnold, and T.L. Innerarity. 1997. A novel translational 
repressor mRNA is edited extensively in livers containing tumors caused by the transgene 
expression of the apoB mRNA-editing enzyme. Genes Dev. 11:321-333. 
Yang, L., L. Zhao, Z. Gan, Z. He, J. Xu, X. Gao, X. Wang, W. Han, L. Chen, T. Xu, W. Li, and 
Y. Liu. 2010. Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis. 
Faseb J. 24:3720-3732. 
Yang, W., T.P. Chendrimada, Q. Wang, M. Higuchi, P.H. Seeburg, R. Shiekhattar, and K. 
Nishikura. 2006. Modulation of microRNA processing and expression through RNA 
editing by ADAR deaminases. Nature structural & molecular biology. 13:13-21. 
Yang, W., Q. Wang, K.L. Howell, J.T. Lee, D.S. Cho, J.M. Murray, and K. Nishikura. 2005. 
ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells. J 
Biol Chem. 280:3946-3953. 
Yi-Brunozzi, H.Y., O.M. Stephens, and P.A. Beal. 2001. Conformational changes that occur 
during an RNA-editing adenosine deamination reaction. J Biol Chem. 276:37827-37833. 
Young, P.J., C.J. DiDonato, D. Hu, R. Kothary, E.J. Androphy, and C.L. Lorson. 2002. SRp30c-
dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by 
a direct interaction with hTra2 beta 1. Hum Mol Genet. 11:577-587. 
Zhang, W., S.W. Han, D.W. McKeel, A. Goate, and J.Y. Wu. 1998. Interaction of presenilins 
with the filamin family of actin-binding proteins. The Journal of neuroscience : the 
official journal of the Society for Neuroscience. 18:914-922. 
Zhou, X., F. Tian, J. Sandzen, R. Cao, E. Flaberg, L. Szekely, Y. Cao, C. Ohlsson, M.O. Bergo, 
J. Boren, and L.M. Akyurek. 2007. Filamin B deficiency in mice results in skeletal 
malformations and impaired microvascular development. Proc Natl Acad Sci U S A. 
104:3919-3924. 
Zhu, H., R.A. Hasman, V.A. Barron, G. Luo, and H. Lou. 2006. A nuclear function of Hu 
proteins as neuron-specific alternative RNA processing regulators. Molecular biology of 
the cell. 17:5105-5114. 
 
	  
	   	   References	  
	  
	  
	  
122	  
	  
	   	   	  
 
	  
	  
123	  
ACKNOWLEGEMENT 
 
First I want to thank Dr.Michael Jantsch for giving me this project  and for all the 
arguments and discussions. 
Thanks to all the members of Jantsch lab especially Mansoureh, Silpi, Maya and 
Conny for a nice friendly atmosphere. Many thanks to Wojtek for teaching 
me so many things with incredible patience. I am really thankful to Klien 
Lab also for their cooperation. 
Many thanks to my family especially my mother and late father for there moral 
support. 
This work is dedicated to my late father.  
My thesis is mainly supported by the funding from higher education commission 
of Pakistan. 
	  
	  
	  
	  
	  
	  
	  
	  
 
 
 
	   	   	  
 
	  
	  
124	  
CURRICULUM VITAE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	  
 
	  
	  
125	  
AAMIRA TARIQ 
	  
Room#119,JosefBaumann gasse 8A, 
1220, Vienna 
aamira.tariq@univie.ac.at 
Phone 0043-69910595413 
	  
Education 
	  
2008-present : Pursuing Ph.D. at MFPL in the field of RNA biology 
	  
2003-2005 : Masters of Philosophy (GPA=4.3).from Quaid-e-Azam 
University,Islamabad and was the first position holder. 
	  
2001-2003 :  Masters in Bio-Chemistry / Molecular Biology scored 85% 
marks from Quaid-e-Azam University, Islamabad and was 
the first position holder in the subject and faculty of natural 
sciences. 
1999-2001 : Bachelor of Science (Botany, Zoology, Chemistry) from 
	  
University of the Punjab, Lahore. 
	  
1997-1999 : Higher Secondary School Certificate from Federal Board of 
	  
	  
Intermediate and Secondary Education. 
	  
	  
1995-1997 : Secondary School Certificate secured 80% marks from 
	  
Rawalpindi Board of Intermediate and Secondary Education 
	  
	  
	  
Strengths 
	  
Highly achievement oriented with a proactive attitude Proactively, I competed at the 
National level entrance test to achieve HEC scholarship for my Ph.D. studies. 
	  
Ability to study new technologies and new concepts and execute them efficiently 
I was always prompt and adept to implement the new concepts and hit the ground running. 
	  
Technical Skills 
	  
Polymerase chain reaction 
	  
Protein and mRNA expression techniques 
	  
Immunoblotting 
	  
Immunostainings 
	  
Cell culture techniques 
	   	   	  
 
	  
	  
126	  
Yeast screening establishment 
Worm based work knowhow 
FACS analysis 
Co-Immunoprecipitations 
	  
Fluorescence microscopy 
	  
Basic biochemical, immunological & molecular techniques 
	  
Computation skills includemicrosoft office and ability to use bioinformatic tools 
	  
Research Experience 
	  
Genetic Mapping Of Candidates Of Non-Syndromic Hereditary Hearing Impairment 
Genes 
A one year project was done in human molecular genetics lab under the supervision of Dr.Wasim Ahmad 
The project comprises of mapping the loci involved in non-syndromic hearing impairment genes. One of 
the most common birth defects in humans is hearing loss or deafness, which can affect as many as three 
of every 1,000 babies born. Upto 1% of the approximately 30,000 or more human genes are necessary 
for hearing. The autosomal recessive forms of deafness are generally the most severe and are most 
exclusively caused by cochlear defects (sensorineural deafness). Out of 59 known DFNB loci, most of 
recessively inherited forms of hearing impairment cause a phenotypically identical severe to profound, 
prelingual hearing loss except DFNB2-MYO7A, DFNB8/10-TMPRSS3 and DFNB16-STRC, cause a 
delayed, childhood onset hearing impairment. Until now, about 21 genes have been identified causing 
autosomal recessive deafness. Linkage in the three families was searched by using polymorphic 
microsatellite markers corresponding to candidate genes involved in related autosomal recessive non- 
syndromic deafness phenotypes. In family ‘A’ and ‘C’ linkage to all known loci was conclusively excluded, 
thus indicating the involvement of novel loci responsible for deafness in these families. In family ‘C’ 
screening of human genome with markers located on chromosome 20 led to the identification of a new 
autosomal recessive non-syndromic hearing loss locus on cytogenetic band 20q13.2-q13.32. In family ‘B’ 
linkage was established to DFNB3 locus on chromosome 17p11.2, suggesting that causative gene in this 
family is MYO15A. 
	  
Modulators of ADAR activity 
	  
Adenosine deamination catalyzed by ADARs is the most prevalent form of RNA editing, diversifying RNA 
from the genomically encoded information. Editing is most prominent in the brain. Known editing 
substrates in this tissue are the transcripts encoding glutamate receptors, serotonin 2C receptor, or 
gamma-aminobutyric acid type A receptor. Deregulation of RNA editing has been linked to diseases of 
the  central  nervous  system,  such  as  depression,  epilepsy,  schizophrenia  and  amyotrophic  lateral 
sclerosis (ALS), but  also to brain tumours. Recently, global hypoediting has been found in tumor tissues 
	   	   	  
 
	  
	  
127	  
indicating a correlation between editing and cancer. Until now much is known about function and activity 
of the enzymes, but plausible mechanisms regulating ADAR mediated editing are yet to be revealed. 
Splicing mediated generation of different ADAR isoforms is one potential regulatory mechanism at the 
transcriptional level. However, an increasing amount of evidence suggests also post-translational modes 
of regulation.To identify potential cellular modulators of ADAR activity a yeast editing assay was 
established. In this assay, an amber stop codon located in a stem loop in the 5’ region of the Ura3 gene 
can be edited into a tryptophan codon by ADAR2. Conversion of the amber codon to a tryptophan codon 
thereby allows Ura3 expression. However, addition of the drug FOA selectively kills the cells expressing 
Ura3. To identify cellular proteins that inhibit editing, a human cDNA library was transformed into the 
reporter strain. In the presence of FOA only colonies that fail to express Ura3, i.e colonies in which editing 
was inhibited could grow. 
Three candidate proteins RPS-14, SRSF9 and DDX-15 were isolated from this screen and could further 
be confirmed as inhibitors of editing in mammalian cells, proving the functionality of the developed 
screening system. 
	  
Professional Experience 
	  
I was appointed as a research associate at the Comsats institute of information technology, Department 
of bioinformatics , Islamabad as a research associate in 2005.In 2006 I was promoted as a lecturer. 
During this era I was teaching basic bioinformatics and biotechnology couses, 
	  
Presentation & Poster 
	  
Presentation at SFB RNA lecture series, 2008 
	  
	  
Presentation at University of Vienna, Newest Developments in Chromosomal Biology, SS 2011 
	  
	  
Poster presentation at EMBO 2011: Third Meeting, Vienna, Austria 
	  
	  
	  
Publications 
	  
Ø High	  throughput	  screen	  to	  identify	  inhibitors	  of	  editing,	  Tariq	  A,	  Garncarz	  W,	  Jantsch	  MF	  
(	  in	  correction	  stage)	  
Ø Isolation	  of	  enhancers	  of	  A	  to	  I	  editing.	  Garncarz	  W,	  Tariq	  A,	  Jantsch	  (	  in	  submission	  
	  
stage)	  
	  
Ø Localization	   of	   a	   novel	   autosomal	   recessive	   nonsyndromic	   hearing	   impairment	   locus	  
DFNB65	  	  	  	  	   to	  	  	  	  	   chromosome	  	  	  	  	   20q13.2-­‐q13.32.	  	  	  	  	   Aamira	  Tariq,	  	  	  	  	   Regie	  Lyn	  P.	  Santos,	  
Mohammad	  Nasim	  Khan,	  	  Kwanghyuk	  Lee,	  	  Muhammad	  Jawad	  Hassan1,	  	  Wasim	  Ahmad	  
and	  Suzanne	  M.	  Leal	  	  	  J.Mol.Med	  2006	  Jun;84(6):484-­‐90.	  Epub	  2006	  May	  4	  
	   	   	  
 
	  
	  
128	  
	  
References 
	  
Dr.	  Michael	  Jantsch	   Associate	  Professor.	  Head	  of	  department	  of	  chromosome	  biology.,	  mfpl	  
	  
Vienna,	  Austria.	  0043-­‐1-­‐427756230.michael.jantsch@univie.ac.at	  
	  
	  
	  
Dr.	  Wasim	  Ahmed	   Professor	  of	  Biochemistry,	  Quaid-­‐e-­‐Azam	  University,	  Islamabad,	  
Pakistan.	  051-­‐90643003.	  	  
ahmad115@hotmail.com	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
